US20080039700A1 - Hydration monitoring - Google Patents

Hydration monitoring Download PDF

Info

Publication number
US20080039700A1
US20080039700A1 US11/841,947 US84194707A US2008039700A1 US 20080039700 A1 US20080039700 A1 US 20080039700A1 US 84194707 A US84194707 A US 84194707A US 2008039700 A1 US2008039700 A1 US 2008039700A1
Authority
US
United States
Prior art keywords
data
probe
hydration
monitoring
data collection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/841,947
Inventor
Darrel Drinan
Carl Edman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Philometron Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/032,765 external-priority patent/US7044911B2/en
Application filed by Individual filed Critical Individual
Priority to US11/841,947 priority Critical patent/US20080039700A1/en
Publication of US20080039700A1 publication Critical patent/US20080039700A1/en
Assigned to PHILOMETRON, INC. reassignment PHILOMETRON, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: DRINAN, DARREL DEAN, EDMAN, CARL FREDERICK
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/05Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves 
    • A61B5/053Measuring electrical impedance or conductance of a portion of the body
    • A61B5/0537Measuring body composition by impedance, e.g. tissue hydration or fat content
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0002Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
    • A61B5/0015Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by features of the telemetry system
    • A61B5/0022Monitoring a patient using a global network, e.g. telephone networks, internet
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/48Other medical applications
    • A61B5/4869Determining body composition
    • A61B5/4875Hydration status, fluid retention of the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/68Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6801Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
    • A61B5/6802Sensor mounted on worn items
    • A61B5/6804Garments; Clothes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/68Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6801Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
    • A61B5/683Means for maintaining contact with the body
    • A61B5/6831Straps, bands or harnesses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/68Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6801Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
    • A61B5/683Means for maintaining contact with the body
    • A61B5/6832Means for maintaining contact with the body using adhesives
    • A61B5/6833Adhesive patches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/68Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6887Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient mounted on external non-worn devices, e.g. non-medical devices
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/60ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to nutrition control, e.g. diets
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/67ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Definitions

  • This disclosure relates to monitoring the hydration of organisms.
  • Dehydration is the excessive depletion of body water.
  • causes of acute dehydration including heat exposure, prolonged vigorous exercise, and diuretics.
  • FM 3-04.301—Aeromedical Training for Flight Personnel describes that when ambient temperature is increased above 82-84° F., sweat production by humans increases abruptly and dehydration may result.
  • Humidity can also impact sweat production and lead to dehydration. For example, with 115° F. and 10% humidity, a human can function normally with water and salt replenishment. However when humidity is 80%, the same person can become incapacitated within 30 minutes at 115° F. due to excessive depletion of body water.
  • Pulmonary edema is the extravascular accumulation of fluid in the lungs. There are a number of causes of pulmonary edema including mitral stenosis or left ventricular failure. Pulmonary edema can be associated with congestive heart failure.
  • Hyperhydration is a state in which the body includes an excessive amount of water. In patients undergoing kidney dialysis, hyperhydration may lead to hypertension and increased mortality.
  • this disclosure describes systems and techniques for monitoring the hydration of an organism. Hydration can be monitored, e.g., to identify dehydration or other disease state of the organism.
  • a device in one implementation, includes a portable hydration monitoring probe dimensioned to be continuously borne by an organism.
  • the probe includes a supply of electrical power, an electrode to exchange electrical energy from the supply with a local portion of the organism bearing the probe, a controller to generate data representing a result of the hydration monitoring, the result reflecting a local bioelectric impedance based on the exchange of electrical energy at the electrode, and a data communication device configured to wirelessly communicate the data representing the hydration monitoring result to a remote apparatus.
  • the portable hydration monitoring probe can include a patch probe.
  • Hydration can be monitored to identify a variety of disease states. Monitoring can be long term, using portable probes dimensioned to be borne by the monitored organism. The impact of skin surface temperature on hydration measurements can be considered when analyzing hydration monitoring results. Hydration monitoring results can be communicated using wireless communication links that do not hinder the mobility of ambulatory subjects.
  • FIG. 1 shows a probe for monitoring the hydration of an organism.
  • FIG. 2 shows a bioelectric impedance spectroscopy probe for monitoring the hydration of an organism.
  • FIG. 3 shows a bandage bioelectric impedance spectroscopy probe.
  • FIGS. 4A and 4B illustrate example deployments of a bioelectric impedance spectroscopy probe and a bandage probe to monitor hydration.
  • FIGS. 5 and 6 show a portable strap bioelectric impedance spectroscopy probe.
  • FIGS. 7, 8A , 8 B, 8 C, 9 A, and 9 B illustrate example deployments of a strap probe to monitor hydration.
  • FIGS. 10A and 10B show other strap bioelectric impedance spectroscopy probes.
  • FIG. 10C shows a graph of example hydration monitoring results that can be obtained using a bioelectric impedance monitor and a skin temperature thermometer.
  • FIG. 11 shows a system for monitoring the hydration of an organism.
  • FIG. 12 shows a data collection apparatus that is usable in a system for monitoring the hydration of an organism.
  • FIG. 13 shows another system for monitoring the hydration of an organism.
  • FIG. 14 shows another system for monitoring the hydration of an organism.
  • FIG. 15 shows an example of a model equivalent circuit that can be used in monitoring the hydration of an organism.
  • FIG. 16 illustrates an example deployment of multiple strap probes to monitor hydration.
  • FIG. 17 shows another system for monitoring the hydration of an organism.
  • FIG. 1 shows a probe 100 for monitoring the hydration of an organism.
  • Probe 100 includes a body 105 , an energy source 110 , and a sensing circuit 115 .
  • Body 105 can be a flexible member in that it can be contoured to follow the skin surface or other portion of an organism, such as, for example, a patch or strap.
  • Body 105 supports probe/organism interfaces 120 , 125 , 130 , 135 which apply or exchange energy with the subject and which sense energy exchange parameters in a way to measure the impedance of a region of the subject.
  • interfaces 120 , 125 130 , 135 will be electrodes adapted to exchange electrical energy with a human, although some optical element adapted to illuminate a human may also be possible.
  • two of the interfaces 120 , 125 are used to force current flow from one point on the subject to a second point on the subject.
  • the other two interfaces 130 , 135 are used to measure the voltage across two points on the subject. It may be noted that the current application points and the voltage measurement points in these embodiments can be the same, adjacent to one another, or at significantly different locations.
  • Energy source 110 can be, e.g., an optical energy source or an electric energy source.
  • energy source can be an alternating and/or direct current and/or voltage source.
  • Energy source 110 is connected to inputs 120 , 125 by leads 140 , 145 .
  • Leads 140 , 145 can conduct energy generated by source 110 for exchange with the portion of the organism coupled to main body 105 .
  • leads 140 , 145 can be electrical wires capable of carrying an electric current for exchange with the portion of the organism, or leads 140 , 145 can be optical waveguides capable of carrying light for exchange with the portion of the organism followed by main body 105 .
  • a sensing circuit 115 comprises a differential amplifier connected to electrodes 120 , 125 by leads 140 , 145 and to electrodes 130 , 135 by leads 150 , 155 .
  • Leads 140 , 145 can conduct voltage across source 110 to amplifier 115 .
  • Leads 150 , 155 can conduct voltage across electrodes 130 , 135 as another input to the amplifier 115 .
  • Amplifier 115 can sense voltages across electrodes 130 , 135 and electrodes 120 , 125 to generate one or more results 160 . It will be appreciated that amplifier 115 could be implemented as two or more amplifiers that separately sense relative voltages across any desired electrode pairs. Current sensing could also be implemented to directly measure the current output from source 110 .
  • main body 105 flexes to follow a portion of an organism and maintain inputs 120 , 125 and outputs 130 , 135 so that they can exchange energy with the followed portion.
  • Source 110 generates one or more types of energy that is conducted over leads 140 , 145 through interfaces 120 , 125 and exchanged with the followed portion of the organism.
  • interfaces 130 , 135 sense one or more energy exchange parameters from the followed portion.
  • Sensing circuit 115 generates a result 160 based on the sensed signals. Result 160 reflects, at least in part, the hydration of the monitored organism.
  • Probe 100 can generate result(s) 160 continuously or intermittently over extended periods of time.
  • result 160 can be a subset of the comparisons of the sensed parameters at interfaces 130 , 135 with the amount of energy input at inputs 120 , 125 , or result 160 can be all such comparisons.
  • result 160 can be intermittent samples of voltages from the results of continuous application of a substantially constant current.
  • result 160 can be periodic (e.g., every 5 to 30 minutes, such as every 10 minutes) results of successive, shorter duration current applications.
  • FIG. 2 shows one implementation of a probe for monitoring the hydration of an organism, namely a bioelectric impedance spectroscopy probe 200 .
  • Bioelectric impedance spectroscopy is a measurement technique in which the electrical conductivity of all or a portion of an organism is measured. When the conductivity of the entirety of an organism is measured such as by passing current from one ankle to an opposite wrist or between both hands, this can be referred to as whole body bioelectric impedance spectroscopy. When the conductivity of a portion of an organism is measured such as by a cluster of more locally placed electrodes, this can be referred to as segmental (or regional) bioelectric impedance spectroscopy. In either case, the measured electrical conductivity can reflect the hydration of the measured organism or the measured portion of the organism.
  • Bioelectric impedance spectroscopy generally involves the exchange of electrical energy with the organism.
  • the exchanged electrical energy can include both alternating current and/or voltage and direct current and/or voltage.
  • the exchanged electrical energy can include alternating currents and/or voltages that alternate at one or more frequencies.
  • the alternating currents and/or voltages can alternate at one or more frequencies between 100 Hz and 1 MHz, preferably at one or more frequencies between 5 KHz and 250 KHz.
  • Different frequencies of electrical energy can be used to measure conductivity in different portions of the organism. For example, in some organisms, lower frequency electrical energy may be conducted preferentially through tissues having fewer membranous components whereas higher frequencies may be conducted through a larger variety of tissues. In many cases, it is advantageous to make impedance measurements at two or more different frequencies in the same region. As explained further below, DC measurements can help characterize impedance over the skin surface. Thus, measurements at different frequencies made by a single probe can provide information regarding both the amount and disposition of water within a probed organism or within a probed portion of the organism.
  • bioelectric impedance spectroscopy probe 200 includes a body 205 , a current source 210 , a digital-to-analog converter 215 , an amplifier 220 , an analog-to-digital converter 225 , a memory 230 , and a controller 235 .
  • Body 205 is a flexible member that supports two working electrodes 245 , 250 and two sensing electrodes 255 , 260 .
  • Body 205 can be flexible enough to follow a portion of the human body to maintain electrodes 245 , 250 , 255 , 260 in contact with that portion.
  • the followed portion can include skin surfaces, mucosal surfaces in the mouth and/or nasal passages, and other body passages or orifices.
  • Body 205 can be sized to probe the conductivity of the entirety of an organism and thus perform whole body bioelectric impedance spectroscopy. In some advantageous embodiments described in detail herein, body 205 is sized to probe the conductivity of a portion of an organism and thus perform segmental bioelectric impedance spectroscopy.
  • Working electrodes 245 , 250 can be adapted to conduct current through or along the probed portion of the monitored organism.
  • Sensing electrodes 255 , 260 can be adapted to measure the potential of locations in the probed portion of the monitored organism.
  • Electrodes 245 , 250 , 255 , 260 are generally electrically conductive in that their electrical impedance is relatively small when compared to the electrical impedance of the monitored portion of an organism at the probed frequency.
  • electrodes 245 , 250 , 255 , 260 can include metals, sintered metallic composites, conductive polymers, gels, carbon-based materials, silicon materials, electrically conductive microneedles, conductive solutions, or combinations thereof.
  • electrodes 245 , 250 , 255 , 260 are electrically conductive adhesive gel electrodes such as the RED DOT electrodes available from 3M Corp. (St. Paul, Minn.).
  • Electrodes 245 , 250 , 255 , 260 can be supported by body 205 on the outer surface of the skin of a monitored organism. Alternatively, electrodes 245 , 250 , 255 , 260 can be supported by body 205 beneath the skin of a monitored organism. For example, electrodes 245 , 250 , 255 , 260 can be supported subdermally or electrodes 245 , 250 , 255 , 260 can be supported on transdermal elements such as microneedles that penetrate the skin. When placed on the skin surface, electrodes 245 , 250 , 255 , 260 can advantageously be each supported by body 205 at positions that are separated from one another by more than approximately ten times the thickness of the skin.
  • electrodes 245 , 250 , 255 , 260 that are above the skin can each generally be supported at positions that are separated from one another by more than 2.5 millimeters.
  • the distance between working electrodes 245 , 250 is greater than 1 cm.
  • the distance between electrodes is advantageously less than about 25 cm so that the impedance measurement is focused regionally on the subject. Such regional measurements have been found to produce useful data that can be generated and distributed with convenient apparatus.
  • working electrodes 245 , 250 are different than sensing electrodes 255 , 260 .
  • working electrodes 245 , 250 can be larger than sensing electrodes 255 , 260 and/or made from different materials.
  • Current source 210 is a source of alternating and/or direct electrical current. As deployed in probe 200 , current source 210 can drive electrical current from working electrode 245 to working electrode 250 through and/or along a monitored organism. In one implementation, current source 210 is capable of driving between 10 microamperes and 10 milliamperes, preferably between 100 microamperes and 1 milliamperes, of one or more frequencies of alternating and/or direct current through or along electrical impedances characteristic of humans. Typically, current is held at a known or measured substantially constant value, and voltage is measured to provide an impedance value. It is also possible to apply a constant voltage and measure the amount of current.
  • Digital-to-analog converter 215 can be an integrated circuit or other electronic device that converts a digital signal into a corresponding analog signal. As deployed in probe 200 , digital-to-analog converter 215 can convert digital control signals from controller 235 into analog control signals to control the output of electrical current from current source 210 .
  • Amplifier 220 can be a differential voltage amplifier in that it amplifies a voltage difference on sensing electrodes 255 , 260 . This voltage difference results from current source 210 driving electrical current from working electrode 245 to working electrode 250 through and/or along the monitored organism.
  • Analog-to-digital converter 225 can be an integrated circuit or other electronic device that converts this sensed voltage difference into a corresponding digital signal for reading by controller 235 and/or storage in memory 230 .
  • Memory 230 can be a data storage device that can retain information in machine-readable format.
  • Memory 230 can be volatile and/or nonvolatile memory.
  • memory 230 can be a RAM device, a ROM device, and/or a memory disk.
  • Controller 235 is a device that manages the generation and flow of data in probe 200 .
  • Controller 235 can be hardware configured to perform select operations or a data processing device that performs operations in accordance with the logic of a set of machine-readable instructions.
  • controller can receive information related to the management of the generation and flow of data in probe 200 via one or more input devices.
  • controller 235 can output information from probe 200 via one or more output devices.
  • Custom ASICs or gate arrays can be used, as well as commercially available microcontrollers from, for example, Texas Instruments and Motorola.
  • the operations performed by controller 235 can include regulating the timing of hydration measurements and the timing of the transmission of hydration measurement results, logic operations, signal processing, and data analysis.
  • data analysis can be used to determine the bioelectric impedance of portions of a monitored organism.
  • equivalent circuit impedance analysis in the time or frequency domain can be performed. Instructions for performing such operations can be stored in a read only memory portion of memory 230 , temporary values generated during such operations can be stored in a random access portion of memory 230 , and the results of operations can be stored in a non-volatile portion of memory 230 .
  • current source 210 drives one or more frequencies of alternating and/or direct current between working electrodes 245 , 250 and through the subject organism.
  • Amplifier 220 buffers and amplifies the potential difference between sensing electrodes 255 , 260 .
  • Analog-to-digital converter 225 converts this signal into a digital form that can be received by controller 235 for storage at memory 230 , as appropriate.
  • controller 235 may control source 210 to change the frequency and/or magnitude of current generated. The control of source 210 can be performed in light of the magnitude of the signal(s) output by amplifier 220 and/or in light of instructions received by controller 235 over one or more input devices.
  • FIG. 3 shows one implementation of a portable bioelectric impedance spectroscopy probe, namely a bandage (or “patch”) probe 300 .
  • Probe 300 can be self-powered in that main body 205 includes (in addition to electrodes 245 , 250 , 255 , 260 ) a portable power source, such as a battery 305 .
  • Probe 300 is portable in that probe 300 can be moved from a fixed location and is adapted to perform at least some of the signal generation and processing, control, and data storage functions of current source 210 , a digital-to-analog converter 215 , an amplifier 220 , an analog-to-digital converter 225 , a memory 230 , and a controller 235 without input from a fixed device.
  • probe 300 can be borne by the monitored organism.
  • Circuitry 310 can be, e.g., an application specific integrated circuit (ASIC) adapted to perform these functions.
  • Circuitry 310 can also be a data processing device and/or one or more input/output devices, such as a data communication device.
  • ASIC application specific integrated circuit
  • Main body 205 also advantageously includes an adhesive 315 .
  • Adhesive 315 can be adapted to adhere to the skin surface of the monitored organism and thereby maintain electrodes 245 , 250 , 255 , 260 in contact with the portion of an organism followed by main body 205 .
  • a portable probe 300 allows a monitored organism to be ambulatory while hydration monitoring occurs. This allows for data collection to be extended beyond periods of confinement. Thus, hydration monitoring can be continued while an organism participates in various activities at different locations, over durations suitable for identifying the onset of disease states.
  • FIGS. 4A and 4B respectively illustrate example deployments of bioelectric impedance spectroscopy probe 200 and bandage probe 300 to monitor hydration.
  • FIG. 4A shows a pair of probes 200 deployed along a steering wheel 400 so that a driver's hands will come into intermittent electrical contact with one or both of probes 200 . During this intermittent contact, the driver's hydration can be monitored.
  • FIG. 4B shows bandage probe 300 deployed to adhere to the torso of person 405 .
  • Bandage probe 300 is sized to probe the conductivity of a portion of person 405 .
  • bandage probe 300 adheres to the front chest of person 405 with one end located in the vicinity of the xiphoid process.
  • Bandage probe 300 extends axially and downward from the xiphoid process towards the lateral side of person 405 .
  • This positioning of bandage probe 300 may facilitate the monitoring of hydration in the underlying tissue and lung, as well as the identification of disease states such as pulmonary edema.
  • FIGS. 5 and 6 show another implementation of a bioelectric impedance spectroscopy probe, namely a portable strap probe 500 .
  • Main body 205 of strap probe 500 is a strap or a belt that can form a loop to encircle the body, or a portion of the body, of a monitored individual. Such an encirclement can maintain electrodes 245 , 250 , 255 , 260 in contact with the encircled portion.
  • main body 205 also includes a data communication device 505 having a transceiver 510 .
  • Data communication device 505 can be a wireless communication device that can exchange information between circuitry 310 and an external entity.
  • Wireless data link 1125 can carry information using any of a number of different signal types including electromagnetic radiation, electrical signals, or acoustic signals.
  • data communication device 505 can be a radio frequency communication device.
  • Transceiver 510 can be an assembly of components for the wireless transmission and reception of information. The components can include, e.g., an RF antenna.
  • the wireless receiver/transmitter circuitry can be made part of any embodiment described herein.
  • the two sets of sensing electrodes 255 , 260 can be used to measure hydration at different locations on a monitored individual. For example, when working electrodes 245 , 250 drive current through and/or along the surface of the encircled portion of a monitored individual, the potential differences between all sensing electrodes 255 , 260 can be used to gain information about the conduction of current in the vicinity of electrodes 255 , 260 .
  • a measurement of multiple potential differences between more than two sensing electrodes 255 , 260 can also be used, e.g., to make cross measurements and ratiometric comparisons that can be used to monitor hydration while aiding in calibration and helping to account for measurement variability such as temperature changes, changes in the position of the monitored individual, and movement of strap probe 500 over time.
  • FIGS. 7, 8A , 8 B, 9 A, and 9 B illustrate example deployments of implementations of strap probe 500 to monitor hydration in a person 405 .
  • strap probe 500 is sized to encircle the torso of person 405 and is deployed to probe the conductivity of the torso of person 405 .
  • Such a positioning of strap probe 500 may facilitate the monitoring of hydration in the underlying tissue and lung, as well as the identification of disease states such as pulmonary edema.
  • strap probe 500 is sized to encircle the thigh of person 405 and is deployed to probe the conductivity of the thigh of person 405 .
  • Such a positioning of strap probe 500 may facilitate the monitoring of hydration in the underlying tissue, as well as the identification of disease states such as acute or chronic dehydration.
  • strap probe 500 is sized to encircle the lower leg of person 405 and is deployed to probe the conductivity of the lower leg of person 405 .
  • strap probe 500 encircles the ankle, but strap probe 500 can also encircle the foot, the calf, or a toe to probe the conductivity of the lower leg.
  • Such a positioning of strap probe 500 may facilitate the monitoring of hydration in the underlying tissue, as well as the identification of disease states such as congestive heart failure where water accumulates in the lower legs.
  • strap probe 500 is sized to encircle the bicep of person 405 and is deployed to probe the conductivity of the bicep of person 405 . Such a positioning of strap probe 500 may facilitate the monitoring of hydration in the underlying tissue, as well as the identification of disease states such as acute or chronic dehydration.
  • strap probe 500 is incorporated into a pair of pants 905 and sized to encircle the torso of person 405 to probe the conductivity of the torso of person 405 . Incorporating a probe 500 into pants 905 may reduce the intrusiveness of probe 500 and help ensure that a monitored individual deploys probe 500 .
  • strap probe 500 is incorporated into a sock 910 and sized to encircle the lower leg of person 405 to probe the conductivity of the lower leg of person 405 . Incorporating a probe 500 into sock 910 may reduce the intrusiveness of probe 500 and help ensure that a monitored individual deploys probe 500 .
  • multiple probes at different locations may be used to monitor the hydration of a single individual.
  • the measurement results from the different probes can be compared and correlated for calibration and error minimization.
  • Other techniques that measure biological parameters can also be used in conjunction with single or multiple probes.
  • the biological parameter measurements can be compared and correlated with the probe measurements to calibrate the measurements and minimize the error associated with the measurements.
  • bioelectric impedance measurements made using a QUANTUM X body composition analyzer (RJL Systems, Inc., Clinton Twp., MI) and/or a Hydra 4200 bioimpedance analyzer (Xitron Technologies Inc., San Diego, Calif.) can be compared and correlated with probe measurements.
  • skin temperature measurements can be used in monitoring the hydration of an individual.
  • skin surface temperature will change with changes in blood flow in the vicinity of the skin surface of an organism. Such changes in blood flow can occur for a number of reasons, including thermal regulation, conservation of blood volume, and hormonal changes.
  • skin surface measurements are made in conjunction with hydration monitoring so that changes in apparent hydration levels, due to such changes in blood flow, can be considered.
  • one or more probes can be moved to different portions of a single individual over time to monitor the hydration of the individual.
  • a probe can monitor the hydration of an individual at a first location (e.g., the torso) for a select period (e.g., between about 1 to 14 days, or about 7 days), and then the same probe can be moved to a different location (e.g., the thigh) to monitor the hydration of the same individual for a subsequent time period.
  • a first location e.g., the torso
  • a select period e.g., between about 1 to 14 days, or about 7 days
  • a different location e.g., the thigh
  • Such movement of a probe can extend the lifespan of a probe and increase the type of information gathered by the probe. Further, movement of the probe can minimize surface adhesion loss and any decrease in hygiene associated with the monitoring.
  • a baseline measurement is a standard response to hydration monitoring.
  • the standard response can be indicative of the absence of a disease state or of the absence of progression in a disease state.
  • Changes in the baseline impedance measurements can result from changes in factors unrelated to a disease state. For example, changes in the baseline impedance measurements can result from different skin thicknesses, body compositions, or other differences between two locations. Measurements made at the different locations can be normalized to account for such differences in baseline measurements. Such a normalization can include adjustments in gain and/or adjustments in offset.
  • Gain adjustments may be based on the absolute value of the impedance measurement(s), the impedance difference(s) observed at the old and the new locations, or combinations thereof. Offset adjustments can generally be made after gain adjustments and can be based on absolute impedance values and/or other factors. Alternatively, analysis thresholds used to identify disease states can be adjusted.
  • the monitored individual may be placed in a non-ambulatory state (e.g., supine and resting) in order to acquire directly comparable baseline measurements at different locations.
  • Multiple probes need not be attached to the same organism in order to normalize baseline measurements.
  • hydration measurement results obtained using a first probe at a first location can be stored and compared with hydration measurement results obtained later using a second probe at a second location. This can be done, e.g., when the time between the collection of the results at the first location and the collection of the results at the second location is relatively short, e.g., less than 1 hr. If the replacement patch is not attached to the patient within this period, comparison of bioelectric impedance values to other calibration standards, e.g., body weight and body weight change, urine specific gravity, blood osmolality, can also be used for such comparisons.
  • bioelectric impedance values to other calibration standards, e.g., body weight and body weight change, urine specific gravity, blood osmolality, can also
  • FIG. 10A shows another implementation of a strap probe, namely a strap probe 1000 .
  • main body 205 also includes an output device 1005 .
  • Output device 1005 can be a visual display device (such as a light emitting diode or a liquid crystal display), an audio output device (such as a speaker or a whistle), or a mechanical output device (such as a vibrating element).
  • output device 1005 can present information regarding the hydration monitoring to a monitored individual.
  • the presented information can be received by output device 1005 from circuitry 310 and can indicate monitoring results and/or alerts.
  • Monitoring results can include the current hydration state of an individual as well as indications that certain disease states, such as acute dehydration, are present or imminent.
  • Monitoring alerts can include indications of current or imminent apparatus malfunction, such as loss of contact between any of electrodes 245 , 250 , 255 , 260 and the monitored individual, a lack of available memory, loss of a data communication link, or low battery levels.
  • FIG. 10B shows another implementation of a strap probe, namely a strap probe 1010 .
  • main body 205 also includes a skin temperature thermometer 1015 .
  • Thermometer 1015 can be a temperature sensing element that senses temperature in ranges encountered on the skin surface of the monitored organism.
  • Thermometer 1015 can be, e.g., a thermister, a thermocouple, a mechanical thermometer, or other temperature-sensing device. This temperature sensor can be part of any probe embodiment described herein.
  • thermometer 1015 can present information regarding skin surface temperature to circuitry 310 .
  • the presented information can be used by circuitry 310 to perform data analysis and other aspects of hydration monitoring.
  • Circuitry 310 can also transmit all or a portion of the temperature information to other devices using, e.g., data communication device 505 and transceiver 510 .
  • FIG. 10C shows a graph 1020 of example hydration monitoring results that were obtained using a bioelectric impedance monitor and a skin temperature thermometer.
  • Graph 1020 shows the observed impedance 1025 of a region on the thigh of a monitored individual as a function of skin temperature 1030 .
  • Graph 1020 includes a pair of traces 1035 , 1040 .
  • Trace 1035 shows the impedance measured with an electrical energy input signal having a frequency of 20 kHz
  • trace 1040 shows the impedance measured with an electrical energy input signal having a frequency of 100 kHz.
  • Traces 1035 , 1040 were obtained as follows.
  • Four Red Dot electrodes (3M Corp., St. Paul, Minn.) were arrayed in a linear axial fashion upon the front of a thigh of a 42 yr old male subject weighing 201.3 pounds.
  • the subject reclined in a supine position for 30 minutes in a room at ambient temperature (74° F.).
  • the bioelectric impedance of the thigh at 20 kHz and 100 kHz was then measured with the subject in the supine position.
  • the measured impedance of the thigh was 45.36 ohms at 20 kHz and 30.86 ohms at 100 kHz.
  • the skin surface temperature of the thigh was then measured using an infrared thermometer (Thermoscan, Braun GmbH, Kronberg, Germany). The measured temperature was 89.0° F. The subject then jogged six miles, taking approximately 90 minutes. The subject was then weighed. The measured weight was 197.6 pounds, indicating a loss of body water of about 3.5 pounds, or about 1.7%. The subject then returned to the supine position in the ambient temperature room. The bioelectric impedance of the thigh at 20 kHz and 100 kHz was then measured periodically, as was skin surface temperature of the thigh.
  • Traces 1035 , 1040 represent the results of these measurements. Initially, the measured bioelectric impedance at both 20 kHz and 100 kHz was lower than before jogging and the measured temperature was higher than before jogging. In other words, the measured bioelectric impedance at both 20 kHz and 100 kHz decreased as skin temperature in the vicinity of the bioelectric impedance measurement increased.
  • both the measured impedance and temperature moved in the direction of the values observed before jogging.
  • the movement showed a linear relationship between measured impedance and measured skin temperature at both 20 kHz and 100 kHz. This relationship can be used to accommodate the impact of skin surface temperature on hydration monitoring results, as discussed further below.
  • local vasodilation or vasoconstriction can be measured by other or additional methods such as with optical methods.
  • a vasodilation parameter whether measured or calculated via a temperature measurement or some other means may be used to correct absolute impedance measurements to appropriately determine impedance changes over time due to hydration changes.
  • the measured impedance of the thigh was 50.27 ohms at 20 kHz and 34.30 ohms at 100 kHz, for a net increase in impedance of 4.91 ohms (10.8%) at 20 KHz and 3.44 ohms (1.1%) at 100 KHz. Similar results have been observed with other subjects and other test conditions.
  • the measurement results in traces 1035 , 1040 can be used by circuitry 310 to perform data analysis and other aspects of hydration monitoring.
  • the impact of skin surface temperature on hydration monitoring results can be accommodated.
  • the relationship between bioelectric impedance and temperature illustrated by traces 1035 , 1040 can be used to compare hydration monitoring results obtained at different skin surface temperatures. For example, with a skin surface temperature of 90.5° F., the measured impedance at 20 kHz was 47.9 ohms.
  • the measured impedance can be adjusted by taking the difference between the two temperatures (i.e., 89° F.-90.5° F.) of ⁇ 1.5° F. and multiplying this difference by the measured dependence of impedance at 20 kHz on temperature (i.e., the slope of ⁇ 1.8052) to generate an adjustment value of 2.71 ohms.
  • the adjustment value can be added to the impedance at 20 kHz measured with a skin surface temperature of 90.5° F. (i.e., 47.9+2.71) to yield an impedance that is comparable with impedance measurements made at 20 kHz with a skin surface temperature of 89° F. (i.e., 50.6 ohms).
  • this adjusted impedance is consistent with the impedance actually measured at this skin surface temperature (i.e., 50.27 ohms).
  • bioelectric impedance measurements can be adjusted based on local skin surface temperature measurements made in the vicinity of the probe. This can improve the predictive value of impedance measurements, even relative to whole body impedance measurements where impedance measurement that reflect the electrical impedance through the entire body may not precisely correlate with temperature measurements made at one or two body locations.
  • Factors unrelated to hydration may influence local skin surface temperature measurements. These factors include the rate of convective cooling, the wind velocity, the presence of thermal insulation such as clothing, and ambient temperature gradients. Such factors that tend to influence heat exchange between the portion of the body of interest and the environment may be accounted for directly (e.g., using additional temperature or humidity sensors) or indirectly (e.g., using standard tables and known values applied to parameters such as the thickness of insulating clothing). The accounting for such factors can include adjustments to the local temperature used to compare hydration monitoring results.
  • hydration monitoring results obtained at portions of a monitored organism that have a known temperature relationship with another portion where skin surface measurement(s) are made can be adjusted based on that known relationship. Also, other factors including weight, height, age, general fitness level, degree of exertion, time of day, stage in a hormonal cycle, and gender can also be used to adjust hydration monitoring results and improve the predictive value of such results.
  • FIG. 11 shows a system 1100 for monitoring the hydration of an organism.
  • System 1100 includes one or more probes 100 along with one or more data collection apparatus 1105 , a data management system 1110 , an input/output device 1115 , and a data storage device 1120 .
  • Probe 100 includes a wireless data communication device 505 that is capable of establishing a wireless data link 1125 with data collection apparatus 1105 .
  • Wireless data link 1125 can transmit data using any of a number of different signals including electromagnetic radiation, electrical signals, and/or acoustic signals.
  • data link 1125 can be a transdermal link in that data link 1125 conducts data along a path through the skin.
  • the data communicated along wireless data link 1125 can include a probe identifier.
  • a probe identifier is information that identifies probe 100 .
  • Probe 100 can be identified, e.g., by make or model.
  • Probe 100 can also be identified by a unique identifier that is associated with a single individual probe 100 .
  • the probe identifier can include a serial number or code that is subsequently associated with data collected by probe 100 to identify that this data was collected by probe 100 .
  • each individual electrode, or a patch or strap containing a set of electrodes incorporates an integrated circuit memory having a stored unique or quasi-unique electrode/patch identifier.
  • An interface between the patch or electrodes and the communication device 505 can be implemented so that the communication device 505 can send electrode or patch identifiers as well as a separate identifier for the other electronics coupled to the patch. In this way, different parts of the probe can be separately replaced, while still allowing complete tracking of the physical data generation, analysis, and communication apparatus used to gather all impedance data.
  • the data communicated along wireless data link 1125 can also include messages to probe 100 .
  • Example messages include commands to change measurement and/or data analysis parameters and queries regarding the status and/or operational capabilities of the probe.
  • Data communication along wireless data link 1125 can also include information related to the initialization and activation of probe 100 .
  • Initialization can include the communication of a probe identifier to data collection apparatus 1105 .
  • Initialization can also include the commencement of measurement activities including, e.g. the start of an internal clock that regulates the timing of hydration measurements and the transmission of hydration measurement results. Such data communication can be conducted as an ongoing dialogue with data collection apparatus 1105 .
  • Data collection apparatus 1105 is a device that generally supplements probe 100 by including components and/or features that complement the components and/or features of probe 100 .
  • such components or features may be too large, too memory intensive, require too sophisticated data processing, and/or only be used too intermittently to be included on probe 100 .
  • FIG. 12 shows one implementation of a data collection apparatus 1105 .
  • Data collection apparatus 1105 can be a portable device in that data collection apparatus 1105 can be moved from a fixed location and perform at least some functions without input from a fixed device.
  • data collection apparatus 1105 can be a handheld device that can be borne by a monitored individual.
  • Data collection apparatus 1105 includes a local user input portion 1205 , a local user output portion 1210 , a wireless data communication portion 1215 , and a wired data communication portion 1217 all arranged on a body 1220 .
  • Local user input portion 1205 includes one or more components that receive visual, audio, and/or mechanical input from a user in the vicinity of data collection apparatus 1105 .
  • local user input portion 1205 can include a keypad 1225 and a mode selection button 1230 .
  • Keypad 1225 can receive alphanumeric input from a user.
  • Mode selection button 1230 can receive an operational mode selection from a user. The operational modes of data collection apparatus 1105 are discussed further below.
  • Local user output portion 1210 includes one or more components that provide visual, audio, and/or mechanical output to a user in the vicinity of data collection apparatus 1105 .
  • local user output portion 1210 can include a display panel 1235 .
  • Display panel 1235 can be, e.g., a liquid crystal display screen.
  • Display panel 1235 includes various regions that display specific information to a local user.
  • display panel 1235 includes a battery charge display region 1240 , an operational mode display region 1245 , a time/date display region 1250 , a measurement result display region 1255 , and an alert display region 1260 .
  • Battery charge display region 1240 includes a graphical device that indicates the charge remaining on a battery or other power element that powers data collection apparatus 1105 .
  • Operational mode display region 1245 includes a text list of the various operational modes of data collection apparatus 1105 .
  • the listed operational modes include a test mode, a set-up mode, a synchronization mode, and a measurement mode.
  • the text indicating measurement mode (i.e., “MEAS”) includes an indicium 1265 that indicates that the current operational mode of data collection apparatus 1105 is the measurement mode.
  • Time/date display region 1250 includes text indicating the current time and date.
  • Measurement result display region 1255 includes text and/or graphical elements that indicate the result(s) of a hydration measurement made by one or more probes 100 .
  • Alert display region 1260 includes a text and/or graphical warning that the probe measurement results are indicative of one or more disease states being present or imminent. Alert display region 1260 can also indicate that a malfunction of probe 100 and/or data collection apparatus 11
  • Wireless data communication portion 1215 can include a first wireless communication transceiver 1265 and a second wireless communication transceiver 1270 .
  • Transceivers 1265 , 1270 can be separate devices or transceivers 1265 , 1270 can include common components for the wireless communication of data.
  • transceivers 1265 , 1270 can each include a separate RF antenna.
  • Transceivers 1265 , 1270 can be dedicated to the exchange of data with a particular device, or a particular class of devices.
  • transceiver 1265 can be dedicated to the exchange of data with one or more probes 100 over one or more wireless data links 1125
  • transceiver 1270 can be capable of exchanging data with other data collection apparatus and/or with one or more data management systems 1110 .
  • Transceivers 1265 , 1270 can function with cellular communication networks, alpha-numeric paging networks, WiFi or other systems for the wireless exchange of data.
  • Wired data communication portion 1217 can include one or more connector ports 1274 adapted to receive a plug or other terminal on one or more wired data links.
  • the wired data links can be capable of exchanging data with other data collection apparatus and/or with one or more data management systems 1110 .
  • the wired data link can be an optical data link and/or an electrical data link.
  • Electrical data links can be analog or digital.
  • the data links can operate in accordance with data communication protocols such as the TCP/IP suite of communications protocols.
  • Body 1220 can be sealed to isolate electrical and other components (not shown) that perform operations such as driving portions 1205 , 1210 , 1215 , 1217 from the ambient environment.
  • Body 1220 can be sized and the components selected to allow data collection apparatus 1105 to be self-powered by an internal power supply (not shown).
  • data collection apparatus 1105 can be powered by an internal rechargeable battery.
  • the components can be, e.g., data storage devices, data processing devices, data communication devices, and driving circuitry for managing the input and output of data from data collection apparatus 1105 .
  • Body 1220 can be designed to operate as an independent unit as shown or body 1220 can be designed to integrate with separate communication devices.
  • body 1220 can be designed to integrate with a cellular phone or personal data assistant to form all or a portion of wireless data communication portion 1215 .
  • system 1100 can include a wired data link 1130 and/or a wireless data link 1135 for the exchange of data between data collection apparatus 1105 and data management system 1110 .
  • Wired data link 1130 can terminate at a connector port 1274 on data collection apparatus 1105
  • wireless data link 1135 can terminate at transceiver 1270 on data collection apparatus 1105 .
  • Wireless data link 1125 , wired data link 1130 and wireless data link 1135 can exchange data in accordance with one or more communication protocols.
  • the communication protocols can determine the format of the transmitted information and the physical characteristics of the transmission.
  • Communication protocols can also determine data transfer mechanisms such as synchronization mechanisms, handshake mechanisms, and repetition rates.
  • the data structures of the protocol may impact the rate of data transfer using the protocol.
  • Data can be organized in blocks or packets and transmissions can be made at specified intervals.
  • a transmission block can include synchronization bits, an address field that includes information identifying the data source, a data field containing the hydration monitoring data, and a checksum field for testing data integrity at the receiver.
  • the length of a data block can vary, e.g., to reduce power consumption and increase device lifetime. The same data can be transmitted multiple times to ensure reception.
  • exchanged data is organized in packets that include four sections, namely, a header section, a 64 bit address section that includes a probe identifier identifying a probe 100 (and/or an electrode or electrode set identifier), an encrypted data section, and a check-sum or error correction section.
  • the data section can be encrypted using an algorithm that relies upon the address section.
  • Probe 100 , data collection apparatus 1105 , and data management system 1110 can all confirm a successful exchange of data using a confirmation such as an electronic handshake.
  • An unsuccessful exchange of data can be denoted by transmission of an error message, which can be responded to by a retransmission of the unsuccessfully exchanged data.
  • probe 100 , data collection apparatus 1105 , and data management system 1110 can exchange data at a number of different frequencies. For example, when system 1100 includes multiple data collection apparatus 1105 , each data collection apparatus 1105 can transmit data over wireless data link 1135 using a different frequency carrier. As another example, when system 1100 includes multiple probes 100 , each probe 100 can transmit data over wireless data link 1125 using a different frequency carrier. It will be appreciated that a variety of multiple access techniques such as time or code division, could be alternatively used.
  • the data communicated along wireless data link 1125 , wired data link 1130 , and wireless data link 1135 can be encrypted in whole or in part.
  • the encryption can be symmetric or asymmetric.
  • the encryption can rely upon encryption keys based on the probe identifier or on alphanumeric codes transmitted with the encrypted data.
  • the encryption may be intended to be decrypted by a specific probe 100 , a specific data collection apparatus 1105 , or a specific data management system 1110 .
  • data communicated along wired data link 1130 is encrypted using 128 bit encryption at the SSL layer of the TCP/IP protocol.
  • GSM global system for mobile communications
  • IP internet protocol
  • wireless link 1125 is a spread-spectrum RF signal at wireless medical band frequencies such as the Medical Implant Communications Service (MICS) (400-406 MHz) or the Wireless Medical Telemetry Service (WMTS) (609-613 MHz and 1390-1395 MHz).
  • wireless medical band frequencies such as the Medical Implant Communications Service (MICS) (400-406 MHz) or the Wireless Medical Telemetry Service (WMTS) (609-613 MHz and 1390-1395 MHz).
  • MIMS Medical Implant Communications Service
  • WMTS Wireless Medical Telemetry Service
  • Data management system 1110 is a data processing device that conducts operations with the data collected by probe 100 that relates to hydration of the organism.
  • the operations can be conducted in accordance with the logic of instructions stored in machine-readable format.
  • the conducted operations can include the processing of such data, the display of such data, and the storage of such data.
  • Data management system 1110 can be remote from data collection apparatus 1105 in that data management system 1110 need not be part of a local data communication network that includes data collection apparatus 1105 .
  • data management system 1110 can be a data processing apparatus that is accessible by one or more medical personnel.
  • the processing of data by data management system 1110 can include data analysis to identify disease states in monitored organisms or problems with the monitoring.
  • data management system 1110 can perform impedance analysis using model equivalent circuits to determine hydration levels at different locations in a monitored organism.
  • the display of data by data management system 1110 can include the rendition of the results of hydration monitoring on one or more input/output devices 1115 .
  • Input/output device 1115 can include visual, auditory, and/or tactile display elements that can communicate information to a human user (such as medical personnel).
  • input/output device 1115 can include a monitor, a speaker, and/or a Braille output device.
  • Input/output device 1115 can also include visual, auditory, and/or tactile input elements such as a keyboard, a mouse, a microphone, and/or a camera. Input/output device 1115 can thus render visual, auditory, and/or tactile results to a human user and then receive visual, auditory, and/or tactile input from the user.
  • the storage of data by data management system 1110 can include the storage of the results of hydration monitoring on one or more data storage devices 1120 that retain information in machine-readable format.
  • Data storage devices 1120 can include volatile and/or nonvolatile memory.
  • data storage devices 1120 can be a RAM device, a ROM device, and/or a memory disk.
  • all or some of the constituent components of system 1100 can operate in one or more operational stages. For example, during a test stage, the constituent components of system 1100 can test themselves to determine that they are functional. For example, probe 100 and data collection apparatus 1105 can confirm that they are capable of exchanging data along link 1125 , and data collection apparatus 1105 and data management system 1110 can confirm that they are capable of exchanging data along one or more of links 1130 , 1135 . As another example, probe 100 can confirm that inputs 120 , 125 and outputs 130 , 135 are properly positioned relative to a monitored organism.
  • probe 100 can confirm that electrodes 245 , 250 , 255 , 260 are in electrical contact with the followed portion of the monitored organism.
  • a probe 100 can determine the baseline measurement result for a given hydration level in a portion of a monitored organism and adjust monitoring parameters accordingly.
  • the input signal level can be increased to accommodate dry skin and high transdermal impedances.
  • Data collection apparatus 1105 can receive user input over one or more of local user input portion 1205 , wireless data communication portion 1215 , and wired data communication portion 1217 .
  • the received input can identify monitoring parameters that are to be adjusted, such as the level at which an alert is to be sounded at probe 100 and/or data collection apparatus 1105 .
  • Data management system 1110 can also receive user input relating to the arrangement of monitoring parameters.
  • data management system 1110 can receive input from medical personnel over input/output device 1115 indicating that hydration measurement results are to be transmitted by probe 100 to data collection apparatus over link 1125 once every four hours. This timing parameter can be relayed from data management system 1110 over link 1130 to data collection apparatus 1105 which relays the timing parameter over wireless link 1125 to probe 100 .
  • Parameters relating to the communication of information over one or more of links 1125 , 1130 , 1135 can also be arranged during a setup stage.
  • the constituent components of system 1100 can select communication protocols or parameters for communication protocols.
  • clocks in two or more of probe 100 , data collection apparatus 1105 , and data management system 1110 are synchronized to enable synchronous data transmission along one or more of links 1125 , 1130 , 1135 .
  • data collection apparatus 1105 transmits synchronization characters to data management system 1110 over wired data link 1130 .
  • Data management system 1110 can receive the synchronization characters and compares the received characters with a synchronization pattern. When the received characters correspond sufficiently with the synchronization pattern, data management system 1110 can exit the synchronization stage and exchange other data synchronously with data collection apparatus 1105 over link 1130 . Such a synchronization process can be repeated periodically.
  • data collection apparatus 1105 can receive and/or display a serial number or other identifier of a synchronized probe 100 .
  • one or more probes 100 can collect data relating to the hydration of one or more monitored individuals.
  • the probes 100 can perform data processing on the collected data, including bioelectric impedance data analysis, filtering, and, event identification.
  • the probes 100 can transmit data relating to the hydration monitoring (including results of processing and analyzing collected data) to one or more data collection apparatus 1105 .
  • the transmitted data can include a probe identifier that identifies the transmitting probe 100 .
  • the transmitted data can be encrypted.
  • Data collection apparatus 1105 can receive the data transmitted from probe 100 and update local user output portion 1210 based on the received data.
  • the updating can include indicating, in operational mode display region 1245 , that probe 100 is monitoring hydration, displaying, in measurement result display region 1255 , recent monitoring results, and generating, in alert display region 1260 , an alert to a user who is local to data collection apparatus 1105 .
  • the alert can indicate, e.g., that a monitored individual is suffering from one or more disease states or that monitoring has somehow become impaired.
  • Data collection apparatus 1105 can also command one or more probes 100 to transmit data relating to the hydration monitoring over link 1125 .
  • data collection apparatus 1105 can transmit a query to probe 100 .
  • the query can request that probe 100 provide information regarding some aspect of the hydration monitoring.
  • a query can request that probe 100 transmit a confirmation that hydration monitoring is occurring over link 1125
  • a query can request that probe 100 transmit a recent measurement result over link 1125
  • a query can request that probe 100 transmit one or more events of a particular character over link 1125 .
  • Data collection apparatus 1105 can transmit queries to probe 100 periodically, e.g., every hour or two.
  • Data collection apparatus 1105 can also relay some or all of the data transmitted from probe 100 to data management system 1110 .
  • the data can be relayed over one or more data links 1130 , 1135 .
  • Data collection apparatus 1105 can relay such data directly, i.e., without performing additional analysis on the information, or data collection apparatus 1105 can perform additional processing on such before relaying a subset of the data to data management system 1110 .
  • Data collection apparatus 1105 can notify a local user that data has been relayed by displaying a data relay notice on local user output portion 1210 . Alternatively, data can be relayed by data collection apparatus 1105 without notification to a local user.
  • Data collection apparatus 1105 can also receive user input over one or more of local user input portion 1205 , wireless data communication portion 1215 , and wired data communication portion 1217 .
  • the received input can identify that data collection apparatus 1105 is to transmit data to one or more probes 100 over link 1125 .
  • the received input can identify that data collection apparatus 1105 is to instruct probe 100 to generate an alarm signal indicating that a monitored person suffers under a disease state.
  • the received input can identify that data collection apparatus 1105 is to transmit a query to a probe 100 over wireless link 1125 .
  • the received input can identify that data collection apparatus 1105 is to transmit an instruction instructing probe 100 to change a parameter of the hydration monitoring, including one or more threshold values for identifying a disease state.
  • Data collection apparatus 1105 can also perform data processing and storage activities that supplement the data processing and storage activities of probe 100 .
  • data collection apparatus 1105 can perform more extended data analysis and storage, including signal processing and analysis.
  • data collection apparatus 1105 can perform impedance analysis using model equivalent circuits to determine hydration levels at different locations in a monitored organism.
  • data collection apparatus 1105 can perform trending analyses that identify a general tendency of hydration levels to change over extended periods of time, or data collection apparatus 1105 can perform comparisons between hydration levels obtained using multiple probes 100 .
  • the multiple probes 100 can monitor the hydration of a single organism, or the multiple probes can monitor the hydration of multiple organisms.
  • Data collection apparatus 1105 can compare and correlate monitoring results from multiple probes to calibrate one or more probe 100 and minimize errors during monitoring.
  • Data collection apparatus 1105 can also compare and/or correlate the results of hydration monitoring with the results of monitoring other biological parameters. For example, data collection apparatus 1105 can compare and correlate the results of hydration monitoring with the results of heart monitoring, drug delivery schedules, and temperature monitoring. Data collection apparatus 1105 can receive the other monitoring results over one or more of local user input portion 1205 , wireless data communication portion 1215 , and wired data communication portion 1217 . For example, data collection apparatus 1105 can receive the other monitoring results over one or more of links 1125 , 1130 , 1135 .
  • Data collection apparatus 1105 can also exchange data with other devices and systems (not shown in FIG. 11 ). For example, data collection apparatus 1105 can receive other monitoring results directly from other monitoring instruments. As another example, data collection apparatus 1105 can transmit data relating to the results of hydration monitoring to other local or remote parties.
  • the other parties can be external entities in that they do not share a legal interest in any of the constituent components of system 1100 .
  • the other parties can be a medical group that has contracted with an owner of system 1100 to monitor hydration of an individual.
  • Data management system 1110 can receive the results of hydration monitoring from data collection apparatus 1105 over one or both of data link 1130 , 1135 .
  • the received results can include analyses of the hydration of an organism, as well as comparisons and correlations of monitoring results from multiple organisms or other biological parameters.
  • Data management system 1110 can conduct operations with the received data, including processing the data to identify disease states and problems with the monitoring. For example, data management system 1110 can perform impedance analysis using model equivalent circuits to determine hydration levels at different locations in a monitored organism. As another example, data management system 1110 can perform trending analyses that identifies a general tendency of hydration levels to change over extended periods of time, or data management system 1110 can perform comparisons between hydration levels obtained using multiple probes 100 . The multiple probes 100 can monitor the hydration of a single organism, or the multiple probes can monitor the hydration of multiple organisms. Data management system 1110 can compare and correlate monitoring results from multiple probes to calibrate one or more probe 100 and minimize errors during monitoring. Data management system 1110 can also perform analyses that require hydration monitoring results from statistically significant numbers of organisms. Such analyses can include billing assessments, geographic assessments, epidemiological assessments, etiological assessments, and demographic assessments.
  • Data management system 1110 can render the results of hydration monitoring on one or more input/output devices 1115 and store the results of hydration monitoring on one or more data storage devices 1120 .
  • Data management system 1110 can also provide the results of the data processing to data collection apparatus 1105 and/or probe 100 over data links 1125 , 1130 , 1135 .
  • the provided results can include an indication that a disease state is present and/or an indication that probe 100 should generate an alarm signal indicating that a monitored organism suffers under a disease state.
  • Data management system 1110 can also provide such indications to external entities, including medical personnel interacting with input/output device 1115 and medical personnel in the vicinity of the monitored organism.
  • an emergency medical technician can be informed that a monitored individual in the EMT's vicinity suffers from acute dehydration.
  • data management system 1110 can also post an indication in an external system such as the clinical information system of a healthcare organization or an Internet portal.
  • data management system 1110 can request, from data collection apparatus 1105 and/or probe 100 , that additional monitoring activities be performed.
  • the request can be spurred by the results of analyses performed at data collection apparatus 1105 and/or the analyses performed at data management system 1110 .
  • the request can also be spurred by a human user such as medical personnel interacting with input/output device 1115 .
  • the requests can be based on the results of hydration monitoring.
  • the additional monitoring activities can be directed to other biological parameters, or the additional monitoring activities can be directed to gaining more information about the hydration of the monitored individual.
  • data management system 1110 can identify surveys and/or survey questions that are to be presented to a monitored organism to facilitate hydration monitoring.
  • a survey is a series of questions designed to gather information about the hydration of a monitored organism.
  • a survey is generally presented to a monitored organism, but a survey can also be presented to individuals having contact with the monitored organism.
  • a survey can be presented, e.g., over a telephone or through the mail.
  • Survey and survey questions can be generated before monitoring begins and stored, e.g., at probe 100 , data collection apparatus 1105 , and/or data management system 1110 .
  • Survey questions can be directed to ascertaining, e.g., body position of a monitored organism, length of time that the monitored organism has been in one position, the diet of the monitored organism, the activity level of the monitored organism, or the time zone of the monitored organism.
  • Example survey questions include “Are you currently exercising?”, “Did you remove the probe?”, and “Have you recently taken a diuretic?”
  • the questions presented during a survey can depend upon the responses to previous questions. For example, if a monitored individual has removed probe 100 , subsequent questions can be deleted.
  • Responses to the questions in the survey can be received using, e.g., an interactive voice recognition system (IVRS) or keypad entry on a touch tone phone.
  • Data management system 1110 can present the survey itself or data management system 1110 can direct another system to present the survey.
  • the responses to survey questions can be scored based upon a predetermined criteria set and used in further analyses in hydration monitoring.
  • FIG. 13 shows another implementation of a system for monitoring the hydration of an organism, namely a system 1300 .
  • system 1300 includes a collection of multiple probes 100 , 1305 , 1310 , 1315 .
  • probes 100 , 1305 , 1310 , 1315 form a data “hopping” network 1317 in which data can be transferred amongst probes 100 , 1305 , 1310 , 1315 .
  • probe 1305 exchanges data with probe 100 over a wireless data link 1320 .
  • Probe 1310 exchanges data with probe 1305 over a wireless data link 1325 .
  • Probe 1315 exchanges data with probe 1310 over a wireless data link 1330 .
  • the data exchanged amongst probes 100 , 1305 , 1310 , 1315 over data links 1320 , 1325 , 1330 can include hydration monitoring results, biological parameter monitoring results, queries, parameter change commands, encryption keys, probe identifiers, handshakes, surveys, and other information.
  • Such a “hopping” network 1317 may extend the range and robustness of data communication in system 1300 .
  • FIG. 14 shows another implementation of a system for monitoring the hydration of an organism, namely a system 1400 .
  • system 1400 includes a pharmaceutical dispenser 1405 .
  • Pharmaceutical dispenser 1405 is a device that provides compositions for ameliorating a disease state of an individual. Pharmaceutical dispenser 1405 can provide such a composition to an individual automatically (i.e., without human intervention) or pharmaceutical dispenser 1405 can provide such a composition in conjunction with the efforts of one or more individuals.
  • pharmaceutical dispenser 1405 can be an implanted controlled-release drug delivery device or pharmaceutical dispenser 1405 can be a pill dispenser that is accessible by a monitored individual or by medical personnel.
  • Pharmaceutical dispenser 1405 includes a communications element 1410 .
  • Communications element 1410 can place dispenser 1405 in data communication with the constitutent components of system 1400 .
  • communications element 1410 can establish a wireless data link 1415 between dispenser 1405 and data collection apparatus 1105 .
  • pharmaceutical dispenser 1405 can receive data such as dispensation instructions from the constitutent components over communications element 1410 .
  • data such as dispensation instructions
  • pharmaceutical dispenser 1405 can receive instructions over element 1410 that instruct dispenser 1405 to provide a composition to the monitored individual that ameliorates the identified disease state.
  • pharmaceutical dispenser 1405 can provide a composition for ameliorating a disease state to the monitored individual.
  • pharmaceutical dispenser 1405 can release a drug into the monitored individual's body or pharmaceutical dispenser 1405 can prepare a dosage of medicine for the monitored individual.
  • the dispensation of a composition by pharmaceutical dispenser 1405 can be recorded at one or more memory devices in system 1400 , e.g., for use in analyzing the results of hydration monitoring.
  • FIG. 15 shows an example of a model equivalent circuit 1500 that can be used in monitoring the hydration of an organism.
  • model equivalent circuit 1500 that can be used to model the electrical conductivity of an organism.
  • Circuit 1500 models the impedances observed in bioelectric impedance spectroscopy using a probe 200 that supports electrodes 245 , 250 , 255 , 260 above a skin surface 1505 of an organism 1510 .
  • Model circuit 1500 includes a series of surface impedances 1515 , 1520 , 1525 , a series of transdermal impedances 1530 , 1535 , 1540 , 1545 , and a series of subdermal impedances 1550 , 1555 , 1560 .
  • Surface impedances 1515 , 1520 , 1525 can model the surface electrical impedances between the relevant of electrodes 245 , 250 , 255 , 260 .
  • Surface impedances 1515 , 1520 , 1525 can model both the conductivity through the surface of the skin and the conductivity through sweat and other conducting fluids on the surface of the skin.
  • surface impedances 1515 , 1520 , 1525 are modeled as non-reactive (i.e., resistive) elements.
  • Transdermal impedances 1530 , 1535 , 1540 , 1545 can model the electrical impedances through the skin of a monitored organism.
  • Transdermal impedance 1530 includes a resistive component 1565 and a reactive component 1570 .
  • Transdermal impedance 1535 includes a resistive component 1575 and a reactive component 1580 .
  • Transdermal impedance 1540 includes a resistive component 1585 and a reactive component 1590 .
  • Transdermal impedance 1545 includes a resistive component 1595 and a reactive component 1597 .
  • Reactive components 1570 , 1580 , 1590 , 1597 can model the electrical impedance through dense cellular layers as a capacitive element, whereas resistive components 1565 , 1575 , 1585 , 1595 can model the electrical impedance through hydrated and other portions of the skin as a resistive element.
  • Subdermal impedances 1550 , 1555 , 1560 can model electrical impedances through a monitored organism.
  • subdermal impedances 1550 , 1555 , 1560 can model the electrical impedances of a portion of the monitored organism as a resistive volume conductor bounded by the skin.
  • probe 200 supports electrodes 245 , 250 , 255 , 260 above skin surface 1505 .
  • Current source 210 can drive electrical current between electrodes 245 , 250 .
  • the driven current can include both direct current and alternating current components.
  • the potential at electrodes 245 , 250 , 255 , 260 provides information about the net impedance across equivalent circuit 1500 as well as the impedance of different paths across equivalent circuit 1500 .
  • Potential measurements at electrodes 245 , 250 , 255 , 260 can be used to estimate impedances 1515 , 1520 , 1525 , 1530 , 1535 , 1540 , 1545 , 1550 , 1555 , 1560 .
  • Such estimations can be made in light of the estimations of surface impedances 1515 , 1520 , 1525 made using direct current.
  • model circuit 1500 The impact of various factors on the electrical conductivity of an organism can be accommodated by changing the mathematical analysis of model circuit 1500 or by changing aspects of data collection.
  • the measured potentials at electrodes 245 , 250 , 255 , 260 can be mathematically corrected to accommodate the lowered conductivity.
  • previously obtained surface impedance estimates can be used to estimate the effect that changes in surface impedances 1515 , 1520 , and 1525 have on the total impedance measurement, and thus isolate the change in sub-dermal impedance so as to more accurately monitor changes in subdermal tissue hydration.
  • bioelectric spectroscopy measurements can be delayed altogether or probe 200 can output an indication to a monitored individual that the individual should dry the measurement region.
  • Model equivalent circuit 1500 can be used in conjunction with custom approaches to data analysis for monitoring the hydration of an organism. Such data analysis approaches can be used to interpret monitoring data and to identify changes in the amount and distribution of water in a monitored organism. Data analysis approaches can also be used to incorporate results of other bioparameter measurements and responses to survey questions into the hydration monitoring.
  • Data analysis approaches can be performed in accordance with the logic of a set of machine-readable instructions.
  • the instructions can be tangibly embodied in machine-readable format on an information carrier, such as a data storage disk or other memory device.
  • the instructions can also be embodied in whole or in part in hardware such as microelectronic circuitry.
  • Data analysis approaches can yield analysis results that can be displayed to a human user.
  • the human user can be the monitored individual or another individual, such as a medical professional.
  • the analysis results can be displayed in response to a prompt from the user or automatically, i.e., without user input.
  • the analysis results can be displayed automatically when hydration indicative of a disease state is identified.
  • hydration monitoring is performed using a system 1100
  • analysis results can be displayed at a probe 100 , at a data collection apparatus 1105 , and/or at a data management system 1110 ( FIGS. 11, 13 , 14 ).
  • Analysis results can be displayed using other output devices such as the postal service, facsimile transmission, voice messages over a wired or wireless telephone network, and/or the Internet or other network-based communication modalities.
  • Data analysis can be performed continuously or intermittently over extended periods of time.
  • the analyzed data can be measurement results collected continuously or intermittently.
  • the analyzed data can be a subset of the data collected or the analyzed data can be all of the data collected.
  • the analyzed data can be intermittent samples redacted from the results of continuous hydration monitoring.
  • the monitoring can be long term in that diurnal, monthly, or other variations in hydration that are not associated with disease states can identified.
  • the monitoring can be individualized in that the analysis results are relevant to a specific monitored organism.
  • Data analysis can accommodate both long and short term variations in hydration that are not associated with disease states by reducing the effect of such variation on analysis.
  • data analysis can accommodate variations associated with respiration and other types of movement.
  • peak/trough analysis and/or frequency analysis of hydration monitoring results obtained from the chest can be used to determine the breathing period. This can be done, e.g., by identifying the rate of change between discrete data points in the measurement results. Once the breathing period is identified, specific measurement results (such as those associated with exhalation) can be identified and relied upon in subsequent analyses.
  • data analysis can accommodate diurnal or monthly variations. Such variations can be identified by peak/trough analysis and/or frequency analysis of longer term measurement results. For example, specific measurement results (such as those associated with exhalation) can be used to identify any reproducible diurnal and/or monthly variability in hydration. Such variability can be accommodated in subsequent measurement results by subtraction of the prior variability or other adjustment approaches.
  • the diurnal pattern of hydration monitoring results may indicate that there is a significant likelihood of a 3% decrease in a bioelectric impedance value for a specific organism in the late afternoon relative to early morning. Hydration measurement results obtained at either time may be adjusted or modified by interpolation to reflect the decrease. Such adjustments can be made to account for predictable or habitual patterns such as, e.g., daily exercise routines or eating/drinking habits.
  • patterned times can be identified, for example, by determining the rate of change in hydration monitoring results.
  • patterned times can be used in conjunction with measurement results obtained with a known hydration status (e.g., the monitored individual is “dry” and unaffected by pulmonary edema) to adjust decision criteria and other analysis parameters.
  • Data analysis of hydration monitoring results can be used to establish a baseline of typical hydration characteristics so that deviations from the baseline, e.g., in response to disease states or other stresses, can be identified.
  • the baseline of typical hydration characteristics can be individualized and relevant to a specific monitored organism, or the baseline of typical hydration can reflect the average hydration of a population of individuals.
  • extended monitoring results can be analyzed to establish a population database of tolerances and ranges for the identification of individual disease states, deviations, and/or anomalies, as well as population trends (as discussed further below).
  • Such a baseline can be obtained for healthy and/or diseased populations with a variety of demographic characteristics.
  • transient periodic hydration monitoring of an individual is less likely to detect individual variations, deviations, or anomalies and does not contribute to the establishment of a population database.
  • Data analysis can include the analysis of subsets of the total hydration monitoring results.
  • the analyzed subsets can have common characteristics that distinguish the subsets from unanalyzed hydration monitoring results.
  • the analyzed subsets can have high signal-to-noise ratios
  • analyzed subsets can be obtained under dry conditions (e.g., when surface impedances 1515 , 1520 , 1525 ( FIG. 15 ) are relatively high)
  • analyzed subsets can be obtained when good contact is maintained between a monitored organism and inputs 120 , 125 and outputs 130 , 135 ( FIG. 1 ), or analyzed subsets can be obtained at the same time of day.
  • Data analysis operations can be performed at one or more of probe 100 , data collection apparatus 1105 , and/or data management system 1110 .
  • data analysis is distributed between probe 100 and data collection apparatus 1105 .
  • probe 100 can perform initial analyses, including signal processing, noise filtering, and data averaging operations.
  • the operations can be performed on data from one or more measurements taken at one or more frequencies.
  • the operations can be performed on raw data or on data where variations have been accommodated. For example, the operations can be performed on data collected at certain points during breathing.
  • These initial analysis results can be transmitted, along with other information such as a probe identifier and a time/date stamp, to data collection apparatus 1105 .
  • data analysis operations can include the identification of trends or shifts in hydration associated with disease states such as pulmonary edema, as well as comparisons between received data and threshold values.
  • data analysis operations are performed primarily at data collection apparatus 1105 and data analysis at probe 100 is minimal.
  • data analysis at probe 100 is minimal, data analysis and data storage can be consolidated at data collection apparatus 1105 and probe 100 can include simplified circuitry with reduced power requirements and cost.
  • Data analysis can also be performed at data management system 1110 .
  • Such data analysis can include multivariable analysis where hydration monitoring results are analyzed in light of other statistical variables such as weight, heart rate, respiration, time of day, month, eating patterns, physical activity levels, and other variables. The other statistical variables need not be entirely independent of the hydration monitoring results.
  • the hydration monitoring results used in multivariable analysis can be obtained over extended periods (e.g., days, weeks, or months) from one or more organisms. The results of such multivariable analysis can be used to develop new and improved analyses of hydration monitoring results, including improved algorithms, improved pattern definition techniques, and/or artificial intelligence systems.
  • a variety of other analysis techniques can be applied to hydration monitoring results. These include the use of established guideline values for data that is used to determine fluid changes associated with the onset or progression of pulmonary edema. Also, clinician-modified variables such as tailored threshold values can be applied to permit increased accuracy and specificity.
  • hydration monitoring results can be made in light the results of monitoring other biological parameters such as respiration, heart rate, hormone (e.g., B-type natriuretic peptide (BNP)) levels, metabolite levels (e.g., blood urea nitrogen (BUN) and/or Na + /K + levels), wedge pressure measurements, electrocardiogram measurements, and others. Analyses made in light of such other parameters may improve the information provided by the analysis process.
  • hormone e.g., B-type natriuretic peptide (BNP)
  • metabolite levels e.g., blood urea nitrogen (BUN) and/or Na + /K + levels
  • wedge pressure measurements e.g., blood urea nitrogen (BUN) and/or Na + /K + levels
  • electrocardiogram measurements e.g., electrocardiogram measurements, and others.
  • Data analysis can include comparisons involving recent hydration monitoring results. For example, recent hydration monitoring results can be compared with previous hydration monitoring results, predicted results, or population results. Future hydration monitoring results can be predicted based on the current state of the monitored individual and on past hydration monitoring results obtained with the same or with other individuals or a population or demographic group. Such comparisons may include, for example, the use of population data tables, multiple reference measurements taken over time, or the results of trend analyses based upon extended hydration monitoring.
  • Such comparisons can also involve other factors, including other bioparameters.
  • hydration monitoring results can be weighted by one or more factors before comparisons are performed.
  • factors include the monitored individual's age, weight, height, gender, general fitness level, ethnicity, heart rate, respiration rate, urine specific gravity value, blood osmolality measurement, time of day, altitude, state of hydration (either subjective or objective), cardiac waveforms, left ventricle ejection fraction, blood oxygen levels, secreted potassium or sodium ions levels, skin surface temperature, ambient temperature, core body temperature, activity/motion assessment, humidity, and other bioparameters.
  • a downward hydration trend over a selected period can be detected and a recommended fluid intake could be presented automatically.
  • the timing and nature of the recommendation could be also based at least in part on the age, gender, or other relevant factors.
  • a recommended intake of a pharmaceutical agent can be automatically provided.
  • Hydration monitoring can proceed in a variety of different environments using a variety of different procedures to monitor a variety of different disease states. For example, in one implementation, where hydration is monitored for indications of pulmonary edema, monitoring can commence after an individual has been identified as at risk for pulmonary edema. For example, such an individual may have been admitted to a care facility for treatment of pulmonary edema. Hydration can be monitored as the individual is “dried out” and excess fluid load in the thoracic region is reduced. Hydration monitoring can be continued after the individual is “dried out.” For example, hydration monitoring can continue after such an individual is released from the care facility, and even as the individual returns to performing workday activities.
  • hydration monitoring can be ongoing and rely upon a portable probe that can be moved from a fixed location by the individual and still perform at least some output signal generation. Analysis of the results of such hydration monitoring can be used to gather information about the reonset and/or progression of pulmonary edema, both in the monitored patient and in population groups that include the monitored patient.
  • Hydration monitoring can be performed to achieve a variety of different objectives, including the identification of levels and distributions of water in organisms that are indicative of one or more acute or chronic disease states. Examples of such monitoring follow.
  • Such activities may include athletics, public safety activities performed by officers/firefighters, combat, and other activities requiring physical exertion.
  • Such environments include hot and humid locales.
  • one or more strap probes can be deployed along a thigh of such individuals to continually monitor the hydration of such individuals.
  • probes can be incorporated into clothing such as the pants and sock illustrated in FIGS. 9A and 9B .
  • a range of data including hydration monitoring results and the results of monitoring other bioparameters, can be transmitted to one or more data processing devices that perform analysis operations.
  • the transmitted data can be used by such devices to establish a baseline from which relative changes in hydration can be determined.
  • the transmitted data can include, e.g., urine specific gravity, blood osmolality, and/or other parameters indicative of hydration status, including, e.g., anthropometric data such as segment size, age, height, weight, and general fitness level.
  • the established baseline can be returned to the probe and used by the probe to provide instantaneous alarms when hydration monitoring results indicative of dehydration are obtained. Further, the results of hydration monitoring generated by the probe can be transmitted to a data collection apparatus and/or data management system for analysis and archiving.
  • a data collection apparatus and/or data management system can also identify hydration monitoring results that are indicative of dehydration. For example, when hydration decreases by a certain threshold amount (e.g., 3%), a data collection apparatus and/or data management system can record the decrease and then trigger an alarm signal at the probe and/or the data collection apparatus. For example, the extent of dehydration can be displayed along with a recommended fluid replacement volume and a recommended recovery time. Further, the alert can be relayed to a third party such as an athlete's coach, a supervisor, or medical personnel.
  • a threshold amount e.g., 3%
  • the monitored individual can remove and replace a probe.
  • the new probe can synched to the data collection apparatus and provided with new baseline impedance measurements.
  • a data collection apparatus can be incorporated into a device commonly used by individuals who find themselves in activities or in environments that are conducive to dehydration.
  • a data collection apparatus can be incorporated into safety equipment, the handlebars of a bicycle, a helmet, or gloves.
  • the data collection apparatus can alert the individual and/or others in the individual's vicinity of the results. For example, a light on the outside of a football player's helmet can flash to alert teammates and coaches of the player's hydration monitoring results. These alerts can be graded with the severity of the hydration monitoring results so that the player and teammates have timely warning prior to passing critical hydration thresholds, such as greater than 5% dehydration.
  • Probes for monitoring the hydration of such individuals can be incorporated into motor vehicles, e.g., at a steering wheel, joystick, or other surface that contacts operating individuals either continually or intermittently. Intermittent contact can be accommodated by limiting data analysis to data obtained during periods of good contact between the probe and the monitored organism.
  • Such vehicles can also include a data collection apparatus.
  • the data collection apparatus can share generic components with the vehicle to perform various operations.
  • Such components include vehicle display systems and data communication devices.
  • the data collection apparatus can alert the individual and/or others in the individual's vicinity of the results. For example, a pit crew can be notified that a driver is becoming dehydrated or a commanding officer can be notified that soldiers in his/her command are becoming dehydrated.
  • bandage probes can be incorporated into clothing.
  • Probe 100 can communicate with data collection apparatus 1105 by a wired data link. Both probe 100 and data collection apparatus 1105 can be incorporated into other items or equipment such as a vehicle, a radio unit, a shoe, football equipment, fire fighting equipment, gloves, hydration systems, bicycle handlebars, and other devices.
  • Data communication along data link 1125 can be asynchronous, and the synch operational mode eliminated from data collection apparatus 1105 .
  • multiple probes i.e., probes 500 and 500 ′
  • strap probe 500 is sized to encircle the thigh of person 405 and is deployed to probe the conductivity of the thigh of person 405
  • strap probe 500 ′ is sized to encircle the lower leg of person 405 and is deployed to probe the conductivity of the lower leg of person 405 .
  • probe 500 ′ can provide hydration measurement results that are used to identify disease states such as congestive heart failure where water accumulates in the lower legs, and probe 500 can provide hydration measurement results that are used to calibrate the hydration measurement results obtained using probe 500 ′.
  • Such a calibration can include making differential measurements that accommodate variation in the hydration monitoring results that is unrelated to cardiac failure.
  • FIG. 17 shows an implementation of a system that uses multiple probes for monitoring the hydration of an organism, namely a system 1700 .
  • system 1700 includes probes 500 , 500 ′.
  • Probes 500 , 500 ′ can be deployed on a single organism 405 as shown in FIG. 16 .
  • Probes 500 , 500 ′ can both establish wireless data links 1125 with data collection apparatus 1105 to communicate information used in hydration monitoring.

Abstract

Systems and techniques for monitoring hydration. In one implementation, a method includes measuring an electrical impedance of a region of a subject to generate an impedance measurement result, and wirelessly transmitting the data to a remote apparatus. The probe with which impedance is measured may in the form of a patch adhesively secured to the subject.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • This application is a continuation-in-part of U.S. application Ser. No. 11/410,519, filed on Apr. 23, 2006, which application is a continuation-in-part of U.S. application Ser. No. 10/032,765 filed Oct. 29, 2001, which claims the benefit of U.S. Provisional Application Ser. No. 60/301,897, filed Jun. 29, 2001. This application is also a continuation of U.S. application Ser. No. 10/922,370 filed Aug. 20, 2004, which claims the benefit of U.S. Provisional Application Ser. No. 60/496,558, filed Aug. 20, 2003 and U.S. Provisional Application Ser. No. 60/570,852 filed May 13, 2004. All of the above mentioned applications are incorporated by reference in their entireties.
  • BACKGROUND
  • This disclosure relates to monitoring the hydration of organisms.
  • Many species of organisms are largely water. The amount and/or disposition of water in an individual organism (i.e., the hydration of the organism) is often correlated with the health of the individual organism. For example, an excess or a scarcity of water can be indicative of acute and/or chronic disease states.
  • One example of such an acute disease state is acute dehydration. Dehydration is the excessive depletion of body water. There are a number of causes of acute dehydration including heat exposure, prolonged vigorous exercise, and diuretics. For example, the US Air Force Field Manual (FM 3-04.301—Aeromedical Training for Flight Personnel) describes that when ambient temperature is increased above 82-84° F., sweat production by humans increases abruptly and dehydration may result. Humidity can also impact sweat production and lead to dehydration. For example, with 115° F. and 10% humidity, a human can function normally with water and salt replenishment. However when humidity is 80%, the same person can become incapacitated within 30 minutes at 115° F. due to excessive depletion of body water.
  • One example of a chronic disease state associated with an excess of water is pulmonary edema. Pulmonary edema is the extravascular accumulation of fluid in the lungs. There are a number of causes of pulmonary edema including mitral stenosis or left ventricular failure. Pulmonary edema can be associated with congestive heart failure.
  • Another example of such a chronic disease state is hyperhydration. Hyperhydration is a state in which the body includes an excessive amount of water. In patients undergoing kidney dialysis, hyperhydration may lead to hypertension and increased mortality.
  • SUMMARY
  • Accordingly, this disclosure describes systems and techniques for monitoring the hydration of an organism. Hydration can be monitored, e.g., to identify dehydration or other disease state of the organism.
  • In one implementation, a device includes a portable hydration monitoring probe dimensioned to be continuously borne by an organism. The probe includes a supply of electrical power, an electrode to exchange electrical energy from the supply with a local portion of the organism bearing the probe, a controller to generate data representing a result of the hydration monitoring, the result reflecting a local bioelectric impedance based on the exchange of electrical energy at the electrode, and a data communication device configured to wirelessly communicate the data representing the hydration monitoring result to a remote apparatus.
  • This and other implementations can include one or more of the following features. The portable hydration monitoring probe can include a patch probe.
  • These and other systems and techniques can be implemented to realize one or more of the following advantages. Hydration can be monitored to identify a variety of disease states. Monitoring can be long term, using portable probes dimensioned to be borne by the monitored organism. The impact of skin surface temperature on hydration measurements can be considered when analyzing hydration monitoring results. Hydration monitoring results can be communicated using wireless communication links that do not hinder the mobility of ambulatory subjects.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 shows a probe for monitoring the hydration of an organism.
  • FIG. 2 shows a bioelectric impedance spectroscopy probe for monitoring the hydration of an organism.
  • FIG. 3 shows a bandage bioelectric impedance spectroscopy probe.
  • FIGS. 4A and 4B illustrate example deployments of a bioelectric impedance spectroscopy probe and a bandage probe to monitor hydration.
  • FIGS. 5 and 6 show a portable strap bioelectric impedance spectroscopy probe.
  • FIGS. 7, 8A, 8B, 8C, 9A, and 9B illustrate example deployments of a strap probe to monitor hydration.
  • FIGS. 10A and 10B show other strap bioelectric impedance spectroscopy probes.
  • FIG. 10C shows a graph of example hydration monitoring results that can be obtained using a bioelectric impedance monitor and a skin temperature thermometer.
  • FIG. 11 shows a system for monitoring the hydration of an organism.
  • FIG. 12 shows a data collection apparatus that is usable in a system for monitoring the hydration of an organism.
  • FIG. 13 shows another system for monitoring the hydration of an organism.
  • FIG. 14 shows another system for monitoring the hydration of an organism.
  • FIG. 15 shows an example of a model equivalent circuit that can be used in monitoring the hydration of an organism.
  • FIG. 16 illustrates an example deployment of multiple strap probes to monitor hydration.
  • FIG. 17 shows another system for monitoring the hydration of an organism.
  • DETAILED DESCRIPTION
  • FIG. 1 shows a probe 100 for monitoring the hydration of an organism. Probe 100 includes a body 105, an energy source 110, and a sensing circuit 115. Body 105 can be a flexible member in that it can be contoured to follow the skin surface or other portion of an organism, such as, for example, a patch or strap. Body 105 supports probe/ organism interfaces 120, 125, 130, 135 which apply or exchange energy with the subject and which sense energy exchange parameters in a way to measure the impedance of a region of the subject. In most embodiments, interfaces 120, 125 130, 135 will be electrodes adapted to exchange electrical energy with a human, although some optical element adapted to illuminate a human may also be possible. Typically, two of the interfaces 120, 125 are used to force current flow from one point on the subject to a second point on the subject. The other two interfaces 130, 135 are used to measure the voltage across two points on the subject. It may be noted that the current application points and the voltage measurement points in these embodiments can be the same, adjacent to one another, or at significantly different locations.
  • Energy source 110 can be, e.g., an optical energy source or an electric energy source. For example, energy source can be an alternating and/or direct current and/or voltage source. Energy source 110 is connected to inputs 120, 125 by leads 140, 145. Leads 140, 145 can conduct energy generated by source 110 for exchange with the portion of the organism coupled to main body 105. For example, leads 140, 145 can be electrical wires capable of carrying an electric current for exchange with the portion of the organism, or leads 140, 145 can be optical waveguides capable of carrying light for exchange with the portion of the organism followed by main body 105.
  • In one electrical embodiment, a sensing circuit 115 comprises a differential amplifier connected to electrodes 120, 125 by leads 140, 145 and to electrodes 130, 135 by leads 150, 155. Leads 140, 145 can conduct voltage across source 110 to amplifier 115. Leads 150, 155 can conduct voltage across electrodes 130, 135 as another input to the amplifier 115. Amplifier 115 can sense voltages across electrodes 130, 135 and electrodes 120, 125 to generate one or more results 160. It will be appreciated that amplifier 115 could be implemented as two or more amplifiers that separately sense relative voltages across any desired electrode pairs. Current sensing could also be implemented to directly measure the current output from source 110.
  • In operation, main body 105 flexes to follow a portion of an organism and maintain inputs 120, 125 and outputs 130, 135 so that they can exchange energy with the followed portion. Source 110 generates one or more types of energy that is conducted over leads 140, 145 through interfaces 120, 125 and exchanged with the followed portion of the organism. In turn, interfaces 130, 135 sense one or more energy exchange parameters from the followed portion. Sensing circuit 115 generates a result 160 based on the sensed signals. Result 160 reflects, at least in part, the hydration of the monitored organism.
  • Probe 100 can generate result(s) 160 continuously or intermittently over extended periods of time. For example, result 160 can be a subset of the comparisons of the sensed parameters at interfaces 130, 135 with the amount of energy input at inputs 120, 125, or result 160 can be all such comparisons. For example, result 160 can be intermittent samples of voltages from the results of continuous application of a substantially constant current. As another example, result 160 can be periodic (e.g., every 5 to 30 minutes, such as every 10 minutes) results of successive, shorter duration current applications.
  • FIG. 2 shows one implementation of a probe for monitoring the hydration of an organism, namely a bioelectric impedance spectroscopy probe 200. Bioelectric impedance spectroscopy is a measurement technique in which the electrical conductivity of all or a portion of an organism is measured. When the conductivity of the entirety of an organism is measured such as by passing current from one ankle to an opposite wrist or between both hands, this can be referred to as whole body bioelectric impedance spectroscopy. When the conductivity of a portion of an organism is measured such as by a cluster of more locally placed electrodes, this can be referred to as segmental (or regional) bioelectric impedance spectroscopy. In either case, the measured electrical conductivity can reflect the hydration of the measured organism or the measured portion of the organism.
  • Bioelectric impedance spectroscopy generally involves the exchange of electrical energy with the organism. The exchanged electrical energy can include both alternating current and/or voltage and direct current and/or voltage. The exchanged electrical energy can include alternating currents and/or voltages that alternate at one or more frequencies. For example, the alternating currents and/or voltages can alternate at one or more frequencies between 100 Hz and 1 MHz, preferably at one or more frequencies between 5 KHz and 250 KHz.
  • Different frequencies of electrical energy can be used to measure conductivity in different portions of the organism. For example, in some organisms, lower frequency electrical energy may be conducted preferentially through tissues having fewer membranous components whereas higher frequencies may be conducted through a larger variety of tissues. In many cases, it is advantageous to make impedance measurements at two or more different frequencies in the same region. As explained further below, DC measurements can help characterize impedance over the skin surface. Thus, measurements at different frequencies made by a single probe can provide information regarding both the amount and disposition of water within a probed organism or within a probed portion of the organism.
  • Referring again to FIG. 2, bioelectric impedance spectroscopy probe 200 includes a body 205, a current source 210, a digital-to-analog converter 215, an amplifier 220, an analog-to-digital converter 225, a memory 230, and a controller 235. Body 205 is a flexible member that supports two working electrodes 245, 250 and two sensing electrodes 255, 260. Body 205 can be flexible enough to follow a portion of the human body to maintain electrodes 245, 250, 255, 260 in contact with that portion. The followed portion can include skin surfaces, mucosal surfaces in the mouth and/or nasal passages, and other body passages or orifices. Body 205 can be sized to probe the conductivity of the entirety of an organism and thus perform whole body bioelectric impedance spectroscopy. In some advantageous embodiments described in detail herein, body 205 is sized to probe the conductivity of a portion of an organism and thus perform segmental bioelectric impedance spectroscopy.
  • Working electrodes 245, 250 can be adapted to conduct current through or along the probed portion of the monitored organism. Sensing electrodes 255, 260 can be adapted to measure the potential of locations in the probed portion of the monitored organism. Electrodes 245, 250, 255, 260 are generally electrically conductive in that their electrical impedance is relatively small when compared to the electrical impedance of the monitored portion of an organism at the probed frequency. For example, electrodes 245, 250, 255, 260 can include metals, sintered metallic composites, conductive polymers, gels, carbon-based materials, silicon materials, electrically conductive microneedles, conductive solutions, or combinations thereof. In one implementation, electrodes 245, 250, 255, 260 are electrically conductive adhesive gel electrodes such as the RED DOT electrodes available from 3M Corp. (St. Paul, Minn.).
  • Electrodes 245, 250, 255, 260 can be supported by body 205 on the outer surface of the skin of a monitored organism. Alternatively, electrodes 245, 250, 255, 260 can be supported by body 205 beneath the skin of a monitored organism. For example, electrodes 245, 250, 255, 260 can be supported subdermally or electrodes 245, 250, 255, 260 can be supported on transdermal elements such as microneedles that penetrate the skin. When placed on the skin surface, electrodes 245, 250, 255, 260 can advantageously be each supported by body 205 at positions that are separated from one another by more than approximately ten times the thickness of the skin. When hydration is monitored in humans, electrodes 245, 250, 255, 260 that are above the skin can each generally be supported at positions that are separated from one another by more than 2.5 millimeters. In one implementation, the distance between working electrodes 245, 250 is greater than 1 cm. For embodiments that include a localized cluster of electrodes on one or more patches secured to the skin, the distance between electrodes is advantageously less than about 25 cm so that the impedance measurement is focused regionally on the subject. Such regional measurements have been found to produce useful data that can be generated and distributed with convenient apparatus.
  • In one implementation, working electrodes 245, 250 are different than sensing electrodes 255, 260. For example, working electrodes 245, 250 can be larger than sensing electrodes 255, 260 and/or made from different materials.
  • Current source 210 is a source of alternating and/or direct electrical current. As deployed in probe 200, current source 210 can drive electrical current from working electrode 245 to working electrode 250 through and/or along a monitored organism. In one implementation, current source 210 is capable of driving between 10 microamperes and 10 milliamperes, preferably between 100 microamperes and 1 milliamperes, of one or more frequencies of alternating and/or direct current through or along electrical impedances characteristic of humans. Typically, current is held at a known or measured substantially constant value, and voltage is measured to provide an impedance value. It is also possible to apply a constant voltage and measure the amount of current. Digital-to-analog converter 215 can be an integrated circuit or other electronic device that converts a digital signal into a corresponding analog signal. As deployed in probe 200, digital-to-analog converter 215 can convert digital control signals from controller 235 into analog control signals to control the output of electrical current from current source 210.
  • Amplifier 220 can be a differential voltage amplifier in that it amplifies a voltage difference on sensing electrodes 255, 260. This voltage difference results from current source 210 driving electrical current from working electrode 245 to working electrode 250 through and/or along the monitored organism. Analog-to-digital converter 225 can be an integrated circuit or other electronic device that converts this sensed voltage difference into a corresponding digital signal for reading by controller 235 and/or storage in memory 230.
  • Memory 230 can be a data storage device that can retain information in machine-readable format. Memory 230 can be volatile and/or nonvolatile memory. For example, memory 230 can be a RAM device, a ROM device, and/or a memory disk.
  • Controller 235 is a device that manages the generation and flow of data in probe 200. Controller 235 can be hardware configured to perform select operations or a data processing device that performs operations in accordance with the logic of a set of machine-readable instructions. In some implementations, controller can receive information related to the management of the generation and flow of data in probe 200 via one or more input devices. In some implementations, controller 235 can output information from probe 200 via one or more output devices. Custom ASICs or gate arrays can be used, as well as commercially available microcontrollers from, for example, Texas Instruments and Motorola.
  • The operations performed by controller 235 can include regulating the timing of hydration measurements and the timing of the transmission of hydration measurement results, logic operations, signal processing, and data analysis. For example, data analysis can be used to determine the bioelectric impedance of portions of a monitored organism. For example, equivalent circuit impedance analysis in the time or frequency domain can be performed. Instructions for performing such operations can be stored in a read only memory portion of memory 230, temporary values generated during such operations can be stored in a random access portion of memory 230, and the results of operations can be stored in a non-volatile portion of memory 230.
  • In operation, current source 210 drives one or more frequencies of alternating and/or direct current between working electrodes 245, 250 and through the subject organism. Amplifier 220 buffers and amplifies the potential difference between sensing electrodes 255, 260. Analog-to-digital converter 225 converts this signal into a digital form that can be received by controller 235 for storage at memory 230, as appropriate. In some implementations, controller 235 may control source 210 to change the frequency and/or magnitude of current generated. The control of source 210 can be performed in light of the magnitude of the signal(s) output by amplifier 220 and/or in light of instructions received by controller 235 over one or more input devices.
  • FIG. 3 shows one implementation of a portable bioelectric impedance spectroscopy probe, namely a bandage (or “patch”) probe 300. Probe 300 can be self-powered in that main body 205 includes (in addition to electrodes 245, 250, 255, 260) a portable power source, such as a battery 305. Probe 300 is portable in that probe 300 can be moved from a fixed location and is adapted to perform at least some of the signal generation and processing, control, and data storage functions of current source 210, a digital-to-analog converter 215, an amplifier 220, an analog-to-digital converter 225, a memory 230, and a controller 235 without input from a fixed device. For example, probe 300 can be borne by the monitored organism. Circuitry 310 can be, e.g., an application specific integrated circuit (ASIC) adapted to perform these functions. Circuitry 310 can also be a data processing device and/or one or more input/output devices, such as a data communication device.
  • Main body 205 also advantageously includes an adhesive 315. Adhesive 315 can be adapted to adhere to the skin surface of the monitored organism and thereby maintain electrodes 245, 250, 255, 260 in contact with the portion of an organism followed by main body 205.
  • A portable probe 300 allows a monitored organism to be ambulatory while hydration monitoring occurs. This allows for data collection to be extended beyond periods of confinement. Thus, hydration monitoring can be continued while an organism participates in various activities at different locations, over durations suitable for identifying the onset of disease states.
  • FIGS. 4A and 4B respectively illustrate example deployments of bioelectric impedance spectroscopy probe 200 and bandage probe 300 to monitor hydration. FIG. 4A shows a pair of probes 200 deployed along a steering wheel 400 so that a driver's hands will come into intermittent electrical contact with one or both of probes 200. During this intermittent contact, the driver's hydration can be monitored.
  • FIG. 4B shows bandage probe 300 deployed to adhere to the torso of person 405. Bandage probe 300 is sized to probe the conductivity of a portion of person 405. In particular, bandage probe 300 adheres to the front chest of person 405 with one end located in the vicinity of the xiphoid process. Bandage probe 300 extends axially and downward from the xiphoid process towards the lateral side of person 405.
  • This positioning of bandage probe 300 may facilitate the monitoring of hydration in the underlying tissue and lung, as well as the identification of disease states such as pulmonary edema.
  • FIGS. 5 and 6 show another implementation of a bioelectric impedance spectroscopy probe, namely a portable strap probe 500. Main body 205 of strap probe 500 is a strap or a belt that can form a loop to encircle the body, or a portion of the body, of a monitored individual. Such an encirclement can maintain electrodes 245, 250, 255, 260 in contact with the encircled portion. In addition to working electrodes 245, 250, two sets of sensing electrodes 255, 260, battery 305, and circuitry 310, main body 205 also includes a data communication device 505 having a transceiver 510. Data communication device 505 can be a wireless communication device that can exchange information between circuitry 310 and an external entity. Wireless data link 1125 can carry information using any of a number of different signal types including electromagnetic radiation, electrical signals, or acoustic signals. For example, data communication device 505 can be a radio frequency communication device. Transceiver 510 can be an assembly of components for the wireless transmission and reception of information. The components can include, e.g., an RF antenna. The wireless receiver/transmitter circuitry can be made part of any embodiment described herein.
  • The two sets of sensing electrodes 255, 260 can be used to measure hydration at different locations on a monitored individual. For example, when working electrodes 245, 250 drive current through and/or along the surface of the encircled portion of a monitored individual, the potential differences between all sensing electrodes 255, 260 can be used to gain information about the conduction of current in the vicinity of electrodes 255, 260. A measurement of multiple potential differences between more than two sensing electrodes 255, 260 can also be used, e.g., to make cross measurements and ratiometric comparisons that can be used to monitor hydration while aiding in calibration and helping to account for measurement variability such as temperature changes, changes in the position of the monitored individual, and movement of strap probe 500 over time.
  • FIGS. 7, 8A, 8B, 9A, and 9B illustrate example deployments of implementations of strap probe 500 to monitor hydration in a person 405. In FIG. 7, strap probe 500 is sized to encircle the torso of person 405 and is deployed to probe the conductivity of the torso of person 405. Such a positioning of strap probe 500 may facilitate the monitoring of hydration in the underlying tissue and lung, as well as the identification of disease states such as pulmonary edema.
  • In FIG. 8A, strap probe 500 is sized to encircle the thigh of person 405 and is deployed to probe the conductivity of the thigh of person 405. Such a positioning of strap probe 500 may facilitate the monitoring of hydration in the underlying tissue, as well as the identification of disease states such as acute or chronic dehydration.
  • In FIG. 5B, strap probe 500 is sized to encircle the lower leg of person 405 and is deployed to probe the conductivity of the lower leg of person 405. As shown, strap probe 500 encircles the ankle, but strap probe 500 can also encircle the foot, the calf, or a toe to probe the conductivity of the lower leg. Such a positioning of strap probe 500 may facilitate the monitoring of hydration in the underlying tissue, as well as the identification of disease states such as congestive heart failure where water accumulates in the lower legs.
  • In FIG. 8C, strap probe 500 is sized to encircle the bicep of person 405 and is deployed to probe the conductivity of the bicep of person 405. Such a positioning of strap probe 500 may facilitate the monitoring of hydration in the underlying tissue, as well as the identification of disease states such as acute or chronic dehydration.
  • In FIG. 9A, strap probe 500 is incorporated into a pair of pants 905 and sized to encircle the torso of person 405 to probe the conductivity of the torso of person 405. Incorporating a probe 500 into pants 905 may reduce the intrusiveness of probe 500 and help ensure that a monitored individual deploys probe 500.
  • In FIG. 9B, strap probe 500 is incorporated into a sock 910 and sized to encircle the lower leg of person 405 to probe the conductivity of the lower leg of person 405. Incorporating a probe 500 into sock 910 may reduce the intrusiveness of probe 500 and help ensure that a monitored individual deploys probe 500.
  • As discussed further below, in some deployments, multiple probes at different locations may be used to monitor the hydration of a single individual. The measurement results from the different probes can be compared and correlated for calibration and error minimization. Other techniques that measure biological parameters can also be used in conjunction with single or multiple probes. The biological parameter measurements can be compared and correlated with the probe measurements to calibrate the measurements and minimize the error associated with the measurements. As one example, bioelectric impedance measurements made using a QUANTUM X body composition analyzer (RJL Systems, Inc., Clinton Twp., MI) and/or a Hydra 4200 bioimpedance analyzer (Xitron Technologies Inc., San Diego, Calif.) can be compared and correlated with probe measurements.
  • As another example, skin temperature measurements can be used in monitoring the hydration of an individual. In general, skin surface temperature will change with changes in blood flow in the vicinity of the skin surface of an organism. Such changes in blood flow can occur for a number of reasons, including thermal regulation, conservation of blood volume, and hormonal changes. In one implementation, skin surface measurements are made in conjunction with hydration monitoring so that changes in apparent hydration levels, due to such changes in blood flow, can be considered.
  • In some deployments, one or more probes can be moved to different portions of a single individual over time to monitor the hydration of the individual. For example, a probe can monitor the hydration of an individual at a first location (e.g., the torso) for a select period (e.g., between about 1 to 14 days, or about 7 days), and then the same probe can be moved to a different location (e.g., the thigh) to monitor the hydration of the same individual for a subsequent time period. Such movement of a probe can extend the lifespan of a probe and increase the type of information gathered by the probe. Further, movement of the probe can minimize surface adhesion loss and any decrease in hygiene associated with the monitoring.
  • The movement of a probe such as probe 500 to a new location on the body, or the attachment of a new probe at a different location, may result in a change in baseline impedance measurements even when the hydration of the monitored organism has not changed. A baseline measurement is a standard response to hydration monitoring. The standard response can be indicative of the absence of a disease state or of the absence of progression in a disease state. Changes in the baseline impedance measurements can result from changes in factors unrelated to a disease state. For example, changes in the baseline impedance measurements can result from different skin thicknesses, body compositions, or other differences between two locations. Measurements made at the different locations can be normalized to account for such differences in baseline measurements. Such a normalization can include adjustments in gain and/or adjustments in offset. Gain adjustments may be based on the absolute value of the impedance measurement(s), the impedance difference(s) observed at the old and the new locations, or combinations thereof. Offset adjustments can generally be made after gain adjustments and can be based on absolute impedance values and/or other factors. Alternatively, analysis thresholds used to identify disease states can be adjusted.
  • In some implementations, the monitored individual may be placed in a non-ambulatory state (e.g., supine and resting) in order to acquire directly comparable baseline measurements at different locations. Multiple probes need not be attached to the same organism in order to normalize baseline measurements. For example, hydration measurement results obtained using a first probe at a first location can be stored and compared with hydration measurement results obtained later using a second probe at a second location. This can be done, e.g., when the time between the collection of the results at the first location and the collection of the results at the second location is relatively short, e.g., less than 1 hr. If the replacement patch is not attached to the patient within this period, comparison of bioelectric impedance values to other calibration standards, e.g., body weight and body weight change, urine specific gravity, blood osmolality, can also be used for such comparisons.
  • FIG. 10A shows another implementation of a strap probe, namely a strap probe 1000. In addition to electrodes 245, 250, 255, 260, battery 305, circuitry 310, data communication device 505, and transceiver 510, main body 205 also includes an output device 1005. Output device 1005 can be a visual display device (such as a light emitting diode or a liquid crystal display), an audio output device (such as a speaker or a whistle), or a mechanical output device (such as a vibrating element).
  • In operation, output device 1005 can present information regarding the hydration monitoring to a monitored individual. The presented information can be received by output device 1005 from circuitry 310 and can indicate monitoring results and/or alerts. Monitoring results can include the current hydration state of an individual as well as indications that certain disease states, such as acute dehydration, are present or imminent. Monitoring alerts can include indications of current or imminent apparatus malfunction, such as loss of contact between any of electrodes 245, 250, 255, 260 and the monitored individual, a lack of available memory, loss of a data communication link, or low battery levels.
  • FIG. 10B shows another implementation of a strap probe, namely a strap probe 1010. In addition to electrodes 245, 250, 255, 260, battery 305, circuitry 310, data communication device 505, and transceiver 510, main body 205 also includes a skin temperature thermometer 1015. Thermometer 1015 can be a temperature sensing element that senses temperature in ranges encountered on the skin surface of the monitored organism. Thermometer 1015 can be, e.g., a thermister, a thermocouple, a mechanical thermometer, or other temperature-sensing device. This temperature sensor can be part of any probe embodiment described herein.
  • In operation, thermometer 1015 can present information regarding skin surface temperature to circuitry 310. The presented information can be used by circuitry 310 to perform data analysis and other aspects of hydration monitoring. Circuitry 310 can also transmit all or a portion of the temperature information to other devices using, e.g., data communication device 505 and transceiver 510.
  • With measurements of hydration and temperature at in the same vicinity of an organism, changes in apparent hydration levels due to changes in skin surface blood flow can be identified and accommodated in data analyses.
  • FIG. 10C shows a graph 1020 of example hydration monitoring results that were obtained using a bioelectric impedance monitor and a skin temperature thermometer. Graph 1020 shows the observed impedance 1025 of a region on the thigh of a monitored individual as a function of skin temperature 1030. Graph 1020 includes a pair of traces 1035, 1040. Trace 1035 shows the impedance measured with an electrical energy input signal having a frequency of 20 kHz, whereas trace 1040 shows the impedance measured with an electrical energy input signal having a frequency of 100 kHz.
  • Traces 1035, 1040 were obtained as follows. Four Red Dot electrodes (3M Corp., St. Paul, Minn.) were arrayed in a linear axial fashion upon the front of a thigh of a 42 yr old male subject weighing 201.3 pounds. The subject reclined in a supine position for 30 minutes in a room at ambient temperature (74° F.). The bioelectric impedance of the thigh at 20 kHz and 100 kHz was then measured with the subject in the supine position. The measured impedance of the thigh was 45.36 ohms at 20 kHz and 30.86 ohms at 100 kHz. The skin surface temperature of the thigh was then measured using an infrared thermometer (Thermoscan, Braun GmbH, Kronberg, Germany). The measured temperature was 89.0° F. The subject then jogged six miles, taking approximately 90 minutes. The subject was then weighed. The measured weight was 197.6 pounds, indicating a loss of body water of about 3.5 pounds, or about 1.7%. The subject then returned to the supine position in the ambient temperature room. The bioelectric impedance of the thigh at 20 kHz and 100 kHz was then measured periodically, as was skin surface temperature of the thigh.
  • Traces 1035, 1040 represent the results of these measurements. Initially, the measured bioelectric impedance at both 20 kHz and 100 kHz was lower than before jogging and the measured temperature was higher than before jogging. In other words, the measured bioelectric impedance at both 20 kHz and 100 kHz decreased as skin temperature in the vicinity of the bioelectric impedance measurement increased.
  • The observed changes in skin temperature are believed to result, at least in part, from local vasodilation as the body sheds excess heat generated during exercise. Such changes in vasodilation appear to decrease local impedance.
  • Over time, both the measured impedance and temperature moved in the direction of the values observed before jogging. The movement showed a linear relationship between measured impedance and measured skin temperature at both 20 kHz and 100 kHz. This relationship can be used to accommodate the impact of skin surface temperature on hydration monitoring results, as discussed further below. If desired, local vasodilation or vasoconstriction can be measured by other or additional methods such as with optical methods. A vasodilation parameter, whether measured or calculated via a temperature measurement or some other means may be used to correct absolute impedance measurements to appropriately determine impedance changes over time due to hydration changes.
  • At the end of the recovery period, the measured impedance of the thigh was 50.27 ohms at 20 kHz and 34.30 ohms at 100 kHz, for a net increase in impedance of 4.91 ohms (10.8%) at 20 KHz and 3.44 ohms (1.1%) at 100 KHz. Similar results have been observed with other subjects and other test conditions.
  • This approximately 11% net increase in measured bioelectric impedance at 20 kHz and 100 kHz is believed to reflect the water loss associated with the observed decrease in body weight (i.e., the decrease of about 1.7%).
  • The measurement results in traces 1035, 1040 can be used by circuitry 310 to perform data analysis and other aspects of hydration monitoring. For example, the impact of skin surface temperature on hydration monitoring results can be accommodated. In one example, the relationship between bioelectric impedance and temperature illustrated by traces 1035, 1040 can be used to compare hydration monitoring results obtained at different skin surface temperatures. For example, with a skin surface temperature of 90.5° F., the measured impedance at 20 kHz was 47.9 ohms. In order to compare this impedance measurement with impedance measurements made at a skin surface temperature of 89° F., the measured impedance can be adjusted by taking the difference between the two temperatures (i.e., 89° F.-90.5° F.) of −1.5° F. and multiplying this difference by the measured dependence of impedance at 20 kHz on temperature (i.e., the slope of −1.8052) to generate an adjustment value of 2.71 ohms. The adjustment value can be added to the impedance at 20 kHz measured with a skin surface temperature of 90.5° F. (i.e., 47.9+2.71) to yield an impedance that is comparable with impedance measurements made at 20 kHz with a skin surface temperature of 89° F. (i.e., 50.6 ohms). As seen, this adjusted impedance is consistent with the impedance actually measured at this skin surface temperature (i.e., 50.27 ohms).
  • Such combinations of skin surface temperature measurements and hydration monitoring results can be used to improve hydration monitoring. For example, bioelectric impedance measurements can be adjusted based on local skin surface temperature measurements made in the vicinity of the probe. This can improve the predictive value of impedance measurements, even relative to whole body impedance measurements where impedance measurement that reflect the electrical impedance through the entire body may not precisely correlate with temperature measurements made at one or two body locations.
  • Factors unrelated to hydration may influence local skin surface temperature measurements. These factors include the rate of convective cooling, the wind velocity, the presence of thermal insulation such as clothing, and ambient temperature gradients. Such factors that tend to influence heat exchange between the portion of the body of interest and the environment may be accounted for directly (e.g., using additional temperature or humidity sensors) or indirectly (e.g., using standard tables and known values applied to parameters such as the thickness of insulating clothing). The accounting for such factors can include adjustments to the local temperature used to compare hydration monitoring results.
  • In some implementations, hydration monitoring results obtained at portions of a monitored organism that have a known temperature relationship with another portion where skin surface measurement(s) are made can be adjusted based on that known relationship. Also, other factors including weight, height, age, general fitness level, degree of exertion, time of day, stage in a hormonal cycle, and gender can also be used to adjust hydration monitoring results and improve the predictive value of such results.
  • FIG. 11 shows a system 1100 for monitoring the hydration of an organism. System 1100 includes one or more probes 100 along with one or more data collection apparatus 1105, a data management system 1110, an input/output device 1115, and a data storage device 1120. Probe 100 includes a wireless data communication device 505 that is capable of establishing a wireless data link 1125 with data collection apparatus 1105. Wireless data link 1125 can transmit data using any of a number of different signals including electromagnetic radiation, electrical signals, and/or acoustic signals. When probe 100 is subdermal, data link 1125 can be a transdermal link in that data link 1125 conducts data along a path through the skin.
  • The data communicated along wireless data link 1125 can include a probe identifier. A probe identifier is information that identifies probe 100. Probe 100 can be identified, e.g., by make or model. Probe 100 can also be identified by a unique identifier that is associated with a single individual probe 100. The probe identifier can include a serial number or code that is subsequently associated with data collected by probe 100 to identify that this data was collected by probe 100. In some embodiments, each individual electrode, or a patch or strap containing a set of electrodes incorporates an integrated circuit memory having a stored unique or quasi-unique electrode/patch identifier. An interface between the patch or electrodes and the communication device 505 can be implemented so that the communication device 505 can send electrode or patch identifiers as well as a separate identifier for the other electronics coupled to the patch. In this way, different parts of the probe can be separately replaced, while still allowing complete tracking of the physical data generation, analysis, and communication apparatus used to gather all impedance data.
  • The data communicated along wireless data link 1125 can also include messages to probe 100. Example messages include commands to change measurement and/or data analysis parameters and queries regarding the status and/or operational capabilities of the probe. Data communication along wireless data link 1125 can also include information related to the initialization and activation of probe 100. Initialization can include the communication of a probe identifier to data collection apparatus 1105. Initialization can also include the commencement of measurement activities including, e.g. the start of an internal clock that regulates the timing of hydration measurements and the transmission of hydration measurement results. Such data communication can be conducted as an ongoing dialogue with data collection apparatus 1105.
  • Data collection apparatus 1105 is a device that generally supplements probe 100 by including components and/or features that complement the components and/or features of probe 100. For example, such components or features may be too large, too memory intensive, require too sophisticated data processing, and/or only be used too intermittently to be included on probe 100. FIG. 12 shows one implementation of a data collection apparatus 1105. Data collection apparatus 1105 can be a portable device in that data collection apparatus 1105 can be moved from a fixed location and perform at least some functions without input from a fixed device. For example, data collection apparatus 1105 can be a handheld device that can be borne by a monitored individual.
  • Data collection apparatus 1105 includes a local user input portion 1205, a local user output portion 1210, a wireless data communication portion 1215, and a wired data communication portion 1217 all arranged on a body 1220. Local user input portion 1205 includes one or more components that receive visual, audio, and/or mechanical input from a user in the vicinity of data collection apparatus 1105. For example, local user input portion 1205 can include a keypad 1225 and a mode selection button 1230. Keypad 1225 can receive alphanumeric input from a user. Mode selection button 1230 can receive an operational mode selection from a user. The operational modes of data collection apparatus 1105 are discussed further below.
  • Local user output portion 1210 includes one or more components that provide visual, audio, and/or mechanical output to a user in the vicinity of data collection apparatus 1105. For example, local user output portion 1210 can include a display panel 1235. Display panel 1235 can be, e.g., a liquid crystal display screen. Display panel 1235 includes various regions that display specific information to a local user. In particular, display panel 1235 includes a battery charge display region 1240, an operational mode display region 1245, a time/date display region 1250, a measurement result display region 1255, and an alert display region 1260.
  • Battery charge display region 1240 includes a graphical device that indicates the charge remaining on a battery or other power element that powers data collection apparatus 1105. Operational mode display region 1245 includes a text list of the various operational modes of data collection apparatus 1105. The listed operational modes include a test mode, a set-up mode, a synchronization mode, and a measurement mode. The text indicating measurement mode (i.e., “MEAS”) includes an indicium 1265 that indicates that the current operational mode of data collection apparatus 1105 is the measurement mode. Time/date display region 1250 includes text indicating the current time and date. Measurement result display region 1255 includes text and/or graphical elements that indicate the result(s) of a hydration measurement made by one or more probes 100. Alert display region 1260 includes a text and/or graphical warning that the probe measurement results are indicative of one or more disease states being present or imminent. Alert display region 1260 can also indicate that a malfunction of probe 100 and/or data collection apparatus 1105 is occurring or imminent.
  • Wireless data communication portion 1215 can include a first wireless communication transceiver 1265 and a second wireless communication transceiver 1270. Transceivers 1265, 1270 can be separate devices or transceivers 1265, 1270 can include common components for the wireless communication of data. For example, transceivers 1265, 1270 can each include a separate RF antenna.
  • Transceivers 1265, 1270 can be dedicated to the exchange of data with a particular device, or a particular class of devices. For example, transceiver 1265 can be dedicated to the exchange of data with one or more probes 100 over one or more wireless data links 1125, whereas transceiver 1270 can be capable of exchanging data with other data collection apparatus and/or with one or more data management systems 1110. Transceivers 1265, 1270 can function with cellular communication networks, alpha-numeric paging networks, WiFi or other systems for the wireless exchange of data.
  • Wired data communication portion 1217 can include one or more connector ports 1274 adapted to receive a plug or other terminal on one or more wired data links. The wired data links can be capable of exchanging data with other data collection apparatus and/or with one or more data management systems 1110. The wired data link can be an optical data link and/or an electrical data link. Electrical data links can be analog or digital. The data links can operate in accordance with data communication protocols such as the TCP/IP suite of communications protocols.
  • Body 1220 can be sealed to isolate electrical and other components (not shown) that perform operations such as driving portions 1205, 1210, 1215, 1217 from the ambient environment. Body 1220 can be sized and the components selected to allow data collection apparatus 1105 to be self-powered by an internal power supply (not shown). For example, data collection apparatus 1105 can be powered by an internal rechargeable battery. The components can be, e.g., data storage devices, data processing devices, data communication devices, and driving circuitry for managing the input and output of data from data collection apparatus 1105.
  • Body 1220 can be designed to operate as an independent unit as shown or body 1220 can be designed to integrate with separate communication devices. For example, body 1220 can be designed to integrate with a cellular phone or personal data assistant to form all or a portion of wireless data communication portion 1215.
  • Returning to FIG. 11, system 1100 can include a wired data link 1130 and/or a wireless data link 1135 for the exchange of data between data collection apparatus 1105 and data management system 1110. Wired data link 1130 can terminate at a connector port 1274 on data collection apparatus 1105, and wireless data link 1135 can terminate at transceiver 1270 on data collection apparatus 1105.
  • Wireless data link 1125, wired data link 1130 and wireless data link 1135 can exchange data in accordance with one or more communication protocols. The communication protocols can determine the format of the transmitted information and the physical characteristics of the transmission. Communication protocols can also determine data transfer mechanisms such as synchronization mechanisms, handshake mechanisms, and repetition rates. The data structures of the protocol may impact the rate of data transfer using the protocol. Data can be organized in blocks or packets and transmissions can be made at specified intervals. For example, a transmission block can include synchronization bits, an address field that includes information identifying the data source, a data field containing the hydration monitoring data, and a checksum field for testing data integrity at the receiver. The length of a data block can vary, e.g., to reduce power consumption and increase device lifetime. The same data can be transmitted multiple times to ensure reception.
  • In one implementation, exchanged data is organized in packets that include four sections, namely, a header section, a 64 bit address section that includes a probe identifier identifying a probe 100 (and/or an electrode or electrode set identifier), an encrypted data section, and a check-sum or error correction section. The data section can be encrypted using an algorithm that relies upon the address section.
  • Probe 100, data collection apparatus 1105, and data management system 1110 can all confirm a successful exchange of data using a confirmation such as an electronic handshake. An unsuccessful exchange of data can be denoted by transmission of an error message, which can be responded to by a retransmission of the unsuccessfully exchanged data.
  • In some implementations, probe 100, data collection apparatus 1105, and data management system 1110 can exchange data at a number of different frequencies. For example, when system 1100 includes multiple data collection apparatus 1105, each data collection apparatus 1105 can transmit data over wireless data link 1135 using a different frequency carrier. As another example, when system 1100 includes multiple probes 100, each probe 100 can transmit data over wireless data link 1125 using a different frequency carrier. It will be appreciated that a variety of multiple access techniques such as time or code division, could be alternatively used.
  • The data communicated along wireless data link 1125, wired data link 1130, and wireless data link 1135 can be encrypted in whole or in part. The encryption can be symmetric or asymmetric. The encryption can rely upon encryption keys based on the probe identifier or on alphanumeric codes transmitted with the encrypted data. The encryption may be intended to be decrypted by a specific probe 100, a specific data collection apparatus 1105, or a specific data management system 1110. In one implementation, data communicated along wired data link 1130 is encrypted using 128 bit encryption at the SSL layer of the TCP/IP protocol.
  • Both proprietary and public protocols can be used to exchange data between probe 100, data collection apparatus 1105, and data management system 1110. For example, the global system for mobile communications (GSM), Bluetooth, and/or the internet protocol (IP) can be used.
  • In one implementation, wireless link 1125 is a spread-spectrum RF signal at wireless medical band frequencies such as the Medical Implant Communications Service (MICS) (400-406 MHz) or the Wireless Medical Telemetry Service (WMTS) (609-613 MHz and 1390-1395 MHz).
  • Data management system 1110 is a data processing device that conducts operations with the data collected by probe 100 that relates to hydration of the organism. The operations can be conducted in accordance with the logic of instructions stored in machine-readable format. The conducted operations can include the processing of such data, the display of such data, and the storage of such data.
  • Data management system 1110 can be remote from data collection apparatus 1105 in that data management system 1110 need not be part of a local data communication network that includes data collection apparatus 1105. For example, data management system 1110 can be a data processing apparatus that is accessible by one or more medical personnel.
  • The processing of data by data management system 1110 can include data analysis to identify disease states in monitored organisms or problems with the monitoring. For example, data management system 1110 can perform impedance analysis using model equivalent circuits to determine hydration levels at different locations in a monitored organism.
  • The display of data by data management system 1110 can include the rendition of the results of hydration monitoring on one or more input/output devices 1115. Input/output device 1115 can include visual, auditory, and/or tactile display elements that can communicate information to a human user (such as medical personnel). For example, input/output device 1115 can include a monitor, a speaker, and/or a Braille output device. Input/output device 1115 can also include visual, auditory, and/or tactile input elements such as a keyboard, a mouse, a microphone, and/or a camera. Input/output device 1115 can thus render visual, auditory, and/or tactile results to a human user and then receive visual, auditory, and/or tactile input from the user.
  • The storage of data by data management system 1110 can include the storage of the results of hydration monitoring on one or more data storage devices 1120 that retain information in machine-readable format. Data storage devices 1120 can include volatile and/or nonvolatile memory. For example, data storage devices 1120 can be a RAM device, a ROM device, and/or a memory disk.
  • In operation, all or some of the constituent components of system 1100 can operate in one or more operational stages. For example, during a test stage, the constituent components of system 1100 can test themselves to determine that they are functional. For example, probe 100 and data collection apparatus 1105 can confirm that they are capable of exchanging data along link 1125, and data collection apparatus 1105 and data management system 1110 can confirm that they are capable of exchanging data along one or more of links 1130, 1135. As another example, probe 100 can confirm that inputs 120, 125 and outputs 130, 135 are properly positioned relative to a monitored organism. For example, when inputs 120, 125 and outputs 130, 135 are electrodes 245, 250, 255, 260, probe 100 can confirm that electrodes 245, 250, 255, 260 are in electrical contact with the followed portion of the monitored organism.
  • During a setup stage, parameters relating to the monitoring of the hydration of an individual can be arranged. For example, a probe 100 can determine the baseline measurement result for a given hydration level in a portion of a monitored organism and adjust monitoring parameters accordingly. For example, the input signal level can be increased to accommodate dry skin and high transdermal impedances. Data collection apparatus 1105 can receive user input over one or more of local user input portion 1205, wireless data communication portion 1215, and wired data communication portion 1217. The received input can identify monitoring parameters that are to be adjusted, such as the level at which an alert is to be sounded at probe 100 and/or data collection apparatus 1105. Data management system 1110 can also receive user input relating to the arrangement of monitoring parameters. For example, data management system 1110 can receive input from medical personnel over input/output device 1115 indicating that hydration measurement results are to be transmitted by probe 100 to data collection apparatus over link 1125 once every four hours. This timing parameter can be relayed from data management system 1110 over link 1130 to data collection apparatus 1105 which relays the timing parameter over wireless link 1125 to probe 100.
  • Parameters relating to the communication of information over one or more of links 1125, 1130, 1135 can also be arranged during a setup stage. For example, the constituent components of system 1100 can select communication protocols or parameters for communication protocols.
  • During a synchronization stage, clocks in two or more of probe 100, data collection apparatus 1105, and data management system 1110 are synchronized to enable synchronous data transmission along one or more of links 1125, 1130, 1135. For example, in one implementation, data collection apparatus 1105 transmits synchronization characters to data management system 1110 over wired data link 1130. Data management system 1110 can receive the synchronization characters and compares the received characters with a synchronization pattern. When the received characters correspond sufficiently with the synchronization pattern, data management system 1110 can exit the synchronization stage and exchange other data synchronously with data collection apparatus 1105 over link 1130. Such a synchronization process can be repeated periodically.
  • In one implementation, data collection apparatus 1105 can receive and/or display a serial number or other identifier of a synchronized probe 100.
  • During a measurement stage, one or more probes 100 can collect data relating to the hydration of one or more monitored individuals. The probes 100 can perform data processing on the collected data, including bioelectric impedance data analysis, filtering, and, event identification.
  • The probes 100 can transmit data relating to the hydration monitoring (including results of processing and analyzing collected data) to one or more data collection apparatus 1105. The transmitted data can include a probe identifier that identifies the transmitting probe 100. The transmitted data can be encrypted.
  • Data collection apparatus 1105 can receive the data transmitted from probe 100 and update local user output portion 1210 based on the received data. The updating can include indicating, in operational mode display region 1245, that probe 100 is monitoring hydration, displaying, in measurement result display region 1255, recent monitoring results, and generating, in alert display region 1260, an alert to a user who is local to data collection apparatus 1105. The alert can indicate, e.g., that a monitored individual is suffering from one or more disease states or that monitoring has somehow become impaired.
  • Data collection apparatus 1105 can also command one or more probes 100 to transmit data relating to the hydration monitoring over link 1125. For example, data collection apparatus 1105 can transmit a query to probe 100. The query can request that probe 100 provide information regarding some aspect of the hydration monitoring. For example, a query can request that probe 100 transmit a confirmation that hydration monitoring is occurring over link 1125, a query can request that probe 100 transmit a recent measurement result over link 1125, or a query can request that probe 100 transmit one or more events of a particular character over link 1125. Data collection apparatus 1105 can transmit queries to probe 100 periodically, e.g., every hour or two.
  • Data collection apparatus 1105 can also relay some or all of the data transmitted from probe 100 to data management system 1110. The data can be relayed over one or more data links 1130, 1135. Data collection apparatus 1105 can relay such data directly, i.e., without performing additional analysis on the information, or data collection apparatus 1105 can perform additional processing on such before relaying a subset of the data to data management system 1110. Data collection apparatus 1105 can notify a local user that data has been relayed by displaying a data relay notice on local user output portion 1210. Alternatively, data can be relayed by data collection apparatus 1105 without notification to a local user.
  • Data collection apparatus 1105 can also receive user input over one or more of local user input portion 1205, wireless data communication portion 1215, and wired data communication portion 1217. The received input can identify that data collection apparatus 1105 is to transmit data to one or more probes 100 over link 1125. For example, the received input can identify that data collection apparatus 1105 is to instruct probe 100 to generate an alarm signal indicating that a monitored person suffers under a disease state. As another example, the received input can identify that data collection apparatus 1105 is to transmit a query to a probe 100 over wireless link 1125. As another example, the received input can identify that data collection apparatus 1105 is to transmit an instruction instructing probe 100 to change a parameter of the hydration monitoring, including one or more threshold values for identifying a disease state.
  • Data collection apparatus 1105 can also perform data processing and storage activities that supplement the data processing and storage activities of probe 100. For example, data collection apparatus 1105 can perform more extended data analysis and storage, including signal processing and analysis. For example, data collection apparatus 1105 can perform impedance analysis using model equivalent circuits to determine hydration levels at different locations in a monitored organism. As another example, data collection apparatus 1105 can perform trending analyses that identify a general tendency of hydration levels to change over extended periods of time, or data collection apparatus 1105 can perform comparisons between hydration levels obtained using multiple probes 100. The multiple probes 100 can monitor the hydration of a single organism, or the multiple probes can monitor the hydration of multiple organisms. Data collection apparatus 1105 can compare and correlate monitoring results from multiple probes to calibrate one or more probe 100 and minimize errors during monitoring.
  • Data collection apparatus 1105 can also compare and/or correlate the results of hydration monitoring with the results of monitoring other biological parameters. For example, data collection apparatus 1105 can compare and correlate the results of hydration monitoring with the results of heart monitoring, drug delivery schedules, and temperature monitoring. Data collection apparatus 1105 can receive the other monitoring results over one or more of local user input portion 1205, wireless data communication portion 1215, and wired data communication portion 1217. For example, data collection apparatus 1105 can receive the other monitoring results over one or more of links 1125, 1130, 1135.
  • Data collection apparatus 1105 can also exchange data with other devices and systems (not shown in FIG. 11). For example, data collection apparatus 1105 can receive other monitoring results directly from other monitoring instruments. As another example, data collection apparatus 1105 can transmit data relating to the results of hydration monitoring to other local or remote parties. The other parties can be external entities in that they do not share a legal interest in any of the constituent components of system 1100. For example, the other parties can be a medical group that has contracted with an owner of system 1100 to monitor hydration of an individual.
  • Data management system 1110 can receive the results of hydration monitoring from data collection apparatus 1105 over one or both of data link 1130, 1135. The received results can include analyses of the hydration of an organism, as well as comparisons and correlations of monitoring results from multiple organisms or other biological parameters.
  • Data management system 1110 can conduct operations with the received data, including processing the data to identify disease states and problems with the monitoring. For example, data management system 1110 can perform impedance analysis using model equivalent circuits to determine hydration levels at different locations in a monitored organism. As another example, data management system 1110 can perform trending analyses that identifies a general tendency of hydration levels to change over extended periods of time, or data management system 1110 can perform comparisons between hydration levels obtained using multiple probes 100. The multiple probes 100 can monitor the hydration of a single organism, or the multiple probes can monitor the hydration of multiple organisms. Data management system 1110 can compare and correlate monitoring results from multiple probes to calibrate one or more probe 100 and minimize errors during monitoring. Data management system 1110 can also perform analyses that require hydration monitoring results from statistically significant numbers of organisms. Such analyses can include billing assessments, geographic assessments, epidemiological assessments, etiological assessments, and demographic assessments.
  • Data management system 1110 can render the results of hydration monitoring on one or more input/output devices 1115 and store the results of hydration monitoring on one or more data storage devices 1120. Data management system 1110 can also provide the results of the data processing to data collection apparatus 1105 and/or probe 100 over data links 1125, 1130, 1135. The provided results can include an indication that a disease state is present and/or an indication that probe 100 should generate an alarm signal indicating that a monitored organism suffers under a disease state. Data management system 1110 can also provide such indications to external entities, including medical personnel interacting with input/output device 1115 and medical personnel in the vicinity of the monitored organism. For example, an emergency medical technician (EMT) can be informed that a monitored individual in the EMT's vicinity suffers from acute dehydration. As another example, data management system 1110 can also post an indication in an external system such as the clinical information system of a healthcare organization or an Internet portal.
  • In one implementation, data management system 1110 can request, from data collection apparatus 1105 and/or probe 100, that additional monitoring activities be performed. The request can be spurred by the results of analyses performed at data collection apparatus 1105 and/or the analyses performed at data management system 1110. The request can also be spurred by a human user such as medical personnel interacting with input/output device 1115. The requests can be based on the results of hydration monitoring. The additional monitoring activities can be directed to other biological parameters, or the additional monitoring activities can be directed to gaining more information about the hydration of the monitored individual. For example, data management system 1110 can identify surveys and/or survey questions that are to be presented to a monitored organism to facilitate hydration monitoring. A survey is a series of questions designed to gather information about the hydration of a monitored organism. A survey is generally presented to a monitored organism, but a survey can also be presented to individuals having contact with the monitored organism. A survey can be presented, e.g., over a telephone or through the mail. Survey and survey questions can be generated before monitoring begins and stored, e.g., at probe 100, data collection apparatus 1105, and/or data management system 1110.
  • Survey questions can be directed to ascertaining, e.g., body position of a monitored organism, length of time that the monitored organism has been in one position, the diet of the monitored organism, the activity level of the monitored organism, or the time zone of the monitored organism. Example survey questions include “Are you currently exercising?”, “Did you remove the probe?”, and “Have you recently taken a diuretic?” The questions presented during a survey can depend upon the responses to previous questions. For example, if a monitored individual has removed probe 100, subsequent questions can be deleted.
  • Responses to the questions in the survey can be received using, e.g., an interactive voice recognition system (IVRS) or keypad entry on a touch tone phone. Data management system 1110 can present the survey itself or data management system 1110 can direct another system to present the survey. The responses to survey questions can be scored based upon a predetermined criteria set and used in further analyses in hydration monitoring.
  • FIG. 13 shows another implementation of a system for monitoring the hydration of an organism, namely a system 1300. In addition to one or more data collection apparatus 1105, data management system 1110, input/output device 1115, and data storage device 1120, system 1300 includes a collection of multiple probes 100, 1305, 1310, 1315. Together, probes 100, 1305, 1310, 1315 form a data “hopping” network 1317 in which data can be transferred amongst probes 100, 1305, 1310, 1315. In particular, in network 1317, probe 1305 exchanges data with probe 100 over a wireless data link 1320. Probe 1310 exchanges data with probe 1305 over a wireless data link 1325. Probe 1315 exchanges data with probe 1310 over a wireless data link 1330. The data exchanged amongst probes 100, 1305, 1310, 1315 over data links 1320, 1325, 1330 can include hydration monitoring results, biological parameter monitoring results, queries, parameter change commands, encryption keys, probe identifiers, handshakes, surveys, and other information.
  • Such a “hopping” network 1317 may extend the range and robustness of data communication in system 1300.
  • FIG. 14 shows another implementation of a system for monitoring the hydration of an organism, namely a system 1400. In addition to one or more data collection apparatus 1105, data management system 1110, input/output device 1115, and data storage device 1120, system 1400 includes a pharmaceutical dispenser 1405. Pharmaceutical dispenser 1405 is a device that provides compositions for ameliorating a disease state of an individual. Pharmaceutical dispenser 1405 can provide such a composition to an individual automatically (i.e., without human intervention) or pharmaceutical dispenser 1405 can provide such a composition in conjunction with the efforts of one or more individuals. For example, pharmaceutical dispenser 1405 can be an implanted controlled-release drug delivery device or pharmaceutical dispenser 1405 can be a pill dispenser that is accessible by a monitored individual or by medical personnel.
  • Pharmaceutical dispenser 1405 includes a communications element 1410. Communications element 1410 can place dispenser 1405 in data communication with the constitutent components of system 1400. For example, in one implementation, communications element 1410 can establish a wireless data link 1415 between dispenser 1405 and data collection apparatus 1105.
  • In operation, pharmaceutical dispenser 1405 can receive data such as dispensation instructions from the constitutent components over communications element 1410. For example, when one or more of probe 100, data collection apparatus 1105, and data management system 1110 identify, based at least in part on the results of hydration monitoring, that a monitored individual suffers under one or more disease states, pharmaceutical dispenser 1405 can receive instructions over element 1410 that instruct dispenser 1405 to provide a composition to the monitored individual that ameliorates the identified disease state.
  • In response to the receipt of dispensation instructions, pharmaceutical dispenser 1405 can provide a composition for ameliorating a disease state to the monitored individual. For example, pharmaceutical dispenser 1405 can release a drug into the monitored individual's body or pharmaceutical dispenser 1405 can prepare a dosage of medicine for the monitored individual. The dispensation of a composition by pharmaceutical dispenser 1405 can be recorded at one or more memory devices in system 1400, e.g., for use in analyzing the results of hydration monitoring.
  • FIG. 15 shows an example of a model equivalent circuit 1500 that can be used in monitoring the hydration of an organism. In particular, model equivalent circuit 1500 that can be used to model the electrical conductivity of an organism. Circuit 1500 models the impedances observed in bioelectric impedance spectroscopy using a probe 200 that supports electrodes 245, 250, 255, 260 above a skin surface 1505 of an organism 1510.
  • Model circuit 1500 includes a series of surface impedances 1515, 1520, 1525, a series of transdermal impedances 1530, 1535, 1540, 1545, and a series of subdermal impedances 1550, 1555, 1560. Surface impedances 1515, 1520, 1525 can model the surface electrical impedances between the relevant of electrodes 245, 250, 255, 260. Surface impedances 1515, 1520, 1525 can model both the conductivity through the surface of the skin and the conductivity through sweat and other conducting fluids on the surface of the skin. In one implementation, surface impedances 1515, 1520, 1525 are modeled as non-reactive (i.e., resistive) elements.
  • Transdermal impedances 1530, 1535, 1540, 1545 can model the electrical impedances through the skin of a monitored organism. Transdermal impedance 1530 includes a resistive component 1565 and a reactive component 1570. Transdermal impedance 1535 includes a resistive component 1575 and a reactive component 1580. Transdermal impedance 1540 includes a resistive component 1585 and a reactive component 1590. Transdermal impedance 1545 includes a resistive component 1595 and a reactive component 1597. Reactive components 1570, 1580, 1590, 1597 can model the electrical impedance through dense cellular layers as a capacitive element, whereas resistive components 1565, 1575, 1585, 1595 can model the electrical impedance through hydrated and other portions of the skin as a resistive element.
  • Subdermal impedances 1550, 1555, 1560 can model electrical impedances through a monitored organism. For example, subdermal impedances 1550, 1555, 1560 can model the electrical impedances of a portion of the monitored organism as a resistive volume conductor bounded by the skin.
  • In one implementation, in bioelectric impedance spectroscopy, probe 200 supports electrodes 245, 250, 255, 260 above skin surface 1505. Current source 210 can drive electrical current between electrodes 245, 250. The driven current can include both direct current and alternating current components. The potential at electrodes 245, 250, 255, 260 provides information about the net impedance across equivalent circuit 1500 as well as the impedance of different paths across equivalent circuit 1500.
  • For example, when direct current is driven across circuit 1500, a large portion of the direct current will pass through surface impedances 1515, 1520, 1525. Potential measurements at electrodes 245, 250, 255, 260 under direct current application can be used to estimate the impedance of surface impedances 1515, 1520, 1525. When certain frequencies of alternating current are driven through circuit 1500, some portion of the alternating current can pass through surface impedances 1515, 1520, 1525, transdermal impedances 1530, 1535, 1540, 1545, and subdermal impedances 1550, 1555, 1560. Potential measurements at electrodes 245, 250, 255, 260 can be used to estimate impedances 1515, 1520, 1525, 1530, 1535, 1540, 1545, 1550, 1555, 1560. Such estimations can be made in light of the estimations of surface impedances 1515, 1520, 1525 made using direct current.
  • The impact of various factors on the electrical conductivity of an organism can be accommodated by changing the mathematical analysis of model circuit 1500 or by changing aspects of data collection. For example, when surface impedances 1515, 1520, 1525 are particularly low, e.g., due to heightened conductivity through sweat or other conducting fluids on the surface of the skin, the measured potentials at electrodes 245, 250, 255, 260 can be mathematically corrected to accommodate the lowered conductivity. For example, previously obtained surface impedance estimates can be used to estimate the effect that changes in surface impedances 1515, 1520, and 1525 have on the total impedance measurement, and thus isolate the change in sub-dermal impedance so as to more accurately monitor changes in subdermal tissue hydration. Alternatively, bioelectric spectroscopy measurements can be delayed altogether or probe 200 can output an indication to a monitored individual that the individual should dry the measurement region.
  • Model equivalent circuit 1500 can be used in conjunction with custom approaches to data analysis for monitoring the hydration of an organism. Such data analysis approaches can be used to interpret monitoring data and to identify changes in the amount and distribution of water in a monitored organism. Data analysis approaches can also be used to incorporate results of other bioparameter measurements and responses to survey questions into the hydration monitoring.
  • Data analysis approaches can be performed in accordance with the logic of a set of machine-readable instructions. The instructions can be tangibly embodied in machine-readable format on an information carrier, such as a data storage disk or other memory device. The instructions can also be embodied in whole or in part in hardware such as microelectronic circuitry.
  • Data analysis approaches can yield analysis results that can be displayed to a human user. The human user can be the monitored individual or another individual, such as a medical professional. The analysis results can be displayed in response to a prompt from the user or automatically, i.e., without user input. For example, the analysis results can be displayed automatically when hydration indicative of a disease state is identified. When hydration monitoring is performed using a system 1100, analysis results can be displayed at a probe 100, at a data collection apparatus 1105, and/or at a data management system 1110 (FIGS. 11, 13, 14). Analysis results can be displayed using other output devices such as the postal service, facsimile transmission, voice messages over a wired or wireless telephone network, and/or the Internet or other network-based communication modalities.
  • Data analysis can be performed continuously or intermittently over extended periods of time. The analyzed data can be measurement results collected continuously or intermittently. The analyzed data can be a subset of the data collected or the analyzed data can be all of the data collected. For example, the analyzed data can be intermittent samples redacted from the results of continuous hydration monitoring.
  • One advantage of the analysis of hydration monitoring results obtained over extended periods of time is that long term monitoring may be achieved. The monitoring can be long term in that diurnal, monthly, or other variations in hydration that are not associated with disease states can identified. The monitoring can be individualized in that the analysis results are relevant to a specific monitored organism.
  • Data analysis can accommodate both long and short term variations in hydration that are not associated with disease states by reducing the effect of such variation on analysis. For example, data analysis can accommodate variations associated with respiration and other types of movement. For example, peak/trough analysis and/or frequency analysis of hydration monitoring results obtained from the chest can be used to determine the breathing period. This can be done, e.g., by identifying the rate of change between discrete data points in the measurement results. Once the breathing period is identified, specific measurement results (such as those associated with exhalation) can be identified and relied upon in subsequent analyses.
  • Changes in impedance measurements due to electrode movement over time or with wear can also be accommodated in data processing routines if necessary.
  • As another example, data analysis can accommodate diurnal or monthly variations. Such variations can be identified by peak/trough analysis and/or frequency analysis of longer term measurement results. For example, specific measurement results (such as those associated with exhalation) can be used to identify any reproducible diurnal and/or monthly variability in hydration. Such variability can be accommodated in subsequent measurement results by subtraction of the prior variability or other adjustment approaches.
  • For example, the diurnal pattern of hydration monitoring results may indicate that there is a significant likelihood of a 3% decrease in a bioelectric impedance value for a specific organism in the late afternoon relative to early morning. Hydration measurement results obtained at either time may be adjusted or modified by interpolation to reflect the decrease. Such adjustments can be made to account for predictable or habitual patterns such as, e.g., daily exercise routines or eating/drinking habits.
  • As another example of accommodating diurnal variations, only measurement results obtained during patterned times of regular breathing (for example, during sleep) are relied upon in subsequent analyses. Such patterned times can be identified, for example, by determining the rate of change in hydration monitoring results. Such patterned times can be used in conjunction with measurement results obtained with a known hydration status (e.g., the monitored individual is “dry” and unaffected by pulmonary edema) to adjust decision criteria and other analysis parameters.
  • Other variations in hydration monitoring results, including random variations such as electronic stray signal or positional signal noise, can be accommodated using digital and/or analog filters, signal averaging, data discarding techniques, and other approaches.
  • Data analysis of hydration monitoring results can be used to establish a baseline of typical hydration characteristics so that deviations from the baseline, e.g., in response to disease states or other stresses, can be identified. The baseline of typical hydration characteristics can be individualized and relevant to a specific monitored organism, or the baseline of typical hydration can reflect the average hydration of a population of individuals. For example, extended monitoring results can be analyzed to establish a population database of tolerances and ranges for the identification of individual disease states, deviations, and/or anomalies, as well as population trends (as discussed further below). Such a baseline can be obtained for healthy and/or diseased populations with a variety of demographic characteristics.
  • In contrast, transient periodic hydration monitoring of an individual (such as, e.g., monitoring an individual for a short time once a day or once a week) is less likely to detect individual variations, deviations, or anomalies and does not contribute to the establishment of a population database.
  • Data analysis can include the analysis of subsets of the total hydration monitoring results. The analyzed subsets can have common characteristics that distinguish the subsets from unanalyzed hydration monitoring results. For example, the analyzed subsets can have high signal-to-noise ratios, analyzed subsets can be obtained under dry conditions (e.g., when surface impedances 1515, 1520, 1525 (FIG. 15) are relatively high), analyzed subsets can be obtained when good contact is maintained between a monitored organism and inputs 120, 125 and outputs 130, 135 (FIG. 1), or analyzed subsets can be obtained at the same time of day.
  • Data analysis operations can be performed at one or more of probe 100, data collection apparatus 1105, and/or data management system 1110. In one implementation, data analysis is distributed between probe 100 and data collection apparatus 1105. In particular, probe 100 can perform initial analyses, including signal processing, noise filtering, and data averaging operations. The operations can be performed on data from one or more measurements taken at one or more frequencies. The operations can be performed on raw data or on data where variations have been accommodated. For example, the operations can be performed on data collected at certain points during breathing. These initial analysis results can be transmitted, along with other information such as a probe identifier and a time/date stamp, to data collection apparatus 1105. At data collection apparatus 1105, data analysis operations can include the identification of trends or shifts in hydration associated with disease states such as pulmonary edema, as well as comparisons between received data and threshold values.
  • In another implementation, data analysis operations are performed primarily at data collection apparatus 1105 and data analysis at probe 100 is minimal. When data analysis at probe 100 is minimal, data analysis and data storage can be consolidated at data collection apparatus 1105 and probe 100 can include simplified circuitry with reduced power requirements and cost.
  • Data analysis can also be performed at data management system 1110. Such data analysis can include multivariable analysis where hydration monitoring results are analyzed in light of other statistical variables such as weight, heart rate, respiration, time of day, month, eating patterns, physical activity levels, and other variables. The other statistical variables need not be entirely independent of the hydration monitoring results. The hydration monitoring results used in multivariable analysis can be obtained over extended periods (e.g., days, weeks, or months) from one or more organisms. The results of such multivariable analysis can be used to develop new and improved analyses of hydration monitoring results, including improved algorithms, improved pattern definition techniques, and/or artificial intelligence systems.
  • A variety of other analysis techniques can be applied to hydration monitoring results. These include the use of established guideline values for data that is used to determine fluid changes associated with the onset or progression of pulmonary edema. Also, clinician-modified variables such as tailored threshold values can be applied to permit increased accuracy and specificity.
  • These and other analyses of hydration monitoring results can be made in light the results of monitoring other biological parameters such as respiration, heart rate, hormone (e.g., B-type natriuretic peptide (BNP)) levels, metabolite levels (e.g., blood urea nitrogen (BUN) and/or Na+/K+ levels), wedge pressure measurements, electrocardiogram measurements, and others. Analyses made in light of such other parameters may improve the information provided by the analysis process.
  • Data analysis can include comparisons involving recent hydration monitoring results. For example, recent hydration monitoring results can be compared with previous hydration monitoring results, predicted results, or population results. Future hydration monitoring results can be predicted based on the current state of the monitored individual and on past hydration monitoring results obtained with the same or with other individuals or a population or demographic group. Such comparisons may include, for example, the use of population data tables, multiple reference measurements taken over time, or the results of trend analyses based upon extended hydration monitoring.
  • Such comparisons can also involve other factors, including other bioparameters. For example, hydration monitoring results can be weighted by one or more factors before comparisons are performed. Examples of such factors include the monitored individual's age, weight, height, gender, general fitness level, ethnicity, heart rate, respiration rate, urine specific gravity value, blood osmolality measurement, time of day, altitude, state of hydration (either subjective or objective), cardiac waveforms, left ventricle ejection fraction, blood oxygen levels, secreted potassium or sodium ions levels, skin surface temperature, ambient temperature, core body temperature, activity/motion assessment, humidity, and other bioparameters.
  • With trend analysis and prediction of future hydration state, it is possible to prevent serious hydration problems from occurring by providing treatment or intervention recommendations to the subject and/or a care provider prior to serious hydration problems occurring. For ambulatory healthy subjects, a downward hydration trend over a selected period can be detected and a recommended fluid intake could be presented automatically. The timing and nature of the recommendation could be also based at least in part on the age, gender, or other relevant factors. For some conditions, such as a prediction that fluid is building in lung tissue during the onset of pulmonary edema, a recommended intake of a pharmaceutical agent can be automatically provided.
  • Hydration monitoring can proceed in a variety of different environments using a variety of different procedures to monitor a variety of different disease states. For example, in one implementation, where hydration is monitored for indications of pulmonary edema, monitoring can commence after an individual has been identified as at risk for pulmonary edema. For example, such an individual may have been admitted to a care facility for treatment of pulmonary edema. Hydration can be monitored as the individual is “dried out” and excess fluid load in the thoracic region is reduced. Hydration monitoring can be continued after the individual is “dried out.” For example, hydration monitoring can continue after such an individual is released from the care facility, and even as the individual returns to performing workday activities. Through all or a part of this time, hydration monitoring can be ongoing and rely upon a portable probe that can be moved from a fixed location by the individual and still perform at least some output signal generation. Analysis of the results of such hydration monitoring can be used to gather information about the reonset and/or progression of pulmonary edema, both in the monitored patient and in population groups that include the monitored patient.
  • Hydration monitoring can be performed to achieve a variety of different objectives, including the identification of levels and distributions of water in organisms that are indicative of one or more acute or chronic disease states. Examples of such monitoring follow.
  • EXAMPLE 1 Ambulatory Bioelectric Impedance Monitoring to Monitor Dehydration of an Individual
  • Many individuals find themselves in activities or in environments that are conducive to dehydration. Such activities may include athletics, public safety activities performed by officers/firefighters, combat, and other activities requiring physical exertion. Such environments include hot and humid locales.
  • In these cases, one or more strap probes can be deployed along a thigh of such individuals to continually monitor the hydration of such individuals. Alternatively, probes can be incorporated into clothing such as the pants and sock illustrated in FIGS. 9A and 9B.
  • During the initialization of hydration monitoring, a range of data, including hydration monitoring results and the results of monitoring other bioparameters, can be transmitted to one or more data processing devices that perform analysis operations. The transmitted data can be used by such devices to establish a baseline from which relative changes in hydration can be determined. The transmitted data can include, e.g., urine specific gravity, blood osmolality, and/or other parameters indicative of hydration status, including, e.g., anthropometric data such as segment size, age, height, weight, and general fitness level.
  • The established baseline can be returned to the probe and used by the probe to provide instantaneous alarms when hydration monitoring results indicative of dehydration are obtained. Further, the results of hydration monitoring generated by the probe can be transmitted to a data collection apparatus and/or data management system for analysis and archiving.
  • A data collection apparatus and/or data management system can also identify hydration monitoring results that are indicative of dehydration. For example, when hydration decreases by a certain threshold amount (e.g., 3%), a data collection apparatus and/or data management system can record the decrease and then trigger an alarm signal at the probe and/or the data collection apparatus. For example, the extent of dehydration can be displayed along with a recommended fluid replacement volume and a recommended recovery time. Further, the alert can be relayed to a third party such as an athlete's coach, a supervisor, or medical personnel.
  • Following a period of monitoring, the monitored individual can remove and replace a probe. The new probe can synched to the data collection apparatus and provided with new baseline impedance measurements.
  • EXAMPLE 2 Ambulatory Bioelectric Impedance Monitoring of Individuals Using a Data Collection Apparatus Incorporated into Other Equipment
  • A data collection apparatus can be incorporated into a device commonly used by individuals who find themselves in activities or in environments that are conducive to dehydration. For example, a data collection apparatus can be incorporated into safety equipment, the handlebars of a bicycle, a helmet, or gloves. When hydration monitoring results indicative of a disease state such as dehydration are obtained, the data collection apparatus can alert the individual and/or others in the individual's vicinity of the results. For example, a light on the outside of a football player's helmet can flash to alert teammates and coaches of the player's hydration monitoring results. These alerts can be graded with the severity of the hydration monitoring results so that the player and teammates have timely warning prior to passing critical hydration thresholds, such as greater than 5% dehydration.
  • EXAMPLE 3 Ambulatory Bioelectric Impedance Monitoring of Individuals in Motorized Vehicles
  • Many individuals who operate motor vehicles are ambulatory but have their mobility restricted in that they are confined within the vehicle for extended times. Such vehicles include cars, airplanes, tanks, ships, and other transportation devices.
  • Probes for monitoring the hydration of such individuals can be incorporated into motor vehicles, e.g., at a steering wheel, joystick, or other surface that contacts operating individuals either continually or intermittently. Intermittent contact can be accommodated by limiting data analysis to data obtained during periods of good contact between the probe and the monitored organism.
  • Such vehicles can also include a data collection apparatus. In some implementations, the data collection apparatus can share generic components with the vehicle to perform various operations. Such components include vehicle display systems and data communication devices.
  • When hydration monitoring results indicative of a disease state such as dehydration are obtained, the data collection apparatus can alert the individual and/or others in the individual's vicinity of the results. For example, a pit crew can be notified that a driver is becoming dehydrated or a commanding officer can be notified that soldiers in his/her command are becoming dehydrated.
  • Although a number of implementations have been described, changes may be made. For example, bandage probes can be incorporated into clothing. Probe 100 can communicate with data collection apparatus 1105 by a wired data link. Both probe 100 and data collection apparatus 1105 can be incorporated into other items or equipment such as a vehicle, a radio unit, a shoe, football equipment, fire fighting equipment, gloves, hydration systems, bicycle handlebars, and other devices. Data communication along data link 1125 can be asynchronous, and the synch operational mode eliminated from data collection apparatus 1105.
  • As shown in FIG. 16, multiple probes (i.e., probes 500 and 500′) can be deployed at different locations at an organism 405 to monitor the hydration of the organism. In particular, strap probe 500 is sized to encircle the thigh of person 405 and is deployed to probe the conductivity of the thigh of person 405, whereas strap probe 500′ is sized to encircle the lower leg of person 405 and is deployed to probe the conductivity of the lower leg of person 405.
  • The measurement results from the probes 500, 500′ can be compared and correlated for calibration and error minimization. For example, probe 500′ can provide hydration measurement results that are used to identify disease states such as congestive heart failure where water accumulates in the lower legs, and probe 500 can provide hydration measurement results that are used to calibrate the hydration measurement results obtained using probe 500′. Such a calibration can include making differential measurements that accommodate variation in the hydration monitoring results that is unrelated to cardiac failure.
  • FIG. 17 shows an implementation of a system that uses multiple probes for monitoring the hydration of an organism, namely a system 1700. In addition to one or more data collection apparatus 1105, data management system 1110, input/output device 1115, and data storage device 1120, system 1700 includes probes 500, 500′. Probes 500, 500′ can be deployed on a single organism 405 as shown in FIG. 16. Probes 500, 500′ can both establish wireless data links 1125 with data collection apparatus 1105 to communicate information used in hydration monitoring.
  • Accordingly, other implementations are within the scope of the following claims.

Claims (13)

1. A system for ambulatory physiological monitoring comprising:
at least one adhesive patch positioned on at least a portion of a subject, said patch comprising a plurality of sensors and at least one communication module, said sensors being configured to sense one or more physiological parameters comprising at least electrical impedance;
a data collection unit configured to receive information collected from said sensors from said communication unit.
2. The system of claim 1, additionally comprising a remote data management system configured to receive information from said data collection unit and process said information.
3. The system of claim 1, wherein said adhesive patch is secured to at least a portion of a thorax of said subject.
4. The system of claim 1, additionally comprising a temperature sensor.
5. The system of claim 1, additionally comprising a subsurface temperature sensor.
6. The system of claim 1, wherein said data collection unit is also configured to process information before sending information to said remote data management system.
7. The system of claim 1, comprising a timer for associating at least one measurement with an absolute time the measurement was taken.
8. The system of claim 1, wherein said remote database is configured to establish an individual baseline parameter value.
9. The system of claim 1, wherein the data management system provides feedback to the data collection unit and/or the communication module.
10. The system of claim 1, wherein said feedback comprises diagnostic knowledge.
11. The system of claim 1, wherein said feedback comprises actions and/or instructions.
12. The system of claim 1, comprising a plurality of communication modules.
13. The system of claim 1, comprising a plurality of data collection units.
US11/841,947 2001-06-29 2007-08-20 Hydration monitoring Abandoned US20080039700A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/841,947 US20080039700A1 (en) 2001-06-29 2007-08-20 Hydration monitoring

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US30189701P 2001-06-29 2001-06-29
US10/032,765 US7044911B2 (en) 2001-06-29 2001-10-29 Gateway platform for biological monitoring and delivery of therapeutic compounds
US49655803P 2003-08-20 2003-08-20
US57085204P 2004-05-13 2004-05-13
US10/922,370 US7783344B2 (en) 2003-08-20 2004-08-20 Hydration monitoring
US11/410,519 US8632463B2 (en) 2001-06-29 2006-04-25 Gateway platform for biological monitoring and delivery of therapeutic compounds
US11/841,947 US20080039700A1 (en) 2001-06-29 2007-08-20 Hydration monitoring

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
US10/922,370 Continuation US7783344B2 (en) 2001-06-29 2004-08-20 Hydration monitoring
US11/410,519 Continuation US8632463B2 (en) 2001-06-29 2006-04-25 Gateway platform for biological monitoring and delivery of therapeutic compounds

Publications (1)

Publication Number Publication Date
US20080039700A1 true US20080039700A1 (en) 2008-02-14

Family

ID=34221417

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/922,370 Expired - Fee Related US7783344B2 (en) 2001-06-29 2004-08-20 Hydration monitoring
US11/841,947 Abandoned US20080039700A1 (en) 2001-06-29 2007-08-20 Hydration monitoring

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US10/922,370 Expired - Fee Related US7783344B2 (en) 2001-06-29 2004-08-20 Hydration monitoring

Country Status (6)

Country Link
US (2) US7783344B2 (en)
EP (2) EP2382920A1 (en)
JP (2) JP5449647B2 (en)
AU (1) AU2004266725B2 (en)
CA (1) CA2539547A1 (en)
WO (1) WO2005018432A2 (en)

Cited By (129)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080234600A1 (en) * 2004-03-04 2008-09-25 Leon Thomas Lee Marsh Hydration Monitor
US20080270051A1 (en) * 2005-08-02 2008-10-30 Impedimed Limited Impedance Parameter Values
US20080284599A1 (en) * 2005-04-28 2008-11-20 Proteus Biomedical, Inc. Pharma-Informatics System
US20080306360A1 (en) * 2007-05-24 2008-12-11 Robertson Timothy L Low profile antenna for in body device
US20080306359A1 (en) * 2005-09-01 2008-12-11 Zdeblick Mark J Medical Diagnostic and Treatment Platform Using Near-Field Wireless Communication of Information Within a Patient's Body
US20080319336A1 (en) * 2004-06-18 2008-12-25 Leigh Ward Oedema Detection
US20090118594A1 (en) * 2006-07-07 2009-05-07 Mark Zdeblick Smart parenteral administration system
US20090125330A1 (en) * 2007-11-09 2009-05-14 Eric Sebban Non-invasive medical data collecting assembly
US20090131767A1 (en) * 2007-11-19 2009-05-21 Arne Lawrence W Body-associated fluid transport structure evaluation devices
US20090171237A1 (en) * 2007-12-31 2009-07-02 Nellcor Puritan Bennett Llc System and sensor for early detection of shock or perfusion failure and technique for using the same
US20090287102A1 (en) * 2008-02-15 2009-11-19 Impedimed Limited Blood flow assessment of venous insufficiency
WO2009153093A1 (en) * 2008-06-19 2009-12-23 Robert Bosch Gmbh Device for determining and/or monitoring the moisture content of the skin
US20100022836A1 (en) * 2007-03-09 2010-01-28 Olivier Colliou In-body device having a multi-directional transmitter
US20100069717A1 (en) * 2007-02-14 2010-03-18 Hooman Hafezi In-Body Power Source Having High Surface Area Electrode
US20100100003A1 (en) * 2007-01-15 2010-04-22 Impedimed Limited Monitoring system
US20100109739A1 (en) * 2007-03-30 2010-05-06 Impedimed Limited Active guarding for reduction of resistive and capacitive signal loading with adjustable control of compensation level
US20100185055A1 (en) * 2007-02-01 2010-07-22 Timothy Robertson Ingestible event marker systems
US20100234755A1 (en) * 2009-03-11 2010-09-16 Latman Neal S Electrode holder for use on hairy animals such as horses, camels, and the like
US20100239616A1 (en) * 2006-10-25 2010-09-23 Hooman Hafezi Controlled activation ingestible identifier
US20100298668A1 (en) * 2008-08-13 2010-11-25 Hooman Hafezi Ingestible Circuitry
US20110009715A1 (en) * 2008-07-08 2011-01-13 David O' Reilly Ingestible event marker data framework
US20110025348A1 (en) * 2007-11-05 2011-02-03 Impedimed Limited Impedance determination
EP2289404A1 (en) * 2009-09-01 2011-03-02 Adidas AG Multi modal method and system for transmitting information about a subject
US20110054271A1 (en) * 2009-09-01 2011-03-03 Adidas Ag Noninvasive Method And System For Monitoring Physiological Characteristics
US20110054290A1 (en) * 2009-09-01 2011-03-03 Adidas AG, World of Sports Method and System for Interpretation and Analysis of Physiological, Performance, and Contextual Information
US20110054343A1 (en) * 2005-07-01 2011-03-03 Impedimed Limited Monitoring system
US20110054272A1 (en) * 2009-09-01 2011-03-03 Adidas AG, World of Sports Method And System For Monitoring Physiological And Athletic Performance Characteristics Of A Subject
US20110054289A1 (en) * 2009-09-01 2011-03-03 Adidas AG, World of Sports Physiologic Database And System For Population Modeling And Method of Population Modeling
US20110060202A1 (en) * 2009-09-08 2011-03-10 Seth Adrian Miller Dehydration detector using micro-needles
US20110087129A1 (en) * 2005-07-01 2011-04-14 Impedimed Limited Monitoring system
US20110105861A1 (en) * 2009-09-01 2011-05-05 Adidas Ag World Of Sports Physiological Monitoring Garment
US20110130643A1 (en) * 2009-09-01 2011-06-02 Adidas Ag Noninvasive Method And System For Monitoring Physiological Characteristics And Athletic Performance
US20110212782A1 (en) * 2008-10-14 2011-09-01 Andrew Thompson Method and System for Incorporating Physiologic Data in a Gaming Environment
US20110319786A1 (en) * 2009-11-20 2011-12-29 Rebello Keith J Apparatus and Method for Measuring Physiological Functions
US8103337B2 (en) 2004-11-26 2012-01-24 Impedimed Limited Weighted gradient method and system for diagnosing disease
US20120029327A1 (en) * 2008-04-22 2012-02-02 Kimon Angelides Controlling Diabetes with a Cellular GPRS-Linked Glucometer-Pedometer
US8116841B2 (en) 2007-09-14 2012-02-14 Corventis, Inc. Adherent device with multiple physiological sensors
US20120146670A1 (en) * 2009-08-21 2012-06-14 Zdeblick Mark J Apparatus and Method for Measuring Biochemical Parameters
US8233974B2 (en) 1999-06-22 2012-07-31 Impedimed Limited Method and device for measuring tissue oedema
US8249686B2 (en) 2007-09-14 2012-08-21 Corventis, Inc. Adherent device for sleep disordered breathing
US8332020B2 (en) 2010-02-01 2012-12-11 Proteus Digital Health, Inc. Two-wrist data gathering system
US8374688B2 (en) 2007-09-14 2013-02-12 Corventis, Inc. System and methods for wireless body fluid monitoring
US8412317B2 (en) 2008-04-18 2013-04-02 Corventis, Inc. Method and apparatus to measure bioelectric impedance of patient tissue
US20130096395A1 (en) * 2010-04-05 2013-04-18 Corventis, Inc. Method and apparatus for personalized physiologic parameters
US8460189B2 (en) 2007-09-14 2013-06-11 Corventis, Inc. Adherent cardiac monitor with advanced sensing capabilities
US8540664B2 (en) 2009-03-25 2013-09-24 Proteus Digital Health, Inc. Probablistic pharmacokinetic and pharmacodynamic modeling
US8545402B2 (en) 2009-04-28 2013-10-01 Proteus Digital Health, Inc. Highly reliable ingestible event markers and methods for using the same
US20130274566A1 (en) * 2010-09-29 2013-10-17 Terumo Kabushiki Kaisha Moisture meter
US8583227B2 (en) 2008-12-11 2013-11-12 Proteus Digital Health, Inc. Evaluation of gastrointestinal function using portable electroviscerography systems and methods of using the same
US20130317367A1 (en) * 2010-05-04 2013-11-28 Michael Simms Shuler Method and system for providing versatile nirs sensors
US8597186B2 (en) 2009-01-06 2013-12-03 Proteus Digital Health, Inc. Pharmaceutical dosages delivery system
CN103648377A (en) * 2011-06-29 2014-03-19 泰尔茂株式会社 Body water content meter and method for controlling display thereof
US8684925B2 (en) 2007-09-14 2014-04-01 Corventis, Inc. Injectable device for physiological monitoring
US20140118931A1 (en) * 2012-10-29 2014-05-01 Kabushiki Kaisha Toshiba Electronic device
US8718752B2 (en) 2008-03-12 2014-05-06 Corventis, Inc. Heart failure decompensation prediction based on cardiac rhythm
US8761870B2 (en) 2006-05-30 2014-06-24 Impedimed Limited Impedance measurements
US8784308B2 (en) 2009-12-02 2014-07-22 Proteus Digital Health, Inc. Integrated ingestible event marker system with pharmaceutical product
US8790259B2 (en) 2009-10-22 2014-07-29 Corventis, Inc. Method and apparatus for remote detection and monitoring of functional chronotropic incompetence
US20140221792A1 (en) * 2013-02-01 2014-08-07 Devin Warner Miller Hydration Monitoring Apparatus
US8802183B2 (en) 2005-04-28 2014-08-12 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
US8810409B2 (en) 2008-03-05 2014-08-19 Proteus Digital Health, Inc. Multi-mode communication ingestible event markers and systems, and methods of using the same
US20140236249A1 (en) * 1996-12-16 2014-08-21 Ip Holdings, Inc. Electronic Skin Patch for Real Time Monitoring of Cardiac Activity and Personal Health Management
US8836513B2 (en) 2006-04-28 2014-09-16 Proteus Digital Health, Inc. Communication system incorporated in an ingestible product
US8868453B2 (en) 2009-11-04 2014-10-21 Proteus Digital Health, Inc. System for supply chain management
US8897868B2 (en) 2007-09-14 2014-11-25 Medtronic, Inc. Medical device automatic start-up upon contact to patient tissue
US8912908B2 (en) 2005-04-28 2014-12-16 Proteus Digital Health, Inc. Communication system with remote activation
US8956287B2 (en) 2006-05-02 2015-02-17 Proteus Digital Health, Inc. Patient customized therapeutic regimens
US8961412B2 (en) 2007-09-25 2015-02-24 Proteus Digital Health, Inc. In-body device with virtual dipole signal amplification
US9014779B2 (en) 2010-02-01 2015-04-21 Proteus Digital Health, Inc. Data gathering system
US20150112162A1 (en) * 2013-10-18 2015-04-23 WiseWear Corporation Fall Prediction Assessment
US20150112163A1 (en) * 2013-10-18 2015-04-23 WiseWear Corporation Fall prediction assessment
US9083589B2 (en) 2006-11-20 2015-07-14 Proteus Digital Health, Inc. Active signal processing personal health signal receivers
US9107806B2 (en) 2010-11-22 2015-08-18 Proteus Digital Health, Inc. Ingestible device with pharmaceutical product
US9125979B2 (en) 2007-10-25 2015-09-08 Proteus Digital Health, Inc. Fluid transfer port information system
US9149423B2 (en) 2009-05-12 2015-10-06 Proteus Digital Health, Inc. Ingestible event markers comprising an ingestible component
US20150305675A1 (en) * 2014-04-25 2015-10-29 Halo Wearables, Llc Wearable stress-testing device
EP2622344A4 (en) * 2010-09-30 2015-11-25 Hydradx Inc Diagnostic device and method for sensing hydration state of a mammallian subject
US9198608B2 (en) 2005-04-28 2015-12-01 Proteus Digital Health, Inc. Communication system incorporated in a container
US9235683B2 (en) 2011-11-09 2016-01-12 Proteus Digital Health, Inc. Apparatus, system, and method for managing adherence to a regimen
US9270025B2 (en) 2007-03-09 2016-02-23 Proteus Digital Health, Inc. In-body device having deployable antenna
US9268909B2 (en) 2012-10-18 2016-02-23 Proteus Digital Health, Inc. Apparatus, system, and method to adaptively optimize power dissipation and broadcast power in a power source for a communication device
US9271897B2 (en) 2012-07-23 2016-03-01 Proteus Digital Health, Inc. Techniques for manufacturing ingestible event markers comprising an ingestible component
US20160073968A1 (en) * 2013-02-19 2016-03-17 Terumo Kabushiki Kaisha Body water meter and terminal
US9411936B2 (en) 2007-09-14 2016-08-09 Medtronic Monitoring, Inc. Dynamic pairing of patients to data collection gateways
WO2016144529A1 (en) * 2015-03-09 2016-09-15 CoreSyte, Inc. Methods for manufacturing biological fluid sensor devices and devices, systems, and methods for measuring biological fluids
US9451897B2 (en) 2009-12-14 2016-09-27 Medtronic Monitoring, Inc. Body adherent patch with electronics for physiologic monitoring
US9504406B2 (en) 2006-11-30 2016-11-29 Impedimed Limited Measurement apparatus
US9579024B2 (en) 2015-03-09 2017-02-28 CoreSyte, Inc. System and method for measuring biological fluid biomarkers
US9585593B2 (en) 2009-11-18 2017-03-07 Chung Shing Fan Signal distribution for patient-electrode measurements
US9597487B2 (en) 2010-04-07 2017-03-21 Proteus Digital Health, Inc. Miniature ingestible device
US9615766B2 (en) 2008-11-28 2017-04-11 Impedimed Limited Impedance measurement process
US9615767B2 (en) 2009-10-26 2017-04-11 Impedimed Limited Fluid level indicator determination
US9622725B2 (en) 2015-03-09 2017-04-18 CoreSyte, Inc. Method for manufacturing a biological fluid sensor
US9636061B2 (en) 2015-03-09 2017-05-02 CoreSyte, Inc. System and method for measuring biological fluid biomarkers
US9645133B2 (en) 2015-03-09 2017-05-09 CoreSyte, Inc. Method for manufacturing a biological fluid sensor
TWI584782B (en) * 2012-03-23 2017-06-01 泰爾茂股份有限公司 Internal moisture meter
US9724012B2 (en) 2005-10-11 2017-08-08 Impedimed Limited Hydration status monitoring
US9756874B2 (en) 2011-07-11 2017-09-12 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
US9796576B2 (en) 2013-08-30 2017-10-24 Proteus Digital Health, Inc. Container with electronically controlled interlock
US9883827B2 (en) 2015-03-09 2018-02-06 CoreSyte, Inc. System and method for measuring biological fluid biomarkers
US9883819B2 (en) 2009-01-06 2018-02-06 Proteus Digital Health, Inc. Ingestion-related biofeedback and personalized medical therapy method and system
US20180103891A1 (en) * 2015-06-24 2018-04-19 Waywearable, Inc. Portable skin condition measuring device, skin condition analyzing method, and program using the same
US10084880B2 (en) 2013-11-04 2018-09-25 Proteus Digital Health, Inc. Social media networking based on physiologic information
US10175376B2 (en) 2013-03-15 2019-01-08 Proteus Digital Health, Inc. Metal detector apparatus, system, and method
US10187121B2 (en) 2016-07-22 2019-01-22 Proteus Digital Health, Inc. Electromagnetic sensing and detection of ingestible event markers
US10223905B2 (en) 2011-07-21 2019-03-05 Proteus Digital Health, Inc. Mobile device and system for detection and communication of information received from an ingestible device
US10307074B2 (en) 2007-04-20 2019-06-04 Impedimed Limited Monitoring system and probe
US10327676B2 (en) 2015-03-09 2019-06-25 CoreSyte, Inc. Device for measuring biological fluids
US10327639B2 (en) 2013-12-25 2019-06-25 Seiko Epson Corporation Biological information measurement apparatus, information processing apparatus, and biological information measurement system
CN109938729A (en) * 2019-03-29 2019-06-28 常州市第二人民医院 A kind of control water early warning Intelligent foot ring
US10398161B2 (en) 2014-01-21 2019-09-03 Proteus Digital Heal Th, Inc. Masticable ingestible product and communication system therefor
US10529044B2 (en) 2010-05-19 2020-01-07 Proteus Digital Health, Inc. Tracking and delivery confirmation of pharmaceutical products
US10561405B2 (en) 2015-03-09 2020-02-18 CoreSyte, Inc. Method for manufacturing a biological fluid sensor
US10806398B2 (en) 2015-02-17 2020-10-20 Halo Wearables, Llc Power management for wearable devices
US11051543B2 (en) 2015-07-21 2021-07-06 Otsuka Pharmaceutical Co. Ltd. Alginate on adhesive bilayer laminate film
US11058318B2 (en) * 2015-07-16 2021-07-13 Impedimed Limited Fluid level determination
US11149123B2 (en) 2013-01-29 2021-10-19 Otsuka Pharmaceutical Co., Ltd. Highly-swellable polymeric films and compositions comprising the same
US11389087B2 (en) 2015-03-09 2022-07-19 CoreSyte, Inc. Device for measuring biological fluids
US11406275B2 (en) * 2015-11-10 2022-08-09 Impedimed Limited Impedance measurement system
US11529106B1 (en) * 2015-05-22 2022-12-20 Cerner Innovation, Inc. Noninvasive tool for assessing hydration status
US11529071B2 (en) 2016-10-26 2022-12-20 Otsuka Pharmaceutical Co., Ltd. Methods for manufacturing capsules with ingestible event markers
US11534077B2 (en) 2015-04-24 2022-12-27 Bruin Biometrics, Llc Apparatus and methods for determining damaged tissue using sub epidermal moisture measurements
US11600939B2 (en) 2018-10-11 2023-03-07 Bruin Biometrics, Llc Device with disposable element
US11627910B2 (en) 2017-02-03 2023-04-18 Bbi Medical Innovations, Llc Measurement of susceptibility to diabetic foot ulcers
US11642075B2 (en) 2021-02-03 2023-05-09 Bruin Biometrics, Llc Methods of treating deep and early-stage pressure induced tissue damage
US11678812B1 (en) * 2015-08-17 2023-06-20 Board Of Trustees Of The University Of Alabama, For And On Behalf Of The University Of Alabama In Huntsville Systems and methods for monitoring hydration
US11744481B2 (en) 2013-03-15 2023-09-05 Otsuka Pharmaceutical Co., Ltd. System, apparatus and methods for data collection and assessing outcomes
US11779265B2 (en) 2010-05-08 2023-10-10 Bruin Biometrics, Llc SEM scanner sensing apparatus, system and methodology for early detection of ulcers
US11883011B2 (en) 2015-03-09 2024-01-30 CoreSyte, Inc. Method for manufacturing a biological fluid sensor

Families Citing this family (175)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6527711B1 (en) * 1999-10-18 2003-03-04 Bodymedia, Inc. Wearable human physiological data sensors and reporting system therefor
US20060122474A1 (en) * 2000-06-16 2006-06-08 Bodymedia, Inc. Apparatus for monitoring health, wellness and fitness
BRPI0414359A (en) 2000-06-16 2006-11-14 Bodymedia Inc body weight monitoring and management system and other psychological conditions that include interactive and personalized planning, intervention and reporting
US7689437B1 (en) * 2000-06-16 2010-03-30 Bodymedia, Inc. System for monitoring health, wellness and fitness
ES2260245T3 (en) * 2000-06-23 2006-11-01 Bodymedia, Inc. SYSTEM TO CONTROL HEALTH, WELFARE AND EXERCISE.
US7044911B2 (en) 2001-06-29 2006-05-16 Philometron, Inc. Gateway platform for biological monitoring and delivery of therapeutic compounds
US7096061B2 (en) * 2002-07-03 2006-08-22 Tel-Aviv University Future Technology Development L.P. Apparatus for monitoring CHF patients using bio-impedance technique
US7020508B2 (en) * 2002-08-22 2006-03-28 Bodymedia, Inc. Apparatus for detecting human physiological and contextual information
US7289837B2 (en) 2002-10-01 2007-10-30 Nellcor Puritan Bennett Incorpoated Forehead sensor placement
MXPA05003688A (en) * 2002-10-09 2005-09-30 Bodymedia Inc Method and apparatus for auto journaling of continuous or discrete body states utilizing physiological and/or contextual parameters.
US20090177068A1 (en) * 2002-10-09 2009-07-09 Stivoric John M Method and apparatus for providing derived glucose information utilizing physiological and/or contextual parameters
US7182738B2 (en) 2003-04-23 2007-02-27 Marctec, Llc Patient monitoring apparatus and method for orthosis and other devices
US8031335B2 (en) * 2003-05-27 2011-10-04 Opto Trace Technologies, Inc. Non-invasive disease diagnosis using light scattering probe
US7047056B2 (en) 2003-06-25 2006-05-16 Nellcor Puritan Bennett Incorporated Hat-based oximeter sensor
FR2856897B1 (en) * 2003-07-04 2007-01-26 Oreal KIT, IN PARTICULAR FOR COSMETIC USE, COMPRISING AN AMBIENT HUMIDITY INDICATOR OR SENSOR
US7169405B2 (en) * 2003-08-06 2007-01-30 Warsaw Orthopedic, Inc. Methods and devices for the treatment of intervertebral discs
CA2538710A1 (en) * 2003-09-12 2005-03-31 Bodymedia, Inc. Method and apparatus for measuring heart related parameters
US8412297B2 (en) * 2003-10-01 2013-04-02 Covidien Lp Forehead sensor placement
US7482935B2 (en) * 2003-10-28 2009-01-27 Jung Kook Lee Baby health monitoring system
EP1734858B1 (en) 2004-03-22 2014-07-09 BodyMedia, Inc. Non-invasive temperature monitoring device
CA2583526A1 (en) * 2004-03-24 2005-10-13 Noninvasive Medical Technologies, Llc Thoracic impedance monitor and electrode array and method of use
US8068906B2 (en) 2004-06-21 2011-11-29 Aorora Technologies Pty Ltd Cardiac monitoring system
EP1784162A2 (en) * 2004-08-23 2007-05-16 Remote Clinical Solutions, Inc. System and method for modifying a fluid for oral administration
WO2006029035A1 (en) * 2004-09-02 2006-03-16 Philometron, Inc. Monitoring platform for wound and ulcer monitoring and detection
US20090105521A1 (en) * 2004-09-13 2009-04-23 Jonathan Bentwich Systems and methods for assessing and treating medical conditions related to the central nervous system and for enhancing cognitive functions
US20060058853A1 (en) 2004-09-13 2006-03-16 Jonathan Bentwich Integrated system and method for treating disease using cognitive-training and brain stimulation and computerized magnetic photo-electric stimulator (cmpes)
US20090099623A1 (en) * 2004-09-13 2009-04-16 Neuronix Ltd. Systems and methods for treatment of medical conditions related to the central nervous system and for enhancing cognitive functions
US8109981B2 (en) * 2005-01-25 2012-02-07 Valam Corporation Optical therapies and devices
US8730031B2 (en) 2005-04-28 2014-05-20 Proteus Digital Health, Inc. Communication system using an implantable device
US8900154B2 (en) 2005-05-24 2014-12-02 Cardiac Pacemakers, Inc. Prediction of thoracic fluid accumulation
KR100634544B1 (en) * 2005-06-04 2006-10-13 삼성전자주식회사 Apparatus and method for measuring moisture content in skin using portable terminal
US8781551B2 (en) 2005-07-01 2014-07-15 Impedimed Limited Apparatus for connecting impedance measurement apparatus to an electrode
US20080287823A1 (en) * 2005-07-20 2008-11-20 Scott Matthew Chetham Index Determination
JP4790343B2 (en) * 2005-08-18 2011-10-12 株式会社タニタ Visceral fat accumulation information estimation device
EP1919356B1 (en) * 2005-09-02 2012-06-13 The Procter & Gamble Company Methods for measuring moisture content of skin
AU2006301927B2 (en) * 2005-10-11 2012-05-17 Impedimed Limited Hydration status monitoring
AT502921B1 (en) * 2005-10-21 2012-01-15 Falko Dr Skrabal DEVICE FOR MEASURING HEART AND VESSEL FUNCTION (FUNCTION) AND BODY SPACES (SPACES) BY MEANS OF IMPEDANCE MEASUREMENT
WO2007053963A1 (en) * 2005-11-10 2007-05-18 Solianis Holding Ag Device for determining the glucose level in body tissue
US9060705B2 (en) * 2005-12-20 2015-06-23 Autopoiese Participacoes, Ltda Electrode assembly for electrical impedance tomography
US20070162089A1 (en) * 2006-01-09 2007-07-12 Transoma Medical, Inc. Cross-band communications in an implantable device
US8660659B2 (en) 2006-01-09 2014-02-25 Greatbatch Ltd. Cross-band communications in an implantable device
US8301254B2 (en) 2006-01-09 2012-10-30 Greatbatch Ltd. Cross-band communications in an implantable device
US20100261985A1 (en) * 2006-03-31 2010-10-14 Koninklijke Philips Electronics, N.V. Method and apparatus for determining hydration levels from skin turgor
US8152710B2 (en) 2006-04-06 2012-04-10 Ethicon Endo-Surgery, Inc. Physiological parameter analysis for an implantable restriction device and a data logger
US8870742B2 (en) 2006-04-06 2014-10-28 Ethicon Endo-Surgery, Inc. GUI for an implantable restriction device and a data logger
US8642060B2 (en) * 2006-04-24 2014-02-04 Warsaw Orthopedic, Inc. Controlled release systems and methods for osteal growth
US7879027B2 (en) * 2006-04-24 2011-02-01 Warsaw Orthopedic, Inc. Controlled release devices for fusion of osteal structures
US8642059B2 (en) * 2006-04-24 2014-02-04 Warsaw Orthopedic, Inc. Controlled release systems and methods for intervertebral discs
US7771414B2 (en) * 2006-04-24 2010-08-10 Warsaw Orthopedic, Inc. Controlled release devices for therapeutic treatments of spinal discs
KR100756409B1 (en) 2006-07-05 2007-09-10 삼성전자주식회사 Apparatus for measuring skin moisture content and method for the operating the apparatus
WO2008021226A1 (en) * 2006-08-12 2008-02-21 Philometron, Inc. Platform for detection of tissue structure change
JP2008051516A (en) * 2006-08-22 2008-03-06 Olympus Corp Tactile sensor
US8057454B2 (en) * 2006-08-25 2011-11-15 Kimberly-Clark Worldwide, Inc. Systems and methods for hydration sensing and monitoring
US8583224B2 (en) * 2006-09-08 2013-11-12 Cardiac Pacemakers, Inc. Implantable medical device and methods for automated detection of infection
US8388534B2 (en) * 2006-10-11 2013-03-05 Samsung Electronics Co., Ltd. Apparatus for providing skin care information by measuring skin moisture content and method and medium for the same
US8054140B2 (en) 2006-10-17 2011-11-08 Proteus Biomedical, Inc. Low voltage oscillator for medical devices
EP2101641A2 (en) * 2006-12-07 2009-09-23 Philometron, Inc. Platform for detection of tissue content and/or structural changes with closed-loop control in mammalian organisms
US8346850B2 (en) * 2006-12-18 2013-01-01 Telefonaktiebolaget Lm Ericsson (Publ) Method and apparatus for establishing a session
EP2126828A4 (en) * 2007-02-16 2012-01-25 Bodymedia Inc Systems and methods for understanding and applying the physiological and contextual life patterns of an individual or set of individuals
US20080262557A1 (en) * 2007-04-19 2008-10-23 Brown Stephen J Obesity management system
US20080306362A1 (en) * 2007-06-05 2008-12-11 Owen Davis Device and system for monitoring contents of perspiration
US10702174B2 (en) * 2007-06-27 2020-07-07 Integra Lifesciences Corporation Medical monitor user interface
US8320981B1 (en) * 2007-06-29 2012-11-27 Pacesetter, Inc. Enhanced optical sensor module
US7493232B1 (en) 2007-08-28 2009-02-17 Surina Blake J Device and method for monitoring hydration status
US20090076559A1 (en) * 2007-09-14 2009-03-19 Corventis, Inc. Adherent Device for Cardiac Rhythm Management
WO2009042721A1 (en) 2007-09-25 2009-04-02 Neosync, Inc. Systems and methods for neuro-eeg synchronization therapy
EP2215726B1 (en) * 2007-11-27 2018-01-10 Proteus Digital Health, Inc. Transbody communication systems employing communication channels
US8467866B2 (en) * 2008-03-13 2013-06-18 Fujitsu Component Limited Biosignal detecting apparatus
KR20100139144A (en) * 2008-04-21 2010-12-31 카를 프레데릭 에드만 Metabolic energy monitoring system
US7988849B2 (en) * 2008-06-03 2011-08-02 Baxter International Inc. Customizable personal dialysis device having ease of use and therapy enhancement features
JP2011524213A (en) * 2008-06-18 2011-09-01 ソリアニス・ホールディング・アーゲー Method and apparatus for characterizing the effects of skin treatments on the skin
US8926490B2 (en) * 2008-09-24 2015-01-06 Neosync, Inc. Systems and methods for depression treatment using neuro-EEG synchronization therapy
US8364220B2 (en) 2008-09-25 2013-01-29 Covidien Lp Medical sensor and technique for using the same
US8257274B2 (en) 2008-09-25 2012-09-04 Nellcor Puritan Bennett Llc Medical sensor and technique for using the same
US8097926B2 (en) 2008-10-07 2012-01-17 Mc10, Inc. Systems, methods, and devices having stretchable integrated circuitry for sensing and delivering therapy
US9123614B2 (en) 2008-10-07 2015-09-01 Mc10, Inc. Methods and applications of non-planar imaging arrays
JP5646492B2 (en) 2008-10-07 2014-12-24 エムシー10 インコーポレイテッドMc10,Inc. Stretchable integrated circuit and device with sensor array
US8389862B2 (en) 2008-10-07 2013-03-05 Mc10, Inc. Extremely stretchable electronics
KR101192690B1 (en) 2008-11-13 2012-10-19 프로테우스 디지털 헬스, 인코포레이티드 Ingestible therapy activator system, therapeutic device and method
EP2346391A4 (en) * 2008-11-18 2012-08-15 Proteus Biomedical Inc Sensing system, device, and method for therapy modulation
US9659423B2 (en) 2008-12-15 2017-05-23 Proteus Digital Health, Inc. Personal authentication apparatus system and method
TWI503101B (en) 2008-12-15 2015-10-11 Proteus Digital Health Inc Body-associated receiver and method
EP2375968B1 (en) 2008-12-15 2018-11-14 Medtronic Monitoring, Inc. Patient monitoring systems and methods
US9439566B2 (en) 2008-12-15 2016-09-13 Proteus Digital Health, Inc. Re-wearable wireless device
CA2750715A1 (en) * 2009-01-27 2010-08-05 Scibase Ab Switch probe for multiple electrode measurement of impedance
US8515515B2 (en) 2009-03-25 2013-08-20 Covidien Lp Medical sensor with compressible light barrier and technique for using the same
US8781548B2 (en) 2009-03-31 2014-07-15 Covidien Lp Medical sensor with flexible components and technique for using the same
WO2011017466A1 (en) 2009-08-06 2011-02-10 Neosync, Inc. Systems and methods for modulating the electrical activity of a brain using neuro-eeg synchronization therapy
US9723122B2 (en) 2009-10-01 2017-08-01 Mc10, Inc. Protective cases with integrated electronics
WO2011059986A1 (en) * 2009-11-12 2011-05-19 Neosync, Inc. Systems and methods for neuro-eeg synchronization therapy
US20110178375A1 (en) * 2010-01-19 2011-07-21 Avery Dennison Corporation Remote physiological monitoring
WO2011112972A2 (en) * 2010-03-11 2011-09-15 Philometron, Inc. Physiological monitor system for determining medication delivery and outcome
EP2418596A1 (en) * 2010-08-11 2012-02-15 Akern S.r.L. A system for monitoring patients that perform a medical self-check and relative method
US20120041282A1 (en) * 2010-08-13 2012-02-16 Conopco, Inc., D/B/A Unilever Device and system for evaluating condition of skin, scalp and hair
JP2014514032A (en) 2011-03-11 2014-06-19 プロテウス デジタル ヘルス, インコーポレイテッド Wearable personal body-related devices with various physical configurations
EP2712491B1 (en) 2011-05-27 2019-12-04 Mc10, Inc. Flexible electronic structure
DE112012003250T5 (en) 2011-08-05 2014-04-30 Mc10, Inc. Catheter Balloon method and apparatus using sensing elements
US20130226021A1 (en) * 2011-08-12 2013-08-29 BAE Systems Information and Electronics Systems Integrations Inc. Protective ensemble hydration monitor
WO2013033724A1 (en) 2011-09-01 2013-03-07 Mc10, Inc. Electronics for detection of a condition of tissue
PL2578147T3 (en) 2011-10-07 2016-10-31 Method and arrangement for determining an overhydration parameter or a body composition parameter
DE102011118998A1 (en) * 2011-11-14 2013-05-16 Seca Ag Method and device for determining the body weight of a person
US9649502B2 (en) 2011-11-14 2017-05-16 Neosync, Inc. Devices and methods of low frequency magnetic stimulation therapy
US9149225B2 (en) 2011-12-14 2015-10-06 Intesection Medical, Inc. Methods for determining the relative spatial change in subsurface resistivities across frequencies in tissue
GB201202387D0 (en) * 2012-02-13 2012-03-28 Nachum Zvi Device for in-vivo determination of eye moisture
US9320375B2 (en) 2014-06-16 2016-04-26 Iqhydr8, Llc Activity and volume sensing beverage container cap system
US9151605B1 (en) 2014-06-16 2015-10-06 Iqhydr8, Llc Beverage container cap
US9327960B2 (en) 2014-06-16 2016-05-03 Iqhydr8, Llc Volume sensing beverage container cap system
US9204816B2 (en) * 2012-03-13 2015-12-08 Vital Connect, Inc. Method and system for determining body impedance
ES2736950T3 (en) 2012-04-26 2020-01-09 Fresenius Medical Care Deutschland Gmbh Electrodes for a bioimpedance measuring device and devices used during dialysis
US9226402B2 (en) 2012-06-11 2015-12-29 Mc10, Inc. Strain isolation structures for stretchable electronics
US9295842B2 (en) 2012-07-05 2016-03-29 Mc10, Inc. Catheter or guidewire device including flow sensing and use thereof
KR20150031324A (en) 2012-07-05 2015-03-23 엠씨10, 인크 Catheter device including flow sensing
WO2014036546A1 (en) * 2012-09-01 2014-03-06 Nova Technology Corporation System for measuring skin hydration
US9171794B2 (en) 2012-10-09 2015-10-27 Mc10, Inc. Embedding thin chips in polymer
CN105008949A (en) 2012-10-09 2015-10-28 Mc10股份有限公司 Conformal electronics integrated with apparel
US9636070B2 (en) 2013-03-14 2017-05-02 DePuy Synthes Products, Inc. Methods, systems, and devices for monitoring and displaying medical parameters for a patient
JP6498177B2 (en) 2013-03-15 2019-04-10 プロテウス デジタル ヘルス, インコーポレイテッド Identity authentication system and method
US9706647B2 (en) 2013-05-14 2017-07-11 Mc10, Inc. Conformal electronics including nested serpentine interconnects
CA2920485A1 (en) 2013-08-05 2015-02-12 Mc10, Inc. Flexible temperature sensor including conformable electronics
RU2736776C2 (en) 2013-09-20 2020-11-20 Протеус Диджитал Хелс, Инк. Methods, devices and systems for receiving and decoding signals in the presence of noise using sections and deformation
US9577864B2 (en) 2013-09-24 2017-02-21 Proteus Digital Health, Inc. Method and apparatus for use with received electromagnetic signal at a frequency not known exactly in advance
KR20160065948A (en) 2013-10-07 2016-06-09 엠씨10, 인크 Conformal sensor systems for sensing and analysis
US10478075B2 (en) * 2013-10-25 2019-11-19 Qualcomm Incorporated System and method for obtaining bodily function measurements using a mobile device
ES2537351B1 (en) 2013-11-04 2015-12-03 Universidad De Sevilla Intelligent bioimpedance sensor for biomedical applications
WO2015077559A1 (en) 2013-11-22 2015-05-28 Mc10, Inc. Conformal sensor systems for sensing and analysis of cardiac activity
WO2015103580A2 (en) 2014-01-06 2015-07-09 Mc10, Inc. Encapsulated conformal electronic systems and devices, and methods of making and using the same
EP3114911B1 (en) 2014-03-04 2023-05-03 Medidata Solutions, Inc. Multi-part flexible encapsulation housing for electronic devices
WO2016005915A2 (en) * 2014-07-08 2016-01-14 Si14 S.P.A. A device, for example in the form of a watch, a bracelet, a belt or an auto-adhesive plaster, capable of monitoring the variations of the body hydration condition, in particular during the performance of sports activities
US20160011921A1 (en) * 2014-07-14 2016-01-14 General Electric Company Cyber secured airgap remote monitoring and diagnostics infrastructure
US10588576B2 (en) 2014-08-15 2020-03-17 Neosync, Inc. Methods and device for determining a valid intrinsic frequency
WO2016030869A1 (en) * 2014-08-29 2016-03-03 Ecole Polytechnique Federale De Lausanne (Epfl) Wearable, multi-parametric wireless system-in-patch for hydration level monitoring
US10368794B2 (en) * 2014-08-29 2019-08-06 Ecole Polytechnique Federale De Lausanne (Epfl) System for the remote monitoring of the hydration status of a living being
USD769063S1 (en) 2014-09-18 2016-10-18 Iqhydr8, Llc Beverage container cap with handle and integrated hole cover
US9899330B2 (en) 2014-10-03 2018-02-20 Mc10, Inc. Flexible electronic circuits with embedded integrated circuit die
US10297572B2 (en) 2014-10-06 2019-05-21 Mc10, Inc. Discrete flexible interconnects for modules of integrated circuits
USD781270S1 (en) 2014-10-15 2017-03-14 Mc10, Inc. Electronic device having antenna
US10004408B2 (en) 2014-12-03 2018-06-26 Rethink Medical, Inc. Methods and systems for detecting physiology for monitoring cardiac health
US10009117B2 (en) 2014-12-26 2018-06-26 Intel Corporation Data storage, input, and output for human body communication
US20160220184A1 (en) * 2015-01-30 2016-08-04 Empire Technology Development Llc Hydration monitor
EP3258837A4 (en) 2015-02-20 2018-10-10 Mc10, Inc. Automated detection and configuration of wearable devices based on on-body status, location, and/or orientation
US10398343B2 (en) 2015-03-02 2019-09-03 Mc10, Inc. Perspiration sensor
WO2016172264A1 (en) * 2015-04-24 2016-10-27 Bruin Biometrics Llc Apparatus and methods for determining damaged tissue using sub-epidermal moisture measurements
ES2862144T3 (en) * 2015-05-06 2021-10-07 Nat Univ Ireland Galway Non-invasive detection of urine reflux
US20160374588A1 (en) * 2015-06-24 2016-12-29 Microsoft Technology Licensing, Llc Monitoring hydration based on galvanic skin response
WO2017015000A1 (en) 2015-07-17 2017-01-26 Mc10, Inc. Conductive stiffener, method of making a conductive stiffener, and conductive adhesive and encapsulation layers
US10709384B2 (en) 2015-08-19 2020-07-14 Mc10, Inc. Wearable heat flux devices and methods of use
WO2017059215A1 (en) 2015-10-01 2017-04-06 Mc10, Inc. Method and system for interacting with a virtual environment
US10532211B2 (en) 2015-10-05 2020-01-14 Mc10, Inc. Method and system for neuromodulation and stimulation
CA3008649A1 (en) 2015-12-16 2017-06-22 Siren Care, Inc. System and method for detecting inflammation in a foot
US10736523B2 (en) * 2016-01-05 2020-08-11 Baxter International Inc. Handheld physiological sensor
US10277386B2 (en) 2016-02-22 2019-04-30 Mc10, Inc. System, devices, and method for on-body data and power transmission
EP3420733A4 (en) 2016-02-22 2019-06-26 Mc10, Inc. System, device, and method for coupled hub and sensor node on-body acquisition of sensor information
US11030911B2 (en) * 2016-03-31 2021-06-08 Casio Computer Co., Ltd. Electronic apparatus, notification method, and computer-readable storage medium
ITUA20162421A1 (en) * 2016-04-08 2017-10-08 Si14 S P A A device, for example in the form of a watch, a bracelet, a belt or a self-adhesive patch, capable of monitoring changes in the state of body hydration, in particular during sports activities.
CN109310340A (en) 2016-04-19 2019-02-05 Mc10股份有限公司 For measuring the method and system of sweat
US10447347B2 (en) 2016-08-12 2019-10-15 Mc10, Inc. Wireless charger and high speed data off-loader
US20180070850A1 (en) * 2016-09-15 2018-03-15 Karen S. Stafford Apparatus and method for detecting body composition and correlating it with cognitive efficiency
EP3519616A4 (en) 2016-09-27 2020-09-23 Siren Care, Inc. Smart yarn and method for manufacturing a yarn containing an electronic device
EP3549515A4 (en) * 2016-12-02 2020-08-05 Bilab Co., Ltd. Electrode belt device for measuring bio-signal
JP1602547S (en) 2017-01-17 2018-04-23
DK3515296T3 (en) 2017-02-03 2023-11-27 Bbi Medical Innovations Llc Measurement of tissue viability
CN109890273B (en) 2017-02-03 2022-10-11 布鲁恩生物有限责任公司 Measurement of edema
MX2020005136A (en) 2017-11-16 2020-08-17 Bruin Biometrics Llc Providing a continuity of care across multiple care settings.
EP3505045A1 (en) * 2017-12-27 2019-07-03 Koninklijke Philips N.V. Determining a water or lipid level of skin
AU2019217995A1 (en) 2018-02-09 2020-08-27 Bruin Biometrics, Llc Detection of tissue damage
US20210244365A1 (en) * 2018-05-11 2021-08-12 Spectronix Inc. Non-invasive epidermal health-monitoring sensor, patch system and method, and epidemiological monitoring and tracking system related thereto
EP3829415A1 (en) * 2018-07-27 2021-06-09 BIOTRONIK SE & Co. KG Device; system and method for determining fluid accumulation in the lower extremities of a patient
WO2020118694A1 (en) 2018-12-14 2020-06-18 Siren Care, Inc. Temperature-sensing garment and method for making same
US20200205895A1 (en) * 2018-12-31 2020-07-02 Massachusetts Institute Of Technology Non-invasive skin contact sensor
US20210000348A1 (en) * 2019-07-01 2021-01-07 Wolfgang Richter Apparatus for measuring vital signs
US11523775B2 (en) * 2019-10-03 2022-12-13 hDrop Technologies Inc. Non-invasive hydration and electrolyte monitoring
US11197634B2 (en) 2020-04-28 2021-12-14 Wayne C. A. Wright Geospatial bioimpedance biosurveillance tool
AU2022257978A1 (en) * 2021-04-13 2023-10-26 WearOptimo Pty Ltd Fluid status monitoring
US20230061041A1 (en) * 2021-08-31 2023-03-02 SeeMedX, Inc. Bio electric impedance monitors, electrode arrays and method of use
EP4299001A1 (en) * 2022-06-27 2024-01-03 Universidad de Jaén Wearable device, system, and method for monitoring homeostatic state

Citations (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4860753A (en) * 1987-11-04 1989-08-29 The Gillette Company Monitoring apparatus
US4966158A (en) * 1987-11-12 1990-10-30 Kao Corporation Measurement method for moisture content in the skin and system therefor
US5038109A (en) * 1988-10-13 1991-08-06 Gyrus Medical Limited Screening and monitoring instrument
US5086781A (en) * 1989-11-14 1992-02-11 Bookspan Mark A Bioelectric apparatus for monitoring body fluid compartments
US5297556A (en) * 1991-06-12 1994-03-29 Florida Atlantic University Research Corp. Method of detecting atherosclerosis while excluding motion artifacts
US5335667A (en) * 1992-11-20 1994-08-09 University Of Utah Research Foundation Method and apparatus for determining body composition using bioelectrical impedance
US5634468A (en) * 1992-04-03 1997-06-03 Micromedical Industries Limited Sensor patch and system for physiological monitoring
US5732710A (en) * 1996-08-09 1998-03-31 R.S. Medical Monitoring Ltd. Method and device for stable impedance plethysmography
US5738107A (en) * 1994-10-11 1998-04-14 Martinsen; Orjan G. Measurement of moisture content in skin
US5749369A (en) * 1996-08-09 1998-05-12 R.S. Medical Monitoring Ltd. Method and device for stable impedance plethysmography
US5788643A (en) * 1997-04-22 1998-08-04 Zymed Medical Instrumentation, Inc. Process for monitoring patients with chronic congestive heart failure
US5935066A (en) * 1997-02-27 1999-08-10 Vanderbilt University System and method for measuring of lung vascular injury by ultrasonic velocity and blood impedance
US5941829A (en) * 1995-11-08 1999-08-24 Instromedix, Inc. Concurrent medical patient data and voice communication method and apparatus
US5964720A (en) * 1996-11-29 1999-10-12 Adaptivity Devices Ltd. Method and system for monitoring the physiological condition of a patient
US5964703A (en) * 1994-01-14 1999-10-12 E-Z-Em, Inc. Extravasation detection electrode patch
US6047203A (en) * 1997-03-17 2000-04-04 Nims, Inc. Physiologic signs feedback system
US6095987A (en) * 1996-04-17 2000-08-01 Imagyn Medical Techonologies California, Inc. Apparatus and methods of bioelectrical impedance analysis of blood flow
US6125297A (en) * 1998-02-06 2000-09-26 The United States Of America As Represented By The United States National Aeronautics And Space Administration Body fluids monitor
US6315719B1 (en) * 1999-06-26 2001-11-13 Astrium Gmbh System for long-term remote medical monitoring
US20010051774A1 (en) * 2000-02-28 2001-12-13 Peter Littrup Multidimensional bioelectrical tissue analyzer
US6331160B1 (en) * 1999-06-03 2001-12-18 Cardiac Intelligence Corporation System and method for providing patient status feedback via an automated patient care system with speech-based wellness monitoring
US6339722B1 (en) * 1995-09-26 2002-01-15 A. J. Van Liebergen Holding B.V. Apparatus for the in-vivo non-invasive measurement of a biological parameter concerning a bodily fluid of a person or animal
US20020019586A1 (en) * 2000-06-16 2002-02-14 Eric Teller Apparatus for monitoring health, wellness and fitness
US20020019584A1 (en) * 2000-03-01 2002-02-14 Schulze Arthur E. Wireless internet bio-telemetry monitoring system and interface
US6370426B1 (en) * 1999-04-20 2002-04-09 Nova Technology Corporation Method and apparatus for measuring relative hydration of a substrate
US20020045836A1 (en) * 2000-10-16 2002-04-18 Dima Alkawwas Operation of wireless biopotential monitoring system
US6416471B1 (en) * 1999-04-15 2002-07-09 Nexan Limited Portable remote patient telemonitoring system
US6459930B1 (en) * 2000-07-31 2002-10-01 Tanita Corporation Dehydration condition judging apparatus by measuring bioelectric impedance
US6496705B1 (en) * 2000-04-18 2002-12-17 Motorola Inc. Programmable wireless electrode system for medical monitoring
US6524239B1 (en) * 1999-11-05 2003-02-25 Wcr Company Apparatus for non-instrusively measuring health parameters of a subject and method of use thereof
US6551252B2 (en) * 2000-04-17 2003-04-22 Vivometrics, Inc. Systems and methods for ambulatory monitoring of physiological signs
US6577893B1 (en) * 1993-09-04 2003-06-10 Motorola, Inc. Wireless medical diagnosis and monitoring equipment
US20030120170A1 (en) * 2000-08-14 2003-06-26 Fansan Zhu Device and method for monitoring and controlling physiologic parameters of a dialysis patient using segmental bioimpedance
US6595929B2 (en) * 2001-03-30 2003-07-22 Bodymedia, Inc. System for monitoring health, wellness and fitness having a method and apparatus for improved measurement of heat flow
US6605038B1 (en) * 2000-06-16 2003-08-12 Bodymedia, Inc. System for monitoring health, wellness and fitness
US6615077B1 (en) * 2000-08-14 2003-09-02 Renal Research Institute, Llc Device and method for monitoring and controlling physiologic parameters of a dialysis patient using segmental bioimpedence
US6636754B1 (en) * 2000-07-10 2003-10-21 Cardiodynamics International Corporation Apparatus and method for determining cardiac output in a living subject
US20040039254A1 (en) * 2002-08-22 2004-02-26 Stivoric John M. Apparatus for detecting human physiological and contextual information
US6714813B2 (en) * 2000-01-21 2004-03-30 Tanita Corporation Method for measuring the degree of edema and apparatus using the same
US20040171962A1 (en) * 2003-01-14 2004-09-02 L`Oreal Apparatus and method to evaluate hydration of the skin or the mucous membranes
US6790178B1 (en) * 1999-09-24 2004-09-14 Healthetech, Inc. Physiological monitor and associated computation, display and communication unit
US6980852B2 (en) * 2002-01-25 2005-12-27 Subqiview Inc. Film barrier dressing for intravascular tissue monitoring system
US7191000B2 (en) * 2001-07-31 2007-03-13 Cardiac Pacemakers, Inc. Cardiac rhythm management system for edema
US7285090B2 (en) * 2000-06-16 2007-10-23 Bodymedia, Inc. Apparatus for detecting, receiving, deriving and displaying human physiological and contextual information

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL116662A0 (en) * 1996-01-03 1996-05-14 N I Medical Ltd Disposable electrodes for bioimpedance mesasurements
JP2000014655A (en) * 1998-07-02 2000-01-18 Ya Man Ltd Body fat measuring clothing
JP2000023935A (en) * 1998-07-14 2000-01-25 Omron Corp Health management guide advising device
US6512949B1 (en) * 1999-07-12 2003-01-28 Medtronic, Inc. Implantable medical device for measuring time varying physiologic conditions especially edema and for responding thereto
JP2001353130A (en) * 2000-04-14 2001-12-25 Zexel Valeo Climate Control Corp Information detector for acquiring physical information
AU2002212848A1 (en) * 2000-10-09 2002-04-22 Neuronz Limited Sensor assembly for monitoring an infant brain
ES2187422T3 (en) * 2000-11-06 2003-06-16 Fresenius Medical Care De Gmbh METHOD AND DEVICE FOR DETERMINING THE DRY WEIGHT OF A PATIENT WITH RENAL FAILURE.
JP3396677B2 (en) * 2001-04-13 2003-04-14 花王株式会社 Body fat measurement device
JP3844421B2 (en) * 2001-03-26 2006-11-15 株式会社タニタ Swelling measuring device
US7044911B2 (en) * 2001-06-29 2006-05-16 Philometron, Inc. Gateway platform for biological monitoring and delivery of therapeutic compounds
JP3915495B2 (en) * 2001-12-05 2007-05-16 松下電器産業株式会社 Biological information measuring device
US20040019292A1 (en) * 2002-07-29 2004-01-29 Drinan Darrel Dean Method and apparatus for bioelectric impedance based identification of subjects
US20060264775A1 (en) * 2003-03-14 2006-11-23 Mills Gary N Methods of and apparatus for determining fluid volume presence in mammalian tissue
WO2006029035A1 (en) * 2004-09-02 2006-03-16 Philometron, Inc. Monitoring platform for wound and ulcer monitoring and detection

Patent Citations (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4860753A (en) * 1987-11-04 1989-08-29 The Gillette Company Monitoring apparatus
US4966158A (en) * 1987-11-12 1990-10-30 Kao Corporation Measurement method for moisture content in the skin and system therefor
US5038109A (en) * 1988-10-13 1991-08-06 Gyrus Medical Limited Screening and monitoring instrument
US5086781A (en) * 1989-11-14 1992-02-11 Bookspan Mark A Bioelectric apparatus for monitoring body fluid compartments
US5297556A (en) * 1991-06-12 1994-03-29 Florida Atlantic University Research Corp. Method of detecting atherosclerosis while excluding motion artifacts
US5634468A (en) * 1992-04-03 1997-06-03 Micromedical Industries Limited Sensor patch and system for physiological monitoring
US5335667A (en) * 1992-11-20 1994-08-09 University Of Utah Research Foundation Method and apparatus for determining body composition using bioelectrical impedance
US6577893B1 (en) * 1993-09-04 2003-06-10 Motorola, Inc. Wireless medical diagnosis and monitoring equipment
US5964703A (en) * 1994-01-14 1999-10-12 E-Z-Em, Inc. Extravasation detection electrode patch
US5738107A (en) * 1994-10-11 1998-04-14 Martinsen; Orjan G. Measurement of moisture content in skin
US6339722B1 (en) * 1995-09-26 2002-01-15 A. J. Van Liebergen Holding B.V. Apparatus for the in-vivo non-invasive measurement of a biological parameter concerning a bodily fluid of a person or animal
US5941829A (en) * 1995-11-08 1999-08-24 Instromedix, Inc. Concurrent medical patient data and voice communication method and apparatus
US6095987A (en) * 1996-04-17 2000-08-01 Imagyn Medical Techonologies California, Inc. Apparatus and methods of bioelectrical impedance analysis of blood flow
US5732710A (en) * 1996-08-09 1998-03-31 R.S. Medical Monitoring Ltd. Method and device for stable impedance plethysmography
US5749369A (en) * 1996-08-09 1998-05-12 R.S. Medical Monitoring Ltd. Method and device for stable impedance plethysmography
US5964720A (en) * 1996-11-29 1999-10-12 Adaptivity Devices Ltd. Method and system for monitoring the physiological condition of a patient
US5935066A (en) * 1997-02-27 1999-08-10 Vanderbilt University System and method for measuring of lung vascular injury by ultrasonic velocity and blood impedance
US6047203A (en) * 1997-03-17 2000-04-04 Nims, Inc. Physiologic signs feedback system
US5788643A (en) * 1997-04-22 1998-08-04 Zymed Medical Instrumentation, Inc. Process for monitoring patients with chronic congestive heart failure
US6125297A (en) * 1998-02-06 2000-09-26 The United States Of America As Represented By The United States National Aeronautics And Space Administration Body fluids monitor
US6416471B1 (en) * 1999-04-15 2002-07-09 Nexan Limited Portable remote patient telemonitoring system
US6370426B1 (en) * 1999-04-20 2002-04-09 Nova Technology Corporation Method and apparatus for measuring relative hydration of a substrate
US6331160B1 (en) * 1999-06-03 2001-12-18 Cardiac Intelligence Corporation System and method for providing patient status feedback via an automated patient care system with speech-based wellness monitoring
US6315719B1 (en) * 1999-06-26 2001-11-13 Astrium Gmbh System for long-term remote medical monitoring
US6790178B1 (en) * 1999-09-24 2004-09-14 Healthetech, Inc. Physiological monitor and associated computation, display and communication unit
US6524239B1 (en) * 1999-11-05 2003-02-25 Wcr Company Apparatus for non-instrusively measuring health parameters of a subject and method of use thereof
US6714813B2 (en) * 2000-01-21 2004-03-30 Tanita Corporation Method for measuring the degree of edema and apparatus using the same
US20010051774A1 (en) * 2000-02-28 2001-12-13 Peter Littrup Multidimensional bioelectrical tissue analyzer
US7499745B2 (en) * 2000-02-28 2009-03-03 Barbara Ann Karmanos Cancer Institute Multidimensional bioelectrical tissue analyzer
US20020019584A1 (en) * 2000-03-01 2002-02-14 Schulze Arthur E. Wireless internet bio-telemetry monitoring system and interface
US6551252B2 (en) * 2000-04-17 2003-04-22 Vivometrics, Inc. Systems and methods for ambulatory monitoring of physiological signs
US6496705B1 (en) * 2000-04-18 2002-12-17 Motorola Inc. Programmable wireless electrode system for medical monitoring
US20020019586A1 (en) * 2000-06-16 2002-02-14 Eric Teller Apparatus for monitoring health, wellness and fitness
US6605038B1 (en) * 2000-06-16 2003-08-12 Bodymedia, Inc. System for monitoring health, wellness and fitness
US7285090B2 (en) * 2000-06-16 2007-10-23 Bodymedia, Inc. Apparatus for detecting, receiving, deriving and displaying human physiological and contextual information
US7261690B2 (en) * 2000-06-16 2007-08-28 Bodymedia, Inc. Apparatus for monitoring health, wellness and fitness
US6636754B1 (en) * 2000-07-10 2003-10-21 Cardiodynamics International Corporation Apparatus and method for determining cardiac output in a living subject
US6459930B1 (en) * 2000-07-31 2002-10-01 Tanita Corporation Dehydration condition judging apparatus by measuring bioelectric impedance
US6615077B1 (en) * 2000-08-14 2003-09-02 Renal Research Institute, Llc Device and method for monitoring and controlling physiologic parameters of a dialysis patient using segmental bioimpedence
US20030120170A1 (en) * 2000-08-14 2003-06-26 Fansan Zhu Device and method for monitoring and controlling physiologic parameters of a dialysis patient using segmental bioimpedance
US20020045836A1 (en) * 2000-10-16 2002-04-18 Dima Alkawwas Operation of wireless biopotential monitoring system
US6595929B2 (en) * 2001-03-30 2003-07-22 Bodymedia, Inc. System for monitoring health, wellness and fitness having a method and apparatus for improved measurement of heat flow
US7191000B2 (en) * 2001-07-31 2007-03-13 Cardiac Pacemakers, Inc. Cardiac rhythm management system for edema
US6980852B2 (en) * 2002-01-25 2005-12-27 Subqiview Inc. Film barrier dressing for intravascular tissue monitoring system
US20040039254A1 (en) * 2002-08-22 2004-02-26 Stivoric John M. Apparatus for detecting human physiological and contextual information
US20040171962A1 (en) * 2003-01-14 2004-09-02 L`Oreal Apparatus and method to evaluate hydration of the skin or the mucous membranes

Cited By (237)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140236249A1 (en) * 1996-12-16 2014-08-21 Ip Holdings, Inc. Electronic Skin Patch for Real Time Monitoring of Cardiac Activity and Personal Health Management
US8233974B2 (en) 1999-06-22 2012-07-31 Impedimed Limited Method and device for measuring tissue oedema
US20080234600A1 (en) * 2004-03-04 2008-09-25 Leon Thomas Lee Marsh Hydration Monitor
US8574165B2 (en) * 2004-03-04 2013-11-05 Inova Design Solutions Ltd Hydration monitor
US8744564B2 (en) 2004-06-18 2014-06-03 Impedimed Limited Oedema detection
US20080319336A1 (en) * 2004-06-18 2008-12-25 Leigh Ward Oedema Detection
US9149235B2 (en) 2004-06-18 2015-10-06 Impedimed Limited Oedema detection
US8103337B2 (en) 2004-11-26 2012-01-24 Impedimed Limited Weighted gradient method and system for diagnosing disease
US8912908B2 (en) 2005-04-28 2014-12-16 Proteus Digital Health, Inc. Communication system with remote activation
US8802183B2 (en) 2005-04-28 2014-08-12 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
US20090227204A1 (en) * 2005-04-28 2009-09-10 Timothy Robertson Pharma-Informatics System
US9962107B2 (en) 2005-04-28 2018-05-08 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
US9161707B2 (en) 2005-04-28 2015-10-20 Proteus Digital Health, Inc. Communication system incorporated in an ingestible product
US9439582B2 (en) 2005-04-28 2016-09-13 Proteus Digital Health, Inc. Communication system with remote activation
US9119554B2 (en) 2005-04-28 2015-09-01 Proteus Digital Health, Inc. Pharma-informatics system
US10517507B2 (en) 2005-04-28 2019-12-31 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
US10542909B2 (en) 2005-04-28 2020-01-28 Proteus Digital Health, Inc. Communication system with partial power source
US10610128B2 (en) 2005-04-28 2020-04-07 Proteus Digital Health, Inc. Pharma-informatics system
US9649066B2 (en) 2005-04-28 2017-05-16 Proteus Digital Health, Inc. Communication system with partial power source
US8847766B2 (en) 2005-04-28 2014-09-30 Proteus Digital Health, Inc. Pharma-informatics system
US20080284599A1 (en) * 2005-04-28 2008-11-20 Proteus Biomedical, Inc. Pharma-Informatics System
US8816847B2 (en) 2005-04-28 2014-08-26 Proteus Digital Health, Inc. Communication system with partial power source
US9681842B2 (en) 2005-04-28 2017-06-20 Proteus Digital Health, Inc. Pharma-informatics system
US9198608B2 (en) 2005-04-28 2015-12-01 Proteus Digital Health, Inc. Communication system incorporated in a container
US11476952B2 (en) 2005-04-28 2022-10-18 Otsuka Pharmaceutical Co., Ltd. Pharma-informatics system
US8674825B2 (en) 2005-04-28 2014-03-18 Proteus Digital Health, Inc. Pharma-informatics system
US20110054343A1 (en) * 2005-07-01 2011-03-03 Impedimed Limited Monitoring system
US8548580B2 (en) 2005-07-01 2013-10-01 Impedimed Limited Monitoring system
US11660013B2 (en) 2005-07-01 2023-05-30 Impedimed Limited Monitoring system
US20110087129A1 (en) * 2005-07-01 2011-04-14 Impedimed Limited Monitoring system
US11737678B2 (en) 2005-07-01 2023-08-29 Impedimed Limited Monitoring system
US20080270051A1 (en) * 2005-08-02 2008-10-30 Impedimed Limited Impedance Parameter Values
US8099250B2 (en) 2005-08-02 2012-01-17 Impedimed Limited Impedance parameter values
US20080306359A1 (en) * 2005-09-01 2008-12-11 Zdeblick Mark J Medical Diagnostic and Treatment Platform Using Near-Field Wireless Communication of Information Within a Patient's Body
US8547248B2 (en) 2005-09-01 2013-10-01 Proteus Digital Health, Inc. Implantable zero-wire communications system
US9724012B2 (en) 2005-10-11 2017-08-08 Impedimed Limited Hydration status monitoring
US11612332B2 (en) 2005-10-11 2023-03-28 Impedimed Limited Hydration status monitoring
US8836513B2 (en) 2006-04-28 2014-09-16 Proteus Digital Health, Inc. Communication system incorporated in an ingestible product
US11928614B2 (en) 2006-05-02 2024-03-12 Otsuka Pharmaceutical Co., Ltd. Patient customized therapeutic regimens
US8956287B2 (en) 2006-05-02 2015-02-17 Proteus Digital Health, Inc. Patient customized therapeutic regimens
US8761870B2 (en) 2006-05-30 2014-06-24 Impedimed Limited Impedance measurements
US20090118594A1 (en) * 2006-07-07 2009-05-07 Mark Zdeblick Smart parenteral administration system
US9084566B2 (en) 2006-07-07 2015-07-21 Proteus Digital Health, Inc. Smart parenteral administration system
US11357730B2 (en) 2006-10-25 2022-06-14 Otsuka Pharmaceutical Co., Ltd. Controlled activation ingestible identifier
US10238604B2 (en) 2006-10-25 2019-03-26 Proteus Digital Health, Inc. Controlled activation ingestible identifier
US20100239616A1 (en) * 2006-10-25 2010-09-23 Hooman Hafezi Controlled activation ingestible identifier
US8945005B2 (en) 2006-10-25 2015-02-03 Proteus Digital Health, Inc. Controlled activation ingestible identifier
US9083589B2 (en) 2006-11-20 2015-07-14 Proteus Digital Health, Inc. Active signal processing personal health signal receivers
US9444503B2 (en) 2006-11-20 2016-09-13 Proteus Digital Health, Inc. Active signal processing personal health signal receivers
US9504406B2 (en) 2006-11-30 2016-11-29 Impedimed Limited Measurement apparatus
US20100100003A1 (en) * 2007-01-15 2010-04-22 Impedimed Limited Monitoring system
US8594781B2 (en) 2007-01-15 2013-11-26 Impedimed Limited Monitoring system
US20100185055A1 (en) * 2007-02-01 2010-07-22 Timothy Robertson Ingestible event marker systems
US8858432B2 (en) 2007-02-01 2014-10-14 Proteus Digital Health, Inc. Ingestible event marker systems
US10441194B2 (en) 2007-02-01 2019-10-15 Proteus Digital Heal Th, Inc. Ingestible event marker systems
US8956288B2 (en) 2007-02-14 2015-02-17 Proteus Digital Health, Inc. In-body power source having high surface area electrode
US20100069717A1 (en) * 2007-02-14 2010-03-18 Hooman Hafezi In-Body Power Source Having High Surface Area Electrode
US11464423B2 (en) 2007-02-14 2022-10-11 Otsuka Pharmaceutical Co., Ltd. In-body power source having high surface area electrode
US9270025B2 (en) 2007-03-09 2016-02-23 Proteus Digital Health, Inc. In-body device having deployable antenna
US20100022836A1 (en) * 2007-03-09 2010-01-28 Olivier Colliou In-body device having a multi-directional transmitter
US8932221B2 (en) 2007-03-09 2015-01-13 Proteus Digital Health, Inc. In-body device having a multi-directional transmitter
US20100109739A1 (en) * 2007-03-30 2010-05-06 Impedimed Limited Active guarding for reduction of resistive and capacitive signal loading with adjustable control of compensation level
US8487686B2 (en) 2007-03-30 2013-07-16 Impedimed Limited Active guarding for reduction of resistive and capacitive signal loading with adjustable control of compensation level
US10307074B2 (en) 2007-04-20 2019-06-04 Impedimed Limited Monitoring system and probe
US8540632B2 (en) 2007-05-24 2013-09-24 Proteus Digital Health, Inc. Low profile antenna for in body device
US10517506B2 (en) 2007-05-24 2019-12-31 Proteus Digital Health, Inc. Low profile antenna for in body device
US20080306360A1 (en) * 2007-05-24 2008-12-11 Robertson Timothy L Low profile antenna for in body device
US8374688B2 (en) 2007-09-14 2013-02-12 Corventis, Inc. System and methods for wireless body fluid monitoring
US8285356B2 (en) 2007-09-14 2012-10-09 Corventis, Inc. Adherent device with multiple physiological sensors
US9538960B2 (en) 2007-09-14 2017-01-10 Medtronic Monitoring, Inc. Injectable physiological monitoring system
US9186089B2 (en) 2007-09-14 2015-11-17 Medtronic Monitoring, Inc. Injectable physiological monitoring system
US10405809B2 (en) 2007-09-14 2019-09-10 Medtronic Monitoring, Inc Injectable device for physiological monitoring
US8684925B2 (en) 2007-09-14 2014-04-01 Corventis, Inc. Injectable device for physiological monitoring
US8591430B2 (en) 2007-09-14 2013-11-26 Corventis, Inc. Adherent device for respiratory monitoring
US9125566B2 (en) 2007-09-14 2015-09-08 Medtronic Monitoring, Inc. Multi-sensor patient monitor to detect impending cardiac decompensation
US8249686B2 (en) 2007-09-14 2012-08-21 Corventis, Inc. Adherent device for sleep disordered breathing
US9770182B2 (en) 2007-09-14 2017-09-26 Medtronic Monitoring, Inc. Adherent device with multiple physiological sensors
US9579020B2 (en) 2007-09-14 2017-02-28 Medtronic Monitoring, Inc. Adherent cardiac monitor with advanced sensing capabilities
US10028699B2 (en) 2007-09-14 2018-07-24 Medtronic Monitoring, Inc. Adherent device for sleep disordered breathing
US10599814B2 (en) 2007-09-14 2020-03-24 Medtronic Monitoring, Inc. Dynamic pairing of patients to data collection gateways
US8116841B2 (en) 2007-09-14 2012-02-14 Corventis, Inc. Adherent device with multiple physiological sensors
US8790257B2 (en) * 2007-09-14 2014-07-29 Corventis, Inc. Multi-sensor patient monitor to detect impending cardiac decompensation
US9320443B2 (en) 2007-09-14 2016-04-26 Medtronic Monitoring, Inc. Multi-sensor patient monitor to detect impending cardiac decompensation
US8460189B2 (en) 2007-09-14 2013-06-11 Corventis, Inc. Adherent cardiac monitor with advanced sensing capabilities
US8897868B2 (en) 2007-09-14 2014-11-25 Medtronic, Inc. Medical device automatic start-up upon contact to patient tissue
US9411936B2 (en) 2007-09-14 2016-08-09 Medtronic Monitoring, Inc. Dynamic pairing of patients to data collection gateways
US9433371B2 (en) 2007-09-25 2016-09-06 Proteus Digital Health, Inc. In-body device with virtual dipole signal amplification
US8961412B2 (en) 2007-09-25 2015-02-24 Proteus Digital Health, Inc. In-body device with virtual dipole signal amplification
US9125979B2 (en) 2007-10-25 2015-09-08 Proteus Digital Health, Inc. Fluid transfer port information system
US8836345B2 (en) 2007-11-05 2014-09-16 Impedimed Limited Impedance determination
US20110025348A1 (en) * 2007-11-05 2011-02-03 Impedimed Limited Impedance determination
US20090125330A1 (en) * 2007-11-09 2009-05-14 Eric Sebban Non-invasive medical data collecting assembly
US8419638B2 (en) 2007-11-19 2013-04-16 Proteus Digital Health, Inc. Body-associated fluid transport structure evaluation devices
US20090131767A1 (en) * 2007-11-19 2009-05-21 Arne Lawrence W Body-associated fluid transport structure evaluation devices
US8750978B2 (en) * 2007-12-31 2014-06-10 Covidien Lp System and sensor for early detection of shock or perfusion failure and technique for using the same
US20090171237A1 (en) * 2007-12-31 2009-07-02 Nellcor Puritan Bennett Llc System and sensor for early detection of shock or perfusion failure and technique for using the same
US20090287102A1 (en) * 2008-02-15 2009-11-19 Impedimed Limited Blood flow assessment of venous insufficiency
US9392947B2 (en) 2008-02-15 2016-07-19 Impedimed Limited Blood flow assessment of venous insufficiency
US9060708B2 (en) 2008-03-05 2015-06-23 Proteus Digital Health, Inc. Multi-mode communication ingestible event markers and systems, and methods of using the same
US9258035B2 (en) 2008-03-05 2016-02-09 Proteus Digital Health, Inc. Multi-mode communication ingestible event markers and systems, and methods of using the same
US8810409B2 (en) 2008-03-05 2014-08-19 Proteus Digital Health, Inc. Multi-mode communication ingestible event markers and systems, and methods of using the same
US8718752B2 (en) 2008-03-12 2014-05-06 Corventis, Inc. Heart failure decompensation prediction based on cardiac rhythm
US8412317B2 (en) 2008-04-18 2013-04-02 Corventis, Inc. Method and apparatus to measure bioelectric impedance of patient tissue
US9668667B2 (en) 2008-04-18 2017-06-06 Medtronic Monitoring, Inc. Method and apparatus to measure bioelectric impedance of patient tissue
US8568309B2 (en) * 2008-04-22 2013-10-29 EOS Health, Inc. Controlling diabetes with a cellular GPRS-linked glucometer-pedometer
US20120029327A1 (en) * 2008-04-22 2012-02-02 Kimon Angelides Controlling Diabetes with a Cellular GPRS-Linked Glucometer-Pedometer
US20110184257A1 (en) * 2008-06-19 2011-07-28 Herbert Boll Device for determining and/or monitoring the moisture content of the skin
WO2009153093A1 (en) * 2008-06-19 2009-12-23 Robert Bosch Gmbh Device for determining and/or monitoring the moisture content of the skin
US10682071B2 (en) 2008-07-08 2020-06-16 Proteus Digital Health, Inc. State characterization based on multi-variate data fusion techniques
US9603550B2 (en) 2008-07-08 2017-03-28 Proteus Digital Health, Inc. State characterization based on multi-variate data fusion techniques
US11217342B2 (en) 2008-07-08 2022-01-04 Otsuka Pharmaceutical Co., Ltd. Ingestible event marker data framework
US20110009715A1 (en) * 2008-07-08 2011-01-13 David O' Reilly Ingestible event marker data framework
US8721540B2 (en) 2008-08-13 2014-05-13 Proteus Digital Health, Inc. Ingestible circuitry
US20110065983A1 (en) * 2008-08-13 2011-03-17 Hooman Hafezi Ingestible Circuitry
US9415010B2 (en) 2008-08-13 2016-08-16 Proteus Digital Health, Inc. Ingestible circuitry
US8540633B2 (en) 2008-08-13 2013-09-24 Proteus Digital Health, Inc. Identifier circuits for generating unique identifiable indicators and techniques for producing same
US20100298668A1 (en) * 2008-08-13 2010-11-25 Hooman Hafezi Ingestible Circuitry
US20110212782A1 (en) * 2008-10-14 2011-09-01 Andrew Thompson Method and System for Incorporating Physiologic Data in a Gaming Environment
US9615766B2 (en) 2008-11-28 2017-04-11 Impedimed Limited Impedance measurement process
US8583227B2 (en) 2008-12-11 2013-11-12 Proteus Digital Health, Inc. Evaluation of gastrointestinal function using portable electroviscerography systems and methods of using the same
US9883819B2 (en) 2009-01-06 2018-02-06 Proteus Digital Health, Inc. Ingestion-related biofeedback and personalized medical therapy method and system
US8597186B2 (en) 2009-01-06 2013-12-03 Proteus Digital Health, Inc. Pharmaceutical dosages delivery system
US20100234755A1 (en) * 2009-03-11 2010-09-16 Latman Neal S Electrode holder for use on hairy animals such as horses, camels, and the like
US9119918B2 (en) 2009-03-25 2015-09-01 Proteus Digital Health, Inc. Probablistic pharmacokinetic and pharmacodynamic modeling
US8540664B2 (en) 2009-03-25 2013-09-24 Proteus Digital Health, Inc. Probablistic pharmacokinetic and pharmacodynamic modeling
US8545402B2 (en) 2009-04-28 2013-10-01 Proteus Digital Health, Inc. Highly reliable ingestible event markers and methods for using the same
US10588544B2 (en) 2009-04-28 2020-03-17 Proteus Digital Health, Inc. Highly reliable ingestible event markers and methods for using the same
US9320455B2 (en) 2009-04-28 2016-04-26 Proteus Digital Health, Inc. Highly reliable ingestible event markers and methods for using the same
US9149423B2 (en) 2009-05-12 2015-10-06 Proteus Digital Health, Inc. Ingestible event markers comprising an ingestible component
US20120146670A1 (en) * 2009-08-21 2012-06-14 Zdeblick Mark J Apparatus and Method for Measuring Biochemical Parameters
US8558563B2 (en) * 2009-08-21 2013-10-15 Proteus Digital Health, Inc. Apparatus and method for measuring biochemical parameters
US8971936B2 (en) 2009-09-01 2015-03-03 Adidas Ag Multimodal method and system for transmitting information about a subject
US20110130643A1 (en) * 2009-09-01 2011-06-02 Adidas Ag Noninvasive Method And System For Monitoring Physiological Characteristics And Athletic Performance
EP2289404A1 (en) * 2009-09-01 2011-03-02 Adidas AG Multi modal method and system for transmitting information about a subject
US9826903B2 (en) 2009-09-01 2017-11-28 Adidas Ag Multi modal method and system for transmitting information about a subject
US20110105861A1 (en) * 2009-09-01 2011-05-05 Adidas Ag World Of Sports Physiological Monitoring Garment
US20110054289A1 (en) * 2009-09-01 2011-03-03 Adidas AG, World of Sports Physiologic Database And System For Population Modeling And Method of Population Modeling
US9326705B2 (en) 2009-09-01 2016-05-03 Adidas Ag Method and system for monitoring physiological and athletic performance characteristics of a subject
US9801583B2 (en) 2009-09-01 2017-10-31 Adidas Ag Magnetometer based physiological monitoring garment
US20110054271A1 (en) * 2009-09-01 2011-03-03 Adidas Ag Noninvasive Method And System For Monitoring Physiological Characteristics
US20110054290A1 (en) * 2009-09-01 2011-03-03 Adidas AG, World of Sports Method and System for Interpretation and Analysis of Physiological, Performance, and Contextual Information
US9526419B2 (en) 2009-09-01 2016-12-27 Adidas Ag Garment for physiological characteristics monitoring
US8475371B2 (en) 2009-09-01 2013-07-02 Adidas Ag Physiological monitoring garment
US9545222B2 (en) 2009-09-01 2017-01-17 Adidas Ag Garment with noninvasive method and system for monitoring physiological characteristics and athletic performance
US20110054272A1 (en) * 2009-09-01 2011-03-03 Adidas AG, World of Sports Method And System For Monitoring Physiological And Athletic Performance Characteristics Of A Subject
US20110054270A1 (en) * 2009-09-01 2011-03-03 Adidas AG, World of Sports Multimodal Method And System For Transmitting Information About A Subject
WO2011031781A1 (en) * 2009-09-08 2011-03-17 Empire Technology Development Llc Dehydration detector using micro-needles
US20110060202A1 (en) * 2009-09-08 2011-03-10 Seth Adrian Miller Dehydration detector using micro-needles
US8790259B2 (en) 2009-10-22 2014-07-29 Corventis, Inc. Method and apparatus for remote detection and monitoring of functional chronotropic incompetence
US10779737B2 (en) 2009-10-22 2020-09-22 Medtronic Monitoring, Inc. Method and apparatus for remote detection and monitoring of functional chronotropic incompetence
US9615757B2 (en) 2009-10-22 2017-04-11 Medtronic Monitoring, Inc. Method and apparatus for remote detection and monitoring of functional chronotropic incompetence
US9615767B2 (en) 2009-10-26 2017-04-11 Impedimed Limited Fluid level indicator determination
US10305544B2 (en) 2009-11-04 2019-05-28 Proteus Digital Health, Inc. System for supply chain management
US8868453B2 (en) 2009-11-04 2014-10-21 Proteus Digital Health, Inc. System for supply chain management
US9941931B2 (en) 2009-11-04 2018-04-10 Proteus Digital Health, Inc. System for supply chain management
US9585593B2 (en) 2009-11-18 2017-03-07 Chung Shing Fan Signal distribution for patient-electrode measurements
US20110319786A1 (en) * 2009-11-20 2011-12-29 Rebello Keith J Apparatus and Method for Measuring Physiological Functions
US8784308B2 (en) 2009-12-02 2014-07-22 Proteus Digital Health, Inc. Integrated ingestible event marker system with pharmaceutical product
US9451897B2 (en) 2009-12-14 2016-09-27 Medtronic Monitoring, Inc. Body adherent patch with electronics for physiologic monitoring
US9014779B2 (en) 2010-02-01 2015-04-21 Proteus Digital Health, Inc. Data gathering system
US10376218B2 (en) 2010-02-01 2019-08-13 Proteus Digital Health, Inc. Data gathering system
US8332020B2 (en) 2010-02-01 2012-12-11 Proteus Digital Health, Inc. Two-wrist data gathering system
US9008761B2 (en) 2010-02-01 2015-04-14 Proteus Digital Health, Inc. Two-wrist data gathering system
US20130096395A1 (en) * 2010-04-05 2013-04-18 Corventis, Inc. Method and apparatus for personalized physiologic parameters
US9173615B2 (en) * 2010-04-05 2015-11-03 Medtronic Monitoring, Inc. Method and apparatus for personalized physiologic parameters
US8965498B2 (en) 2010-04-05 2015-02-24 Corventis, Inc. Method and apparatus for personalized physiologic parameters
US10207093B2 (en) 2010-04-07 2019-02-19 Proteus Digital Health, Inc. Miniature ingestible device
US9597487B2 (en) 2010-04-07 2017-03-21 Proteus Digital Health, Inc. Miniature ingestible device
US11173290B2 (en) 2010-04-07 2021-11-16 Otsuka Pharmaceutical Co., Ltd. Miniature ingestible device
US20130317367A1 (en) * 2010-05-04 2013-11-28 Michael Simms Shuler Method and system for providing versatile nirs sensors
US11779265B2 (en) 2010-05-08 2023-10-10 Bruin Biometrics, Llc SEM scanner sensing apparatus, system and methodology for early detection of ulcers
US10529044B2 (en) 2010-05-19 2020-01-07 Proteus Digital Health, Inc. Tracking and delivery confirmation of pharmaceutical products
US20130274566A1 (en) * 2010-09-29 2013-10-17 Terumo Kabushiki Kaisha Moisture meter
US9433370B2 (en) * 2010-09-29 2016-09-06 Terumo Kabushiki Kaisha Moisture meter
EP2622344A4 (en) * 2010-09-30 2015-11-25 Hydradx Inc Diagnostic device and method for sensing hydration state of a mammallian subject
US9107806B2 (en) 2010-11-22 2015-08-18 Proteus Digital Health, Inc. Ingestible device with pharmaceutical product
US11504511B2 (en) 2010-11-22 2022-11-22 Otsuka Pharmaceutical Co., Ltd. Ingestible device with pharmaceutical product
CN103648377A (en) * 2011-06-29 2014-03-19 泰尔茂株式会社 Body water content meter and method for controlling display thereof
US9756874B2 (en) 2011-07-11 2017-09-12 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
US11229378B2 (en) 2011-07-11 2022-01-25 Otsuka Pharmaceutical Co., Ltd. Communication system with enhanced partial power source and method of manufacturing same
US10223905B2 (en) 2011-07-21 2019-03-05 Proteus Digital Health, Inc. Mobile device and system for detection and communication of information received from an ingestible device
US9235683B2 (en) 2011-11-09 2016-01-12 Proteus Digital Health, Inc. Apparatus, system, and method for managing adherence to a regimen
TWI584782B (en) * 2012-03-23 2017-06-01 泰爾茂股份有限公司 Internal moisture meter
US9271897B2 (en) 2012-07-23 2016-03-01 Proteus Digital Health, Inc. Techniques for manufacturing ingestible event markers comprising an ingestible component
US9268909B2 (en) 2012-10-18 2016-02-23 Proteus Digital Health, Inc. Apparatus, system, and method to adaptively optimize power dissipation and broadcast power in a power source for a communication device
US9176529B2 (en) * 2012-10-29 2015-11-03 Kabushiki Kaisha Toshiba Electronic device
US20140118931A1 (en) * 2012-10-29 2014-05-01 Kabushiki Kaisha Toshiba Electronic device
US11149123B2 (en) 2013-01-29 2021-10-19 Otsuka Pharmaceutical Co., Ltd. Highly-swellable polymeric films and compositions comprising the same
US20140221792A1 (en) * 2013-02-01 2014-08-07 Devin Warner Miller Hydration Monitoring Apparatus
US11395603B2 (en) * 2013-02-01 2022-07-26 Tula Health, Inc. Hydration monitoring apparatus
US10463273B2 (en) * 2013-02-01 2019-11-05 Halo Wearables, Llc Hydration monitor
US20160073968A1 (en) * 2013-02-19 2016-03-17 Terumo Kabushiki Kaisha Body water meter and terminal
US10251609B2 (en) * 2013-02-19 2019-04-09 Terumo Kabushiki Kaisha Body water meter and terminal
US11744481B2 (en) 2013-03-15 2023-09-05 Otsuka Pharmaceutical Co., Ltd. System, apparatus and methods for data collection and assessing outcomes
US10175376B2 (en) 2013-03-15 2019-01-08 Proteus Digital Health, Inc. Metal detector apparatus, system, and method
US9796576B2 (en) 2013-08-30 2017-10-24 Proteus Digital Health, Inc. Container with electronically controlled interlock
US10421658B2 (en) 2013-08-30 2019-09-24 Proteus Digital Health, Inc. Container with electronically controlled interlock
US10743811B2 (en) * 2013-10-18 2020-08-18 Carepredict, Inc. Fall prediction assessment
US10799173B2 (en) * 2013-10-18 2020-10-13 Carepredict, Inc. Fall prediction assessment
US20150112162A1 (en) * 2013-10-18 2015-04-23 WiseWear Corporation Fall Prediction Assessment
US20150112163A1 (en) * 2013-10-18 2015-04-23 WiseWear Corporation Fall prediction assessment
US10084880B2 (en) 2013-11-04 2018-09-25 Proteus Digital Health, Inc. Social media networking based on physiologic information
US10327639B2 (en) 2013-12-25 2019-06-25 Seiko Epson Corporation Biological information measurement apparatus, information processing apparatus, and biological information measurement system
US10398161B2 (en) 2014-01-21 2019-09-03 Proteus Digital Heal Th, Inc. Masticable ingestible product and communication system therefor
US20150305675A1 (en) * 2014-04-25 2015-10-29 Halo Wearables, Llc Wearable stress-testing device
US10898075B2 (en) * 2014-04-25 2021-01-26 Halo Wearables, Llc Wearable stress-testing device
US11109805B1 (en) 2015-02-17 2021-09-07 Tula Health, Inc. Power management for wearable devices
US10806398B2 (en) 2015-02-17 2020-10-20 Halo Wearables, Llc Power management for wearable devices
US11857337B1 (en) 2015-02-17 2024-01-02 Tula Health, Inc. Power management for wearable devices
US11389140B2 (en) 2015-03-09 2022-07-19 CoreSyte, Inc. Method for manufacturing a biological fluid sensor
US9883827B2 (en) 2015-03-09 2018-02-06 CoreSyte, Inc. System and method for measuring biological fluid biomarkers
US11883011B2 (en) 2015-03-09 2024-01-30 CoreSyte, Inc. Method for manufacturing a biological fluid sensor
US11389087B2 (en) 2015-03-09 2022-07-19 CoreSyte, Inc. Device for measuring biological fluids
US9622725B2 (en) 2015-03-09 2017-04-18 CoreSyte, Inc. Method for manufacturing a biological fluid sensor
US9645133B2 (en) 2015-03-09 2017-05-09 CoreSyte, Inc. Method for manufacturing a biological fluid sensor
US9579024B2 (en) 2015-03-09 2017-02-28 CoreSyte, Inc. System and method for measuring biological fluid biomarkers
US9636061B2 (en) 2015-03-09 2017-05-02 CoreSyte, Inc. System and method for measuring biological fluid biomarkers
WO2016144529A1 (en) * 2015-03-09 2016-09-15 CoreSyte, Inc. Methods for manufacturing biological fluid sensor devices and devices, systems, and methods for measuring biological fluids
US10561405B2 (en) 2015-03-09 2020-02-18 CoreSyte, Inc. Method for manufacturing a biological fluid sensor
US10327676B2 (en) 2015-03-09 2019-06-25 CoreSyte, Inc. Device for measuring biological fluids
US11832929B2 (en) 2015-04-24 2023-12-05 Bruin Biometrics, Llc Apparatus and methods for determining damaged tissue using sub-epidermal moisture measurements
US11534077B2 (en) 2015-04-24 2022-12-27 Bruin Biometrics, Llc Apparatus and methods for determining damaged tissue using sub epidermal moisture measurements
US11529106B1 (en) * 2015-05-22 2022-12-20 Cerner Innovation, Inc. Noninvasive tool for assessing hydration status
US20180103891A1 (en) * 2015-06-24 2018-04-19 Waywearable, Inc. Portable skin condition measuring device, skin condition analyzing method, and program using the same
US11058318B2 (en) * 2015-07-16 2021-07-13 Impedimed Limited Fluid level determination
US11051543B2 (en) 2015-07-21 2021-07-06 Otsuka Pharmaceutical Co. Ltd. Alginate on adhesive bilayer laminate film
US11678812B1 (en) * 2015-08-17 2023-06-20 Board Of Trustees Of The University Of Alabama, For And On Behalf Of The University Of Alabama In Huntsville Systems and methods for monitoring hydration
US11406275B2 (en) * 2015-11-10 2022-08-09 Impedimed Limited Impedance measurement system
US10187121B2 (en) 2016-07-22 2019-01-22 Proteus Digital Health, Inc. Electromagnetic sensing and detection of ingestible event markers
US10797758B2 (en) 2016-07-22 2020-10-06 Proteus Digital Health, Inc. Electromagnetic sensing and detection of ingestible event markers
US11529071B2 (en) 2016-10-26 2022-12-20 Otsuka Pharmaceutical Co., Ltd. Methods for manufacturing capsules with ingestible event markers
US11793419B2 (en) 2016-10-26 2023-10-24 Otsuka Pharmaceutical Co., Ltd. Methods for manufacturing capsules with ingestible event markers
US11627910B2 (en) 2017-02-03 2023-04-18 Bbi Medical Innovations, Llc Measurement of susceptibility to diabetic foot ulcers
US11600939B2 (en) 2018-10-11 2023-03-07 Bruin Biometrics, Llc Device with disposable element
US11824291B2 (en) 2018-10-11 2023-11-21 Bruin Biometrics, Llc Device with disposable element
CN109938729A (en) * 2019-03-29 2019-06-28 常州市第二人民医院 A kind of control water early warning Intelligent foot ring
US11642075B2 (en) 2021-02-03 2023-05-09 Bruin Biometrics, Llc Methods of treating deep and early-stage pressure induced tissue damage

Also Published As

Publication number Publication date
CA2539547A1 (en) 2005-03-03
WO2005018432A2 (en) 2005-03-03
EP1677674A2 (en) 2006-07-12
US20050070778A1 (en) 2005-03-31
US7783344B2 (en) 2010-08-24
EP2382920A1 (en) 2011-11-02
EP1677674A4 (en) 2009-03-25
JP2012143574A (en) 2012-08-02
JP2007502675A (en) 2007-02-15
AU2004266725A1 (en) 2005-03-03
JP5449647B2 (en) 2014-03-19
WO2005018432A3 (en) 2005-05-06
AU2004266725B2 (en) 2011-03-10

Similar Documents

Publication Publication Date Title
US7783344B2 (en) Hydration monitoring
US20060058593A1 (en) Monitoring platform for detection of hypovolemia, hemorrhage and blood loss
US20220015647A1 (en) Apparatus and system for monitoring
JP5801878B2 (en) Electronic health journal
EP1551282B1 (en) Apparatus for detecting, receiving, deriving and displaying human physiological and contextual information
US10448831B2 (en) Wearable sensor
CN101188967A (en) Wireless medical sensor system
CN102281816A (en) Method and apparatus for determining critical care parameters
GB2436721A (en) Automated method for adapting the settings of a patient monitor
JP2006520657A (en) Personal condition physiological monitoring system and structure, and monitoring method
AU2011202767A1 (en) Hydration monitoring
JP2000333918A (en) Method for continuously measuring blood pressure and continuous health control system
AU2020244432A1 (en) Apparatus and system for monitoring
WO2001095802A1 (en) Body activity detection and processing
WO2024015327A1 (en) Assisted mobile ad-hoc network with physical layer adaptation
AU2022291482A1 (en) Apparatus and system for monitoring

Legal Events

Date Code Title Description
AS Assignment

Owner name: PHILOMETRON, INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:DRINAN, DARREL DEAN;EDMAN, CARL FREDERICK;SIGNING DATES FROM 20110303 TO 20110322;REEL/FRAME:026100/0574

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION